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SUMMARY OF THESIS 
This thesis, after a general introduction, is divided into two parts. 
Part I Studies of the Influence of Volatile Anaesthetic Drugs on 
the Blood Flow and Oxygen Uptake of the Cerebral Cortex 
(1) This Part begins with a detailed account of the methodology of the 
techniques used for measuring the blood flow and oxygen uptake of the 
cerebral cortex in the dog including discussion of relevant anaesthetic, 
anatomical and surgical details. 
(2) It is demonstrated that halothane dilates the blood vessels of the 
cerebral cortex, producing increases in cerebral cortical perfusion. The 
intensity of cerebral vasodilatation increases with increasing concentration 
of halothane so that cerebral cortical blood flow is greater with 2% 
halothane than with 0.5. Also with the higher concentration the flow 
increase is maintained for at least one hour while with 0.5% halothane it 
lasts only about 20 minutes. These increases in cerebral cortical blood 
flow with 0.5¡ and 2¡ halothane occur despite the lowering of systemic 
arterial blood pressure produced by these concentrations of halothane. 
However in the case of 2 halothane, the increase in cerebral cortical blood 
flow is greater when the mean arterial pressure is above 90 mm.Hg. With 
the highest halothane concentration studied (4) the fall in blood pressure 
is such that flow is not above control (nitrous oxide -oxygen) levels. By 
administering a vasopressor drug the underlying vasodilatation produced by 
4 halothane is revealed. Finally it is demonstrated that blood flow over 
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the cortical surface is uniform within the reproducibility of the method, 
during anaesthesia with 0.5% and 2% halothane. 
Halothane depresses the oxygen uptake of the cerebral cortex and the 
amount of the depression is greater with 2% than with 0.5¡ halothane. The 
E.E.G. patterns pre.5ent at the times of these changes in cerebral metabolic 
activity are illustrated. 
As a result of the changes in the blood flow and oxygen uptake of the 
cerebral cortex, the oxygen saturation of cerebral venous blood rises and 
the arterio- venous differences across the cerebral cortex for oxygen, carbon 
dioxide and hydrogen ion concentration are narrowed. The consequent 
changes in mean tissue oxygen and carbon dioxide tensions are calculated. 
(3) It is shown that trichloroethylene, in concentrations of less than l%. 
increases blood flow through the cerebral cortex in the first 20 minutes of 
its administration but that thereafter flow tends to return to control 
values. 
These concentrations of trichloroethylene reduce the oxygen uptake of 
the cerebral cortex by approximately the same amount as does 0.5% halothane. 
As with halothane, trichloroethylene increases venous and tissue 
oxygen tensions, especially in the first 20 minutes of its administration. 
(4) The findings with l% chloroform are similar to those with halothane, 
cerebral cortical blood flow increasing despite a fall in mean blood 
pressure. The depression noted in oxygen uptake with this drug does not 
however reach statistical significance. 
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(5) Finally in Part I, it is shown that cerebrovascular sensitivity to 
alterations in Paco2 is fully maintained during anaesthesia with these 
drugs provided that due allowance is made for the concomitant fall in mean 
blood pressure. 
(6) At the conclusion of each of the above sections, the relevant 
literature is fully reviewed and previous findings compared with the present 
results. 
(7) Part I of the thesis concludes with an extended discussion of the 
possible mechanisms by which the observed changes may be produced. The 
most likely explanation would appear to be that these anaesthetic drugs 
relax by a "direct" action the normal tone of the cerebral arterioles and 
it is postulated that they do this by inhibiting the enzymatic reaction 
responsible for the generation of energy for vascular smooth muscle tone. 
The interrelationships between the actions of these drugs and the 
effects of alterations in blood pressure and in arterial Pco2 are considered. 
From the clinical point of view, these findings are used to describe 
the sequence of changes in cerebral blood flow and metabolism which occur 
with commonly employed anaesthetic techniques. The possible use of volatile 
anaesthetic agents to increase the tolerance of the brain to temporary 
regional or total ischaemia is then discussed in relation to the common clini al 
problems of induced hypotension, cerebral arteriosclerosis and deliberate 
circulatory arrest. It is concluded from this that the demonstrated 
depression of cerebral oxygen requirements, especially with deep anaesthesia, 
may render partial protection to the brain during ischaemia and an attempt 
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is made to make a quantitative prediction of the possible extension of the 
period of safe circulatory arrest by this means. 
Part II Studies of the Influence of Volatile Anaesthetic Drugs on 
Cerebrospinal Fluid and Cerebral Venous Pressures 
(1) The methodology of cerebrospinal fluid, cerebral venous and central 
venous pressure measurements in dogs is first critically discussed. 
Cerebral venous pressure is measured in the superior sagittal sinus and c.s.f. 
pressure in the cisterna magna. Ventilation is controlled to maintain a 
constant Paco 
(2) It is demonstrated that halothane and chloroform increase cerebrospinal 
fluid pressure and that, in the case of halothane, the extent of the increase 
in c.s.f. pressure is greater with 2% than with 0.5% inspired concentration. 
It is also noted that the changes in c.s.f. pressure with halothane are not 
maintained with time but reach a peak value in from 3 -9 minutes and then 
begin to fall towards the initial control value. Edith halothane 
administration, c.s.f. and cerebral venous pressures both increase together 
and to the same degree. Significant changes in central venous pressure do 
not occur. 
(3) In some of the experiments of Part I, cerebral venous pressure in the 
superior sagittal sinus was measured and the results are displayed and 
discussed at this point. It is observed that halothane, chloroform and 
trichloroethylene in the first 20 minutes of its administration increase 
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cerebral venous pressure and that the changes in cerebral venous pressure 
are closely correlated with increases in measured cerebral cortical blood 
flow. 
(4) A clinical study of lumbar c.s.f. pressure changes in patients 
anaesthetised for surgical treatment of lumbar disc protrusions follows. 
It is demonstrated that halothane and trichloroethylene increase c.s.f. 
pressure despite careful maintenance of a constant Paco2. The observed 
changes are not the result of changes in central venous pressure. The 
extent of the c.s.f. pressure rise is greater with 1% than with 0.5% 
halothane but, at the same halothane concentration, the increase is smaller 
in patients who are first hyperventilated. There appears to be no 
important difference between the extent of the c.s.f. pressure increase with 
0.9% trichloroethylene as compared with 0.5q halothane. 
(5) These findings are discussed and related to the previous literature on 
this subject. It is argued that the most likely explanation of the changes 
observed is that the increases in cerebral blood flow seen in Part I result 
in increases in the pressure within the superior sagittal sinus because 
this vessel has relatively rigid walls and therefore a low compliance. 
This pressure rise is transmitted back to the thin walled cerebral veins 
which thereby become more distended. The blood volume on the venous side 
of the cerebral circulation therefore increases and because of the low 
compliance of the intracranial theca, pressure rises within the skull and 
throughout the c.s.f. space. In this way the findings of the two Parts 
of the thesis become mutually corroborative. 
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(6) Finally intraventricular c.s.f. pressure is measured in 4 patients 
undergoing surgical treatment of intracranial tumours and it is shown that 
considerably greater increases in cerebrospinal fluid pressure occur in 
this group as compared with patients without intracranial space occupying 
lesions. 
(7) It is pointed out that this finding could be clinically important if 
differentials of pressure are established within the central nervous 
system or if the perfusion pressure of the brain (mean arterial - mean 
intracranial pressure) falls below the critical level required to sustain 
adequate cerebral perfusion. It is calculated that during halothane 
administration in these patients with cerebral tumours, cerebral perfusion 
pressure is lowered to a level at which others have demonstrated reductions 
in cerebral blood flow. While not necessarily damaging in itself, this 
situation is one in which the normal reserves of cerebrovascular 
compensation are exhausted and cerebral ischaemia may occur at a level of 
blood pressure which would not normally be considered inadequate. It is 
demonstrated in one patient that prior hyperventilation avoids this 
potentially hazardous position. 
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INTRODUCTION 
"It is then useful to study it (General Anaesthesia) not only from the point 
of view of surgical operations but by itself and for its own sake.... 
only thus could we safely, and with a clear conscience, apply it to man." 
Magendie, F. (1847). C.R. Acad. Sci. Paris. 24,137. 
This thesis was planned in 1963 and the work for it began then. At 
that time there was virtually no knowledge of the action of commonly used 
volatile anaesthetic drugs on either cerebral circulation or cerebral 
metabolism. The position at that period is best illustrated by quoting 
from the authoritative and exhaustive review by Sokoloff (1963) on the 
effects of anaesthetic agents on cerebral blood flow: - 
"Although the barbiturates are hardly representative, it is likely that most 
general anaesthetic agents have similar effects on the cerebral circulation 
and metabolism. All reduce cerebral metabolic rate in anaesthetizing 
doses. With the possible exception of ether, which appears to have specific 
vasodilator properties, there is little evidence that any of them exert any 
greater direct action on the cerebral circulation than the barbiturates. 
Any influence they may have is also probably chiefly secondary to their 
effects on blood pressure, cerebral metabolic rate and the respiratory gas 
tensions in the blood." 
It is clear from this account that experimental evidence on the effects 
of all the commonly employed anaesthetic drugs, except the barbiturates and 
ether, was scarce. In fact even this cautious summary slightly overstretche. 
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the evidence when it states that "all (anaesthetics) reduce cerebral 
metabolic rate" for this had only been established for the barbiturates and, 
on the basis of one unpublished account, for ether. 
More investigative work had been done on the changes produced by 
anaesthetic drugs on cerebrospinal fluid pressures but the results of these 
studies, which will of course be reviewed in detail subsequently, were 
contradictory in the extreme. On the one hand, it was said that anaesthetic 
drugs had no important effects on cerebrospinal fluid pressure provided they 
were administered skilfully (Stephen, Woodhall, Golden, Martin and Nowill, 
1954), while on the other Woringer, Brogly and Dorgler (1954) considered 
that all volatile anaesthetic drugs elevated cerebrospinal fluid pressure. 
In 1960, Small, Weitzner and Nahas concluded that clinically undetected 
hypercapnia was the cause of the c.s.f. pressure increases sometimes 
reported to occur after administration of various anaesthetics. 
It therefore appeared necessary to attempt to add to the available 
evidence on the effects of volatile anaesthetic drugs on cerebral blood 
flow, cerebral metabolism and cerebrospinal fluid pressure. It also seemed 
important to. investigate this subject for practical reasons. The clinical 
questions which this thesis set out to answer were:- 
(See Overpage 
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(1) is cerebral perfusion adequate to avoid cerebral hypoxia during 
anaesthesia with these drugs? If cerebral blood flow is adequate, does it 
remain so when hypotension accompanies anaesthetic administration? Does 
the cerebral circulation respond to hypocapnia during anaesthesia with these 
drugs? (The last question appeared important in relation to the clinical 
use of hyperventilation techniques in neurosurgical anaesthesia.) 
(2) is the aerobic metabolism of the brain depressed by volatile anaestheti 
drugs and, if so, by how much? If depression of cerebral oxygen requirements 
occurs, is it of a degree which could influence cerebral neuronal survival 
during periods of cerebral ischaemia? Do different volatile anaesthetics 
produce similar degrees of cerebral metabolic depression and is the degree 
of any depression which occurs related to the concentration of the 
anaesthetic administered? 
(3) how does administration of these drugs affect operating conditions for 
neurosurgery? Is the brain rendered more vascular and is the intracranial 
pressure increased so that brain herniation may occur? If the intracranial 
pressure does increase with these drugs, does it help to hyperventilate the 
patient? Under what circumstances is it safe to administer volatile 
anaesthetic drugs to patients with intracranial tumours? 
In order to answer these questions, it was obviously necessary to 
measure cerebral blood flow, cerebral oxygen consumption and intracranial 
or cerebrospinal fluid pressures. In order to measure cerebral blood flow 
and to derive cerebral oxygen consumption, measurements of radioactive 
gas clearance from the cerebral cortex were made by a technique to which I 
was introduced by Dr. A. Murray Harper. For the measurements of intracrani=l 
and cerebrospinal fluid pressures, I was most fortunate in obtaining the 
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interest and cooperation of Mr. W. Bryan Jennett and Dr. John Barker. 
planning and direction of all this work was of course my own as was the 
collection and processing of all the data presented in this thesis. 
Since as indicated above, this work was closely connected with important 
clinical problems, some of the studies have been published in order to make 
the information quickly and readily available to clinicians. Reprints of 
these publications are attached. In this thesis, all the studies which I 
have carried out in the past 4 years in this field are presented in detail 
and are considered with reference to one another. The thesis is divided 
into two Parts: - 
Part I consists of a full account of the blood flow and oxygen uptake of the 
cerebral cortex during anaesthesia with halothane, trichioroethylene and 
chloroform. 
Part II deals with the changes in intracranial and cerebrospinal fluid 
pressure produced by these three drugs. 
The thesis particularly discusses three clinical aspects of these 
investigations. Firstly a quantitative assessment is made of the oxygenation 
of the brain during anaesthesia in terms of cerebral venous and cerebral 
tissue oxygen tensions. Secondly the relationship of the findings to 
clinical situations of general and local cerebral ischaemia is explored and 
finally the question of the safety of anaesthetic administration to patients 
with intracranial tumours is discussed. 
(Tables referred to in Text with prefix App. before the table number will be 
found in the Appendix which starts on p. 232). 
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AUTHOR' S WORK 
PART I 
Studies of the Influence of Volatile Anaesthetic Drugs 
on the Blood Flow and Oxygen Uptake of the Cerebral Cortex 
1V 
CHAPTER 1 
General Description of the Methodology of Blood Flow 
and Oxygen Uptake Measurement 
The studies were carried out on unpremedicated, unselected mongrel 
dogs. Anaesthesia was induced with a sleep dose of thiopentone just 
sufficient to produce unconsciousness and a cuffed endotracheal tube was 
inserted. Muscular paralysis was obtained with suxamethonium chloride and 
ventilation was controlled with nitrous oxide- oxygen using a constant 
volume ventilator. Either one or two additional supplements of 
thiopentone of 50 -100 mgs. were given during the surgical preparation to 
ensure that anaesthesia was adequate. 
The femoral artery was cannulated to allow sampling of arterial blood 
and measurement of mean arterial blood pressure. The femoral vein was 
also cannulated for the administration of increments of suxamethonium as 
required to maintain control of ventilation. A cannula was placed in 
either the superior thyroid or the lingual branch of the common carotid 
artery so that its tip lay just at the entrance of this branch into the 
main artery. Through this cannula, krypton 85, dissolved in saline, was 
injected for the flow measurements. 
The skin and subcutaneous tissues of the scalp were reflected and 
the temporalis muscle on one side of the skull was removed. A trephine 
hole was made and the dura reflected to expose an area of parietal cortex. 
This was covered with a thin plastic membrane (6 u polyethylene 
teraphthalate - "Melinex I.C.I.) to prevent dessication of the brain 
surface. In some animals the superior sagittal sinus was exposed and was 
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cannulated to allow sampling of cerebral venous blood. In those 
animals in which the sinus was cannulated the bone overlying the sinus 
was removed as far anteriorly as the frontal air sinuses in order to sever 
as many emissary veins as possible. 
A Geiger Muller tube was mounted 2 -5 mms. above the membrane 
covering the exposed area of cortex and the surrounding brain and bone 
shielded from the counting field by lead foil. The Geiger Muller tube 
was attached to a ratemeter and linear direct writing recorder. 
To measure flow, krypton 85, dissolved in saline, was injected at a 
rate just sufficient to maintain a constant level of radioactivity in the 
monitored area of cortex for 2 -3 minutes. During this time equilibrium 
was reached between arterial and cerebral tissue tensions of krypton in 
even the most slowly perfused areas of the cortex. At the end of this 
equilibration period, the injection was suddenly stopped and the rate of 
clearance of the radioactive krypton recorded. The linear record was 
subsequently plotted on semilogarithmic graph paper, of which the y axis 
was logarithmic and the x axis was linear. Radioactivity in arbitrary 
units was plotted on the y axis and time in seconds on the x axis. The 
best straight line fit to the initial slope of this clearance plot was 
drawn and the time to half clearance in seconds measured from this. Mean 
cortical blood flow was then calculated by substituting this value for Ti 
in the following equation:- Flow (ml /G /min) = loge2 x 60 
(Lassen & Ingvar; 1961) Ti 
The values used for the blood -brain partition coefficient (X ) were 
obtained from the work of Glass & Harper (1962). The particular value 
used depended on the arterial blood haematocrit existing at the time of 
the flow measurement. 
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A number of measurements of flow were made during unsupplemented 
nitrous oxide - oxygen anaesthesia and then the volatile drug under study 
(halothane, trichloroethylene or chloroform) was introduced into the same 
nitrous oxide - oxygen mixture from a calibrated vaporiser and further 
measurements of flow carried out. 
During each flow measurement arterial blood was sampled for measurement 
of arterial pH, Pco2 and oxygen saturation. In many animals cerebral 
venous bLood from the superior sagittal sinus was also obtained and 
analysed for pH, Pco2 and oxygen saturation. Arterial Pco2 was maintained 
constant by adjusting the stroke volume of the ventilator when necessary. 
The oxygen uptake of the cerebral cortex was calculated as the 
product of the measured cortical blood flow and the arterio- venous oxygen 
content difference across the cerebral cortex. 
Cerebrovascular resistance (C.V.R.) was calculated as the ratio of 
cerebral cortical blood flow to mean arterial blood pressure and expressed, 
as is customary, in arbitory units. Since cerebrovascular resistence is 
really an expression of the relationship between flow and perfusion 
pressure, cerebral venous pressure should theoretically be subtracted from 
the mean arterial pressure in calculating this ratio. However the values 
obtained for cerebral venous pressure were so low (approximately 4 mm.Hg. - 
see Part II) in relation to the values for the arterial blood pressure that 
it was decided not to include cerebral venous pressure in these calculations. 
It was felt that this was a reasonable decision since the error involved was 
almost certainly less than that involved in assessing the arterial perfusion 
pressure of the brain from measurements of aortic blood pressure. 
The above was the standard protocol of the experiments but many 
variations were made to elucidate particular points and these will be 
described as they arise. 
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CHAPTER 2 
Detailed Discussion of Methodology 
(a) Anaesthetic Technique 
Thiopentone in a 5% solution was used for the induction of anaesthesia. 
The dose used was carefully adjusted to be just sufficient to produce 
sleep; this averaged 20 mgs. /kg. This is considerably in excess of the 
dosage required to produce sleep in man but is in agreement with the 
figures given in the veterinary anaesthetic literature (Westhues & Fritsch, 
1965; Hall, 1966). 
In addition to the fact that higher dosage is required, the dog 
metabolises thiopentone at a considerably slower rate than does man. 
Brodie, Mark, Papper, Lief, Bernstein & Rovenstine (1950) have shown that 
man reduces the level of thiopentone in his plasma by 15% per hour but that 
the dog lowers his plasma thiopentone concentration by only 50% in 24 hours. 
However these authors also showed that, after a normal anaesthetic dose of 
thiopentone, there is an initial very rapid drop in plasma concentration of 
thiopentone in both dog and man which is due, not to metabolic breakdown, 
but to redistribution of the drug away from organs such as the brain and 
towards neutral fat stores. It is this initial redistribution which 
accounts for the rapid recovery of consciousness after thiopentone 
administration in normal dosage. It was on account of this rapid 
redistribution within the first 5 -30 minutes after administration that it 
was deemed necessary to give one and occasionally two supplements of 
thiopentone during the performance of necessary surgery. Usually one 
RESIDUAL THIOPENTONE 
1 hour later 
Figure 1 The lessening of thiopentone depression of the E.E.G. The 
lower record was obtained 1 hour after the upper and shows the E.E.G. 
activity present at the time of control flow measurements. 
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supplementary dose was given 30 minutes after induction, and the surgery 
was completed (except for reflection of the dura) in 1 -li hours after 
induction. If, in any particular animal, the surgery was progressing 
slowly, a second supplement was given one hour after induction. After the 
final completion of the preparation which, including reflexion of the dura, 
would be about 2 hours after the start, a pause of one hour was made to 
allow the brain level of thiopentone to fall to very low levels and to 
allow the brain surface to stabilise after the surgical interference. In 
many of the animals, the E.E.G. was recorded and it was always found that, 
employing this dose -time schedule, only minimal barbiturate activity 
remained in the E.E.G. at the time of the first flow measurement. Figure 1 
consists of two E.E.G. records obtained from one animal, the lower being 
recorded one hour after the upper. The upper record, taken approximately 
1 hour after the induction of anaesthesia with 30 mgs. /kg. thiopentone and 
during nitrous oxide- oxygen anaesthesia, shows delta activity with some 
superimposed fast activity in the beta range. One hour later the record 
is devoid of delta waves though barbiturate fast activity is still evident. 
This latter type of barbiturate effect is equivalent to barbiturate 
sedation and not anaesthesia (anaesthesia in these animals being maintained 
with nitrous oxide) and this degree of barbiturate depression would not be 
sufficient to affect cerebral blood flow or metabolism itself though it may 
have potentiated the effect of nitrous oxide (see below). The control 
measurements of flow in the experiments to be described were obtained when 
the E.E.G. resembled the lower one in Fig. 1. (Nitrous oxide itself has 
little effect on the E.E.G.; Clutton- Brock, 1961) 
The relatively slow metabolic breakdown of thiopentone in the dog was 
an advantage because it meant that any residual effect on the brain after 
16. 





- 35 mins. 0.76 36 120 1.58 
- 15 mins. 0.72 37 120 1.67 
Zero I.V. 12.5 mgs. /kg. Thiopentone 
+ 20 mins. 0.55 40 105 1.91 
+ 1 hr. 0.58 37 110 1.90 
+ 1 hr. 15 mins. 0.49 38 105 2.14 
+ 1 hr. 35 mins. 0.72 35 105 1.46 
+ 2 hr. 15 mins. 0.78 37 110 1.41 
Table 1 The effect on cerebral cortical blood flow and 
cerebrovascular resistance of I.V. thiopentone (12.5 mgs. /kg.) 
in one dog (6/8/64). 
(Blood flow in mis. /G. /min; Paco2 in mm.Hg; 
Blood pressure in mm.Hg. and cerebrovascular 
resistance (C.V.R.) in arbitory units) 
the initial rapid fall in thiopentone concentration would remain fairly 
constant throughout the time occupied by these experiments. 
These points are, of course, important to this study because 
thiopentone is known to have profound effects on cerebral blood flow and 
metabolism. The evidence in favour of a reduction in cerebral metabolic 
rate by anaesthetic doses of this drug is overwhelming (Schmidt, Kety & 
Penner, 1945; Homburger, Himwich, Etsten, York, Maresca & Himwich, 1946; 
Geiger & Magnes, 1947; Himwich, Homburger, Maresca & Himwich, 1947; 
Wechsler, Dripps & Kety, 1951; McCall & Taylor, 1952; Pazekas & Bessman, 
1953; Schieve & Wilson, 1953; Wilson, Odom & Schieve, 1953; Gleichmann, 
Ingvar, Lassen, Lubbers, Siesjo & Thews, 1962; Pierce, Lambertsen, Deutsch, 
Chase, Linde, Dripps & Price, 1962) and recent studies in which arterial 
Pco2 has been controlled have shown that this depression of metabolic rate 
is accompanied by a proportionate reduction in cerebral blood flow. 
(Landau, Freygang, Rowland, Sokoloff & Kety, 1955; Gleichmann et al, 1962; 
Pierce et al, 1962) 
In order to determine the effect of thiopentone on cerebral cortical 
blood flow as measured in these experiments repeated blood flow measure- 
ments were made in one animal under nitrous oxide -oxygen anaesthesia before 
and after one intravenous injection of 12.5 mgs. /kg. thiopentone. The 
results are given in Table 1 from which it will be seen that blood flow 
fell by about 25';'.; immediately after thiopentone injection and returned to 
control values in approximately l hours. The blood pressure fell 
slightly with the thiopentone injection. The reduction in blood flow was 
however not due to this reduced perfusion pressure since cerebrovascular 
resistance increased indicating active cerebral vasoconstriction 
following thiopentone. 
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The amount of the reduction in cerebral metabolic rate for oxygen 
(C.M.R.o2) and in cerebral blood flow (C.B.F.) is proportional to the 
dosage of thiopentone administered (or more correctly to the depth of 
anaesthesia) (Homburger et a1, 1946). Gleichmann et al.(1962) have shown 
that a close correlation exists between C.B.F., C.M.R.o2 and E.E.G. 
frequency under barbiturate anaesthesia. Furthermore, Landau et al.(1955) 
have demonstrated that not only is flow reduced by thiopentone but that the 
PATTERN of flow over the cerebral cortex is altered in that those areas 
which have the highest flow during consciousness (sensorimotor, visual and 
auditory cortex) show the greatest reductions during light thiopentone 
anaesthesia. Flow therefore becomes more uniform over the cerebral cortex 
during barbiturate anaesthesia than during consciousness. This can be 
correlated with Roth's demonstration (1963) that thiopentone, immediately 
after administration, is distributed throughout the brain in accordance 
with the rate of local blood flow existing at the moment of barbiturate 
injection so that areas with the highest flows receive and take up the 
; greatest thiopentone concentrations. 
From the above, it is clear that it was essential in these studies to 
' allow sufficient time for the brain concentration of thiopentone to fall 
below the level which produces anaesthesia and the accompanying alterations 
in cerebral blood flow. The evidence for believing that this condition 
was satisfied is as follows: - 
(1) the time -dose schedule was such that the animal would have recovered 
consciousness long before the first flow measurement was made had 
anaesthesia not been maintained with nitrous oxide -oxygen. To be certain 
on this point, a 13.5 kgs. dog was anaesthetised with 30 mgs. /kg. 
thiopentone, allowed to breath air spontaneously for 30 minutes, then given 
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a supplementary dose of 100 mgs. thiopentone (which was the maximum 
supplement used in the experiments discussed in this thesis). 1 hour 
after induction of anaesthesia, the eyelash reflex had returned. At 
1 hours, the dog's eyes were open and he cocked his ears in response to 
I 
auditory stimuli. At 2 hours he was lifting his head to look round and 
at 24 hours was walking, though still ataxic; 
(2) in all animals in which the E.E.G. was monitored, the pattern was 
devoid of slow wave activity by the time of the first flow measurement. 
Delta and theta activity due to residual thiopentone were,of course, seen 
during the earlier stages of preparing the animal (see Figure 1). 
(3) there was no tendency for the values for flow to increase during the 
control period of measurement under unsupplemented nitrous oxide -oxygen 
anaesthesia which would have occurred if the animal were still recovering 
from thiopentone at this time. 
It is none the less certain that detectable thiopentone would still be 
present in the blood of these animals throughout these experiments though 
the concentration would be below the level required for anaesthesia. 
Since it has been shown that below anaesthetic dosage thiopentone has no 
influence on cerebral blood flow or metabolism (Kety, Woodford, Harmel, 
Freygang, Appel & Schmidt, 1948), the residual thiopentone could not by 
itself affect the results obtained. However, it cannot be denied that 
some potentiation of the action of both nitrous oxide and of the volatile 
agents may have been produced by the low concentrations of thiopentone 
still circulating and indeed evidence will be presented subsequently which 
showsthat this was the case. Fortunately, due to the slow metabolic 
breakdown of thiopentone in the dog, this factor would be reasonably 
constant throughout these experiments. 
The only other drugs used constantly in these experiments were 
20. 
suxamethonium chloride and nitrous oxide. 
The influence of suxamethonium chloride on cerebral blood flow is 
unknown though it has been shown that this relaxant drug elevates cerebro- 
spinal fluid pressure (Halldin & Wahlin, 1959). It is not clear from the 
literature whether these increases in c.s.f. pressure are the result of 
changes in central venous pressure consequent upon chest wall muscle 
fasciculations or are due to increases in cerebral blood flow. Halldin & 
Wahlin (1959) concluded that the latter was the correct explanation and 
therefore it was deemed wise to avoid administration of suxamethonium 
immediately before or during measurement of cerebral blood flow. 
In all this work it was necessary that the animals be anaesthetised 
and for this purpose nitrous oxide and oxygen in the ratio of at least 2:1 
were administered throughout these studies. It was therefore not possible 
to elucidate the effects of nitrous oxide itself on C.B.F. and C.M.R.o2. 
The possibility of making control measurements under nitrous oxide and then 
administering the volatile agent in oxygen enriched air was considered and 
in fact a group of experiments was performed in this way. This technique 
was abandoned however because it involved the alteration of two variables 
between the control and study measurements. In all the experiments 
reported here the volatile agent under study was added to the same nitrous 
oxide -oxygen mixture as had been used for the control measurements so 
that any influence exerted by nitrous oxide would be constant. Wollman, 
Alexander, Cohen, Smith, Chase & Molen (1965) have shown that in man 
anaesthetised with nitrous oxide total cerebral blood flow is very close to 
that in conscious man but that cerebral metabolic rate is depressed by 
about 237. It may be therefore that the values given here for C.M.R.o2 
are lower than in the conscious dog but any such depression must have been 
21. 
DATE OF EXPERIMENT FRONTAL CORTEX PARIETAL CORTEX 
6/8/64 1.08 0.93 





28/12/64 0.72 0.93 
0.79 0.82 
Means 0.96 10.15 0.92 ±0.09 
Table 2. Blood flow in different areas of cerebral cortex under 
constant conditions during nitrous oxide - oxygen anaesthesia. 
(Blood flow in mis. /G. /min.) 
equal in control and study measurements. 
More urgent questions in the present discussion are however 
(1) what was the relationship between the flow measured in the area of 
parietal cortex studied to flow in other areas of the cortex, and 
(2) was the flow in the monitored area constant under unchanged nitrous 
oxide- oxygen anaesthesia? 
A comparison of flow through different areas of cortex under nitrous 
oxide -oxygen anaesthesia was made in four dogs and the results are shown 
in Table 2. Because of limitations in available equipment, flow measure- 
ments in different areas could not be made simultaneously; they were 
however made as close to one another as possible, i.e. between five and ten 
minutes apart, this being the time required to establish the clearance 
various parts of 
curve of the preceding flow. The measurements were made over the supra- 
lateral surface of the frontal and of the parietal cortex. In each case 
the area measured from had a diameter of approximately 1 cm. 
It will be seen from Table 2 that with only one exception (the first 
pair of flows on 28/12/64) there was excellent correlation between flow in 
the different areas. In considering these results it is necessary to bear 
in mind that this method of flow measurement has a 10% coefficient of 
variation for multiple measurements in any one area under constant conditions 
(Harper, Glass & Glover, 1961). Furthermore Betz (1967) has shown that 
spontaneous fluctuations in cerebral blood flow of up to 25% occur 
frequently. It can therefore be concluded that there is no systematic 
difference in flow between these different areasof cerebral cortex. This 
point is further verified by the close agreement of the two mean values for 
frontal and parietal flows. Harper et al. (1961), using the same method, 








































































































































































































































































































































































































































































































































































































































































































between different areas of cortex under nitrous oxide -oxygen anaesthesia. 
This subject of flow variation between areas of cerebral cortex will arise 
again in connection with the study of halothane anaesthesia. 
Was the flow in the single monitored area of cortex constant under 
unchanged nitrous oxide -oxygen anaesthesia? As already stated, Betz (1967) 
has shown that spontaneous fluctuations in regional cerebral blood flow do 
occur under apparently constant conditions. Such spontaneous changes last 
up to 2 minutes and so could introduce variability in individual flow 
determinations in the present experiments. Such fluctuations apparently 
occur randomly and therefore would not affect the conclusions of the 
present thesis which are based on comparisons between the means of multiple 
measurements. The question which is more vital to the present work is 
whether there was any progressive trend either upwards or downwards in 
regional cerebral blood flow with time during these experiments. Such 
time dependent trends would if present complicate the interpretation of 
the studies of the volatile anaesthetic drugs. 
Four animals were studied during continuous nitrous oxide- oxygen 
anaesthesia at constant arterial Pco2 within the eucapnic range and 
repeated blood flow estimations were performed. The results are given in 
Table 3 from which it is apparent that there is no evidence of any time 
dependent flow trend except that there is a suggestion that in the first 
hour after opening the dura, cerebral blood flow was greater than in the 
second or subsequent hours. This rapid flow after reflection of the dura 
probably resulted from slight mechanical irritation of the cortical surface 
during the exposure. This early vasodilatation did not influence any of 
the results to be reported since no flow determinations were made during 








30/4/63 -1.0 cms.H 
2 
0 170 mm.Rg. 
20/6/63 0 " " 145 " " 
20/12/63 +4.0 " " 160 " " 
30/12/63 +3.2 " " 150 " " 
19/2/64 +1.8 " " 165 " " 
25/3/64 +3.4 " " 15o " 
26/2/65 o " " 15o " " 
17/3/65 +1.0 " " 15o " " 
16/8/65 +2.2 " " 145 " " 
17/12/65 +3.5 it " 160 " " 
Means +1.8 -1.7 155 19 
Table 4. Mean central venous pressure and mean arterial blood 
pressure during controlled ventilation with the Starling 
ventilator in dogs anaesthetised with nitrous oxide -oxygen. 
¿b. 
cerebral blood flow during prolonged nitrous oxide -oxygen anaesthesia. 
The last question to be considered in connection with anaesthetic 
technique is that relating to the use of prolonged positive pressure 
ventilation. Firstly, did this mechanically elevate venous pressure and 
so influence the flow determinations and, secondly, did it result in 
progressive deterioration in respiratory gas exchange? 
The ventilator used throughout was the Starling respiratory pump which 
is a constant volume, time cycled ventilator. The ratio of inspiratory to 
expiratory/ 
time is fixed at 1 : 1 and the respiratory rate used was 24 /minute. In 
order to determine the influence of this ventilatatory pattern on the 
haemodynamics of the dog, a number of measurements of central venous pressure 
were made following 3 - 5 hours of nitrous oxide- oxygen anaesthesia and 
controlled ventilation. The results are given in Table 4, from which it 
will be seen that in most instances the mean intrathoracic venous pressure 
was rendered positive with respect to atmospheric pressure by this technique 
of intermittent positive pressure ventilation ( I.P.P.V.). However the 
absolute values for central venous pressure were well below those necessary 
to affect cerebral cortical blood flow as determined by Jacobson, Harper 
& McDowall (1963). From Table 4 it can also be seen that this technique of 
I.P.P.V. did not produce arterial hypotension. 
As regards possible deterioration of respiratory gas exchange, this 
could affect flow via alterations in arterial carbon dioxide and oxygen 
tensions. In these studies such alterations in blood gas tensions did not 
occur because Paco2 and Pao2 were measured with each flow measurement and 
necessary adjustments in the tidal volume and inspired oxygen content 
were made. 
However impaired lung function in the form of increased pulmonary venous 
27. 
admixture could also influence the results by increasing the recirculation 
(See Technique of Flow Measurement p. 33) 
of the isotope. / Such increases in venous admixture have been shown to 
occur during prolonged anaesthesia in the dog by Finley, Lenfant, Haab, 
Piiper & Rahn (1960) and by McDowall (1964). No attempt was made in the 
present study to quantitate venous admixture but at the end of the 
experiment a large dose of krypton was administered intravenously and the 
beta emisJions from the cortex were counted. In this way it was possible 
to determine the efficiency of lung clearance of the isotope and hence the 
danger of increased arterial recirculation. A significant beta count from 
the cortex after intravenous injection was obtained in only two animals and 
these animals were therefore excluded; in all other experiments significant 
increases in isotope recirculation following prolonged anaesthesia did not 
occur. 
28. 
(b) The Surgical Preparation 
The cannulation of the femoral vessels and the carotid artery have 
already been described. 
The trephine used for removing the segment of skull over the area of 
flow measurements was of 2.5 cros. diameter. After the bone segment had 
been detached, bleeding from the bone edges was stopped with bone wax. 
The dura was then opened in a cruciate fashion. Large durai arteries were 
divided and ligated. Diathermy was not used to coagulate durai vessels 
lest the underlying cortical surface be damaged. The opening in the dura 
was usually of a diameter of 2 cros. 
Immediately the brain was exposed, it was covered with a 6 u layer of 
polyethylene teraphthalate ( "Melinex" I.C.I.). Great care had to be 
taken in laying the membrane on the brain to avoid trapping air bubbles. 
Even the smallest air bubble under the membrane resulted in fallacious 
underestimates of flow because krypton quickly entered the trapped air from 
the blood and was only slowly cleared (because of its high gas -blood 
partition coefficient). 
The purposes served by the "Melinex" membrane were (1) to reduce heat 
loss from the cerebral cortex, (2) to limit diffusion of CO2 from the 
brain into the atmosphere and (3) to limit diffusion of krypton from the 
brain. Because of its high blood flow, exposed cerebral cortex is close 
to blood temperature except for the most superficial layer. By covering 
this surface layer with a membrane and thereby trapping a layer of c.s.f. 
it is believed that cooling of the brain was avoided. Certainly whenever 
the temperature of the brain surface was measured, it was very close to 
blood temperature. 
29. 
Loss of CO2 from the brain surface is a more serious difficulty and 
of course unless CO2 loss is prevented, measurements of cerebral cortical 
flow may be fallacious. The Pco2 of the exposed brain quickly falls due 
to the rapid diffusion of CO2 from the brain into the air. When a CO2 
electrode is first applied to the brain surface the reading obtained is at 
first very low but rises over a period of 10 - 15 minutes since the 
electrode itself prevents further loss of CO2 to the atmosphere. 
Similarly when a pH electrode is applied to the brain which has been 
exposed for a few minutes to the air, a very alkaline pH of about 7.8 is 
recorded and this falls over 10 - 15 minutes to the normal brain pH of 
7.25 - 7.33 due to the arrest of CO2 escape by the electrode (personal 
unpublished observations). Loss of CO2 from the exposed and uncovered 
cerebral cortex has also been reported by Meyer, Gotoh, Tazaki, Hamaguchi, 
Ishikawa, Nouailhat & Symon (1962). 
The permeability of "Melinex" to CO2 has been tested by comparing 
its behaviour with that of "Teflon" when used as the outer membrane on a 
CO2 electrode ( "Teflon" is relatively permeable to CO2). It was found that 
after a step change in Pco2 at the electrode surface , from 40 to 20 mm. Hg., 
the "Teflon" covered membrane registered 95% response in 24 seconds while 
the "Melinex" covered electrode required more than 15 minutes. It can 
therefore be stated that the "Melinex" membrane on the brain surface 
greatly reduded the escape of CO2. This together with the high blood flow 
of the cerebral cortex ensured that the tissue Pco2 in the area of flow 
measurement was similar to that in areas of cortex not exposed. 
The membrane in addition to stopping the loss of CO2 from the brain 
surface also prevented the escape of krypton to the atmosphere. This was 
important since krypton leaving the brain in this way would lead to a 
30. 
fallacious overestimation of blood flow. 
Over the membrane was placed a thin sheet of lead with a central 
aperture of 1 cm. diameter through which the G.M. tube "looked at" the area 
of exposed cerebral cortex. This lead sheet shielded out radioactivity 
coming from non cerebral sources and cut down the background effect of 
Bremsstrahlung (Glass, Harper & Glover, 1961). 
Cerebral venous blood was sampled from the superior sagittal sinus. 
The blood in the sagittal sinus of the dog has drained mainly from the 
cerebral cortex but also there are a number of large emissary veins which 
enter it. These veins may bring into the sinus blood which has drained 
from the diploe and from extracranial muscle, skin and subcutaneous tissue. 
At its anterior end, the sagittal sinus in the dog commences as the union 
of several small veins draining the anterior ethmoidal air sinuses. These 
then constitute a source of non cerebral blood which could be removed only 
by the most radical surgery. As the sinus passes caudalward there are 
two further important sources of "contamination "; the first is the frontal 
air sinuses and the second is the parietal emissary vein (Hegedus & 
Shackelford, 1965). 
The problem was to decide how radically the sinus should be cleared 
of these extra cerebral connections. Gleichmann et al. (1962) found that, 
in order to get good correlation between cerebral venous Pco2 and cerebral 
tissue Pco2, it was necessary to completely deroof the sagittal sinus to 
avoid extracranial contamination. This however is a very extensive 
surgical procedure involving considerable trauma and blood loss. It is 
after just such traumatic procedures that normal cerebrovascular control 
tends to be lost (Harper, 1965). Consequently, in the experiments to be 
discussed in this thesis, the sinus was deroofed as far anteriorly as the 
,)1 
frontal air sinuses and no further. 
interruption of the two major sources 
This resulted in complete 
of contamination, i.e. the frontal and 
the parietal emissary veins and was decided upon as a result of latex 
injection studies of the cerebral venous system. In addition the sampling 
cannula was placed as far caudalward in the sinus as possible since the 
ratio of extracerebral to cerebral blood becomes progressively smaller the 
further posteriorly the samples are obtained after deroofing the sinus as 
described above. Finally, the sampling of venous blood was always carried 
out very slowly, i.e. 2 ccs. over 2 minutes to avoid any tendency to 
aspirate extracerebral blood into the sinus. Evidence that these measures 
were successful in yielding venous blood almost entirely of cerebral origin 
is as follows: - 
(1) the arterio- venous oxygen difference and the calculated cerebral 
j cortical oxygen uptake were high. The values obtained for the oxygen 
uptake of the cerebral cortex under nitrous oxide -oxygen anaesthesia in the 
various studies to be described in this thesis varied from 0.060 to 
0.070 ml. 02 /G /min. This range is in agreement with the values obtained 
by others in the dog (Homburger et al., 1946; Gleichmann et al., 1962). 
If significant contamination of the sagittal sinus with non -cerebral venous 
blood had occured then the calculated oxygen uptake would have been low 
because of the relatively low oxygen extraction of extracranial tissues. 
( 
Further support for the use of this technique of venous sampling comes from 
2) the arterio- venous carbon dioxide tension difference was large. 
the studies of Hegedus and Shackelford (1965). These authors state that 
in the dog "the posterior third of the (sagittal) sinus is the site to 
obtain cerebral venous blood specimens with minimal admixture of extra- 
cerebral blood "and that surgical exposure of the sinus "interrupts the 
JG 
frontal and parietal emissary veins and the connecting dipoic veins and 
thereby only a small and constant contamination by extracerebral blood 
through the anterior ethmoidal veins will occur ". 
-J .J 
(c) The Technique of Flow Measurement 
The technique used has been fully described by Lassen and Ingvar 
(1961) who introduced it. Like the Kety -Schmidt technique (1948) it 
relies on study of the rate of uptake or removal of an inert gas by the 
brain. 
Krypton was the inert gas used in the form of its radioactive isotope 






highly unstable isotope (half life 
6x10-7 secs.) 
From this schema, it can be seen that 99.3% of the krypton 85 atoms 
disintegrate directly to Rb85 with the emission of beta radiation. The 
other 0.7% of the Kr85 emits beta radiation of lower energy to form a 
highly unstable intermediate isotope which disintegrates almost at once to 
Rb85 with the emission of gamma radiation. Kr85 therefore emits both beta 
and gamma radiation but approximately 150 times as much beta as gamma. 
The gamma radiation of Kr85 is however of relatively high energy and 
therefore the isotope has to be handled with some care. 
Handling of the Isotope, 
Kr85 has a physical half life of 10.6 years. It was received in 
sealed glass ampoules from the Radioisotope Centre at Amersham; each 
34. 
ampoule contained 1 -2 curies of radioactivity. The Kr85 was transferred 
to an evacuated metal box and the remainder of the vacuum filled with 
saline. The box was left for 24 hours during which time the krypton gas 
dissolved in the saline; thereafter the saline containing dissolved 
krypton was drawn off as required. The box in which the krypton was 
stored was heavily shielded with lead. 
During the animal experiments a wide bore tube was attached to the 
expiratory port of the ventilator so that the krypton excreted from the 
lungs was carried directly to the outside of the building. 
Biological Characteristics of Kr85 
The predominant beta radiation of Kr85 with its peak energy of 0.67 
MeV has a maximum tissue penetration of 2.6 mms. and an average penetration 
of 0.7 mm. (Harper et al., 1961) or expressed differently 95% of the beta 
emissions counted at the surface have originated in the superficial 1.5 mms. 
of brain (Lassen, 1965). Since the thickness of the dog's cerebral cortex 
over the fronto -parietal area is approximately 2 mms. (Ingvar & Lassen, 
1962) virtually all the activity recorded by the Geiger Muller tube mounted 
above the cortex must have emanated from the cortex with insignificant 
contribution from the subcortical white matter. 
Krypton is poorly soluble in blood and therefore its clearance by the 
lungs is efficient. Chidsey, Fritts, Hardewig, Richards and Cournand 
(1959) found that only 5% of an intravenously 
injected bolus reached the 
arterial blood while with more prolonged injection (over 2 
minutes) 15% 
reached the arterial blood. However the total body dose of krypton 
in the 
present experiments was smaller because the isotope was introduced 
only into 
the carotid circulation. It was therefore diluted with 
the entire venous 
return before passing through the lungs. Under these 
circumstances 
Ingvar and Lassen (1962) have shown that arterial recirculation amounts to 
only 1% of the administered dose. The problem of increasing arterial 
recirculation with prolonged anaesthesia has been dealt with above. It is 
not necessary that the arterial concentration of krypton should fall to zero 
at the end of krypton injection but it is important that the arterial 
krypton concentration be constant for if it is not then arterial blood 
clearance of krypton will appear to be brain clearance and therefore result 
in a calculated blood flow higher than the true flow. 
The next biological characteristic of krypton which is of importance 
to the method is its brain -blood partition coefficient (A ). Since the 
recorded beta radiation is emanating almost entirely from the cerebral 
cortex, it is the cerebral cortex -blood partition coefficient which is 
relevant. This has been measured by Ingvar and Lassen (1962) who obtained 
a ,X of 0.92 at a haematocrit of 50% and by Glass and Harper (1962) who 
reported a value of 0.91 ±6% at the same haematocrit. The exact value of A 
varies with the blood haematocrit and in all the results to be presented the 
used was that appropriate to the haematocrit existing at the time of the 
;measurement using the formula of Lassen and Munck (1955). 
Saturation and Desaturation 
The krypton 85 dissolved in saline was injected for between 2 and 3 
minutes into the common carotid artery. The isotope was carried by the 
1 
:carotid circulation to the brain where its concentration was monitored by a 
Geiger Muller tube placed over the parietal cortex. 
During the period of injection, the radioisotope concentration in the 
monitored area of the brain was held constant by varying the rate of 
injection. A fast rate was required at first to obtain the desired 
level, 
thereafter the rate of injection was decreased progressively. The isotope 
Jb. 
on reaching the cortex diffused into the cortical tissue according to its 
blood -brain partition coefficient. At first the most rapidly perfused 
components of the counting field had the highest concentrations and the 
more slowly perfused components lower concentrations; consequently a 
disproportionate amount of the total radioactivity measured at the surface 
was originating from the fast components. During the subsequent 2 to 3 
minutes of injection, the krypton concentration in the slowly perfused 
components rose and the concentration in the fast components fell until at 
the end of the injection time all components were at equal concentration. 
At this time arterial and venous concentrations of krypton were equal since 
the cortex had been saturated for the existing blood tension of krypton. 
The tissue concentration at this time was uniform and equal to arterial or 
venous concentration x partition coefficient. 
The injection of krypton into the carotid artery was then suddenly 
stopped. Since arterial recirculation was small (see above) the arterial 
concentration fell to a low value relative to the brain concentration on 
cessation of the injection. The krypton in the cerebral cortical tissues 
then diffused back into the blood and was carried away in the venous 
drainage to the lungs where it was almost entirely excreted. Since 
krypton is an inert gas, the rate of fall in krypton concentration was 
dependent only on the volume of blood washing it out of the cortical 
tissues; consequently the rate of fall of radioactivity bore a relationship 
to the cerebral blood flow. 
If blood flow through the counting field (i.e. the volume of cortex 
"seen" by the G.M. tube) were uniform then the clearance of krypton would 
be a monoexponential function. Replotting the clearance curve on semil- 
logarithmic paper (y axis = beta counting rate and x axis = time) would 
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Figure 3 This figure is the plot of the clearance curve shown in 
Figure 2. The y axis is logarithmic and depicts beta counts in arbitrary 
units and the x axis is arithmetic and registers time. 
-)7 
give a straight line; the time taken for this line to fall to half of its 
initial height would give the Tfr, from which flow could be calculated. 
However, cerebral cortical flow does not appear to be uniform but to 
consist of several compartments of flow (Harper et al., 1961; Lassen, 1965) 
Consequently the clearance curve is multiexponential and the plot on semil- 
ogarithmic paper is not a single straight line. However Ingvar and 
Lassen (1962) have shown that, provided all the compartments in the counting 
field have equal krypton concentration at the beginning of the clearance, 
then the slope of the first part of the clearance curve gives the mean 
blood flow through the area studied, i.e. the mean of all the different 
rates of blood flow through the cortical volume seen by the counter weighted 
in proportion to their actual weights. These points are illustrated in 
Figures 2 and 3; Figure 2 shows a typical clearance curve recorded from 
the cerebral cortex and Figure 3 is the plot of this clearance curve 
transposed onto semilogarithmic paper. The best straight line fit to the 
initial part of this plot yields a value for mean blood flow through the 
area of cortex monitored. It is clear however that slower rates of 
cerebral perfusion are also present as evidenced by the departure of the 
plot from the initial slope. 
For this derivation of mean cortical flow to be valid it is essential 
that even the most slowly perfused component in the counting field be 
saturated with krypton at the start of the clearance. If it were not then 
the flow value obtained would be too high since the unsaturated slow 
component would be underrepresented in the clearance curve. Harper et al. 
(1961) have shown, by calculating flows after different times of injection, 
that equilibrium is reached after an injection time of 100 seconds. The 
2 - 3 minutes of injection used in the following studies were therefore 
yv 
more than adequate to saturate the counting field with krypton. 
The reasons why this equilibration time is so much shorter than that 
reported by Alexander, Wollman, Cohen, Chase & Behar (1964) to be necessary 
for brain saturation with krypton administered by inhalation are: - 
(1) there is no lag in the rise of the arterial concentration, 
(2) a large volume of krypton is introduced at the beginning of the 
injection so that the krypton tension gradient into the cortex is 
at first very high, 
and (3) cerebral cortical flow is 5 times as high as blood flow through 
white matter (Landau et al., 1955) and therefore equilibrium is 
reached more readily in the cortex than in whole brain. 
Before leaving the subject of the injection of krypton the possibility 
that the intracarotid injections themselves might have altered cerebral 
blood flow has to be considered. Betz (1965) has shown that rapid 
intracarotid injections can in fact readily affect cerebral blood flow. 
I therefore went to Betz's laboratory to carry out a study on the effect 
of injections of saline given into the common carotid artery on cerebral 
blood flow in the dog. Flow on the cortical surface was measured by the 
heat clearance technique (Betz & Hensel, 1962) while intracarotid injections 
of saline at various rates were made. Rapid injections, i.e. more rapid 
than 1 ml. in one second certainly produced large alterations in flow but 
when saline was infused in the same way as in the experiments under 
discussion, i.e. at a rate of less than 6 mis. per 2 minutes, there was no 
alteration in cerebral cortical flow. 
The last methodological question requiring consideration is the 
possible influence on the measured flow of cerebral arteries and veins in 
the counting field. Since at the cessation of the injection 
the arterial 
y.t 
concentration falls almost to zero, the presence of a large volume of 
arterial blood in the field might be expected to lead to an initial very 
rapid drop in counting rate. However the time constant of the arterial 
washout phase is so rapid that it was not registered by the recording 
system used which had a time constant at least 5 times as great. 
Cerebral veins containing blood only from the counting field would 
have little effect on the calculated flow because the krypton concentration 
in them would be close to that in the tissue and would fall at the same 
rate. Unfortunately large cerebral veins in the counting field would 
certainly be carrying blood from areas of cortex other than that under study 
However because cerebral cortical flow is relatively uniform under nitrous 
oxide -oxygen anaesthesia the influence of such venous blood on the 
calculated flow would be negligible. Nonetheless, the G.I. tube was 
placed to avoid the largest cortical arteries and veins. 
Since there are several components of flow in any area of cortex, it 
is important that the geometry of the counting field be maintained constant 
so as to avoid changes in the weighting of different components from one 
flow measurement to another. Constant geometry was maintained as far as 
possible in the experiments to be discussed. 
(d) Associated Measurements. 
Temperature 
The pharyngeal temperature was measured with a mercury in glass 
thermometer. Heating by infra red lamps was applied to the animal to 
maintain the pharyngeal temperature close to 38 °C. No measurements of 
cerebral blood flow were made if the temperature fell below 36.5 °C. The 
electrodes for blood gas and pH measurement were maintained at 38 °C. 
Blood Pressure 
The mean arterial blood pressure was measured continuously with a 
damped mercury manometer connected to the cannula in the femoral artery. 
The Electroencephalograph 
The E.E.G. was recorded either with an Offner recorder or with the 
equipment produced by Elema Schonander. The electrodes used were needles, 
which were inserted into the subcutaneous tissues of the scalp, one just 
anterior to and the other just posterior to the area of exposed brain. 
Blood Gases 
Arterial and cerebral venous pH were measured with the pH electrode 
no. G297/G2, and the pH meter 22 produced by Radiometer Ltd. The pH 
electrode was calibrated with two known buffers of pH 6.841 and 7.381. 
Arterial Pco2 and cerebral venous Pco2 were measured by the inter- 
polation technique of Andersen, Engel, Jorgensen & Astrup (1960). In the 
case of the venous Pco2 the correction factors given by Andersen & Engel 
(1960) for haemoglobin desaturation were applied. 
In the later experiments arterial Pco2 and cerebral venous 
Pco2 were 
measured with the direct CO2 electrode produced by Electronic 
Instruments 
Ltd. and amplified by a pH meter 22 of Radiometer 




was calibrated with three gases of known CO2 concentration. 
Oxyhaemoglobin Determination 
The oxygen saturation of arterial and cerebral venous blood was 
measured with the Brinkman haemoreflector (Brinkman & Zijlstra, 1949). 
The instrument was calibrated for each experiment by fully reducing and 
fully oxygenating samples of the animal's blood and obtaining an upper and 
lower calibration point. A straight line was then drawn between these two 
points. It is known, however, that the relationship between oxygen 
saturation and the intensity of reflected light in the band 600 -700 nM. 
is not linear but is curvilinear at low values of saturation (below 40). 
In the range of saturations encountered in these studies, i.e. above 50,, 
the assumption of a linear relationship does not introduce significant 
errors (Zijlstra, Mook, ten Hoor & Kruzinga, 1966). Duplicate measurements 
of saturation were carried out on each sample and the results discarded if 
these did not agree within 2;.. 
Haemoglobin and Packed Cell Volume 
The haemoglobin concentration of arterial blood was measured for each 
Lewis 
flow determination by the cyanhaemoglobin method (Dacie/ 1963) with 
spectronhotometric analysis at 540 mu. wavelength. Packed cell volume 
was also determined on each sample. 
4y. 
(e) The Calculation of Cerebral Oxygen Uptake 
The cerebral oxygen uptake was calculated by multiplying the 
measured cerebral cortical blood flow by the arteriovenous oxygen 
difference. These determinations therefore included the errors associated 
with the flow determination, the haemoglobin estimation and the saturation 
measurements. There was therefore a relatively wide scatter of values for 
oxygen uptake and it was necessary to make multiple determinations in order 
to detect significant changes. 
The calculation of cerebral oxygen uptake in this way depends on two 
assumptions (1) that the venous blood sampled from the superior sagittal 
sinus has drained from the cerebral cortex and (2) that blood flow in the 
area monitored is the same as blood flow over the rest of the cortical 
surface from which venous blood drains into the sagittal sinus. Evidence 
has been presented above that both these criteria were fulfilled. 
The measurements are therefore valid values for the oxygen uptake of 
the cerebral cortex of the dog under the particular conditions of this 
study. These conditions were that the dog was anaesthetised with a "sleep" 
dose of thiopentone and thereafter ventilated with nitrous oxide and oxygen. 
There is a great deal of evidence (already stated) that barbiturate 
anaesthesia reduces the oxygen uptake of the cerebral cortex. For this 
reason no measurements of flow or oxygen uptake were made in these studies 
for at least 2 hours after the last dose of thiopentone had been given. 
This time scale was based on considerations and investigations of 
barbiturate activity in the dog which have already been described. None- 
theless it was felt that a comparison of blood flow 
and oxygen uptake of 
the cerebral cortex should be made between animals 
in which anaesthesia was 
`t 
induced with barbiturates and animals in which a non -barbiturate induction 
of anaesthesia was performed. 
Study 
Method 
In 4 dogs anaesthesia was induced without barbiturates using volatile 
agents only; after induction and surgical preparation anaesthesia was 
maintained with unsupplemented nitrous oxide and oxygen. Measurements 
of cerebral cortical blood flow and oxygen uptake were made and compared 
with measurements made in another group of animals during nitrous oxide - 
oxygen anaesthesia but after induction with thiopentone. 
In the non - barbiturate group anaesthesia was induced by placing the 
dog in a large perspex box through which nitrous oxide and oxygen were 
blown at 15 litres /minute. Halothane was introduced into this mixture up 
to a concentration of 8%. Provided the dog was competently handled and 
was given time to become accustomed to the box before induction was 
commenced, anaesthesia could be accomplished in this way without causing 
the animal any distress. As soon as unconsciousness supervened, the dog 
was quickly intubated and ventilated with nitrous oxide and oxygen and 
0.5-1% halothane while the surgical preparations were performed. The 
halothane was then discontinued and no flow measurements were made until the 
last evidence of halothane had been absent from the E.E.G. for at least one 
hour. The average period of halothane administration during surgical 
preparation was 42 minutes and the average time allowed for washout before 
the first measurements was 2 hours 15 minutes. The time between induction 
of anaesthesia and measurement of flow was therefore the same as in the 
group induced with thiopentone, i.e. 3 - 4 hours. 
The anaesthetic technique for the animals induced with 
thiopentone 
4b. 
BLOOD FLOW OXYGEN UPTAKE Pa 
CO2 
B.P. 






















Table 5. Comparisons of blood flow and oxygen uptake of the cerebral 
cortex together with Pa and blood pressure values between 
2 
animals in which anaesthesia had been induced with thio- 
pentone and those in which thiopentone had not been used. 
All measurements made during nitrous oxide - oxygen anaesthesia 
(*=p <.05; **=p<.01; ***=p<.001) 
(Blood flow and oxygen uptake in ml. /G. /min; 
B.P. and Paco2 
in mm.Hg. Mean values for blood flow are 
based on 84 
measurements in 24 dogs in the thiopentone 
group and 14 
measurements in 4 dogs in the non -barbiturate 
group. Mean value= 
for oxygen uptake are based on 
52 measurements in 15 dogs in the 
+Iiinnantone group and 8 measurements in 3 dogs 
in the non -barbi 'ate 
47. 
has already been described. 
Results 
All the results for blood flow and oxygen uptake of the cerebral 
cortex obtained in the four animals studied without thiopentone 
administration are given in Table App. I together with the levels of blood 
pressure and of Paco2 existing at the time of the flow determinations. 
In Table 5 the mean results are presented and compared with the group of 
dogs in which anaesthesia was induced with thiopentone: these latter 
results were obtained from a subsequent series of experiments, the detailed 
results of which will be found in Tables App. 2, App. 3, App. 4 and App. 9. 
The mean value for cerebral cortical flow under nitrous oxide 
anaesthesia without thiopentone induction (1.17 
± 
0.22 mls./G./min.) was 
33% greater than the value for flow under nitrous oxide following 
thiopentone induction (0.88 ± 0.19 mls./G./min.). This difference is 
highly significant (p,(.001). 
The mean value for oxygen uptake of the cerebral cortex was slightly 
higher in the group that had not received thiopentone (0.070 
± 
0.004 mls./ 
G. /min, compared with 0.066 ± 0.014 mls./G./min.) but this difference was 
not statistically significant. 
The mean blood pressure during nitrous oxide anaesthesia without 
thiopentone was significantly higher than in the group which had been 
induced with thiopentone (153 
± 
22 mm.Hg. and 141 ± 14 mm.Hg. respectively). 
The Paco2 values were not significantly different between the two groups. 
Comment 
Both cerebral cortical flow and mean blood pressure were significantly 
higher in the group which had not received thiopentone. The higher 
cerebral cortical flow probably reflects a higher oxygen requirement, on 
the basis of the theory of regulation of cerebral flow to metabolic 
requirement to be discussed more fully subsequently. The failure to 
detect an increased oxygen uptake in this study was not surprising in view 
of the small number of animals and the wide scatter of oxygen uptake 
in the non -barbiturate group 
results. The higher blood pressure /supports the contention that the level 
of anaesthesia was lighter in the group which did not have thiopentone. 
This is not to say that barbiturate itself was responsible for lowering 
flow and oxygen uptake so long after its administration but merely to 
postulate that the nitrous oxide anaesthesia was being potentiated by low 
levels of circulating barbiturate. It should be noted therefore throughout 
this thesis that the control values for cerebral cortical flow and oxygen 
uptake are probably slightly lower than would occur with nitrous oxide - 
oxygen anaesthesia alone in the dog. 
CHAPTER 3 
The Influence of Halothane on the Blood Flow 
and Oxygen Uptake of the Cerebral Cortex 
(a) Introduction 
Halothane is the first drug to be considered in this thesis because 
it is a very widely used volatile anaesthetic which is frequently 
recommended for neurosurgical anaesthesia (Gilbert, Millar & Brindle, 1960). 
The chemical formula of halothane is:- 
F H 
{ 
F- C - C -Br 
I 
F Cl 
It has a blood:gas partition coefficient of 2.3 and a brain:blood 
coefficient of 2.6. Halothane therefore is more blood soluble than 
nitrous oxide but less soluble than either trichloroethylene or chloroform. 
The rate of increase in arterial concentration is therefore more rapid 
than with the latter two drugs. 
In clinical practice, halothane is commonly employed as a supplement 
to nitrous oxide -oxygen in concentrations of 0.5 to 2.0% and this 
therefore was the range of concentrations which was particularly studied 
a 
in the following experiments, though few measurements were made during 









Table 6. Concentrations of halothane obtained with the vaporiser 




The methodology was as described in the main methodology section (see 
above). After making several measurements under unsupplemented nitrous 
oxide - oxygen anaesthesia, halothane in concentrations of 0.5%, 2% or 4% was 
added to the anaesthetic mixture. The drug was vaporised from an accurate, 
temperature compensated vaporiser (Fluctec II), the calibration of which had 
been checked by refractometry (see Table 6). Further measurements of 
cerebral cortical flow and cerebral cortical oxygen uptake were then made. 
In order to gain more information about the effects of 0.5% halothane 
during the first 20 minutes of administration, a slightly different 
protocol was followed in some of the later experiments. A measurement of 
flow was first made during unsupplemented nitrous oxide - oxygen anaesthesia; 
following this, 0.5% halothane was added for a period of 10 -15 minutes 
when a further measurement was carried out. The halothane was then 
discontinued and after a time for washout, which was always in excess of the 
duration of administration, a second control measurement under nitrous 
oxide anaesthesia was made. In this way several short periods of halothane 
















































































































































































































































































































































































































































































































































































































































































A Blood Flow 
Oxygen Uptake 
0.5% Halothane 2% Halothane 4% Halothane 
The effect of 0.5%, 2% and 4% halothane on the blood flow and 
oxygen uptake of the cerebral cortex. The figure illustrates changes in 
flow and oxygen uptake produced by halothane as compared with the values 




Over 60 minutes 
0.5% Halothane % Change 
Blood 1.02 0.84 ** 
-18% 
Flow -0.25 -0.27 
Mean 132.0 123.1 ** 
B.P. ±16.9 -15.6 
- o 7
Pa 40.0 39.0 
cot 
±5.1 13.4 
Table 8. Comparison of cerebral cortical blood flow during the 
first 20 minutes of 0.5% halothane administration with 
flow following more than 60 minutes of 0.5% halothane. 
(* = p .05; ** = p .01; 
*** = p.001) 
(Blood flow in mls./G./min; B.P. and Paco2 in mm.Hg.) 
N20 + 02 0.5% Halothane 
All Measurements 
N20 + 02 0.5% Halothane 
1st 20 minutes 
C.V.R. 
1.67 1.45 1.68 
1.36xxx 
±0.37 -0.47 ±0.37 ±0.36 
Mean 141 126 142 132 
B.P. ±14 ±17 ±14 -17 
Table 9. The effect of 0.5% halothane on cerebrovascular resistance 
and on blood pressure. 
( * = P < . 0 5 ; ** = P < .01; 
xxx = P < .001) 
( Cerebrovascular resistance (C.V.R.) in arbitory units 







ALL 0.5% EARLY 0.5% 2% 4% 
HALOTHANE HALOTHANE HALOTHANE HALOTHANE 
Figure 5 The effect of different concentrations of halothane on blood 
pressure and cerebrovascular resistance. With early 0.5% halothane and 
with 2% halothane the reduction in cerebrovascular resistance was greater 
than would be accounted for by the reduction in blood pressure. 
(c) Results 
Effect of Halothane on Blood Flow through the Cerebral Cortex 
0.57, Halothane 
17 dogs were studied using the continuous administration method and a 
further 7 using the repeated short administration technique. In all, 
there were 84 measurements during nitrous oxide -oxygen anaesthesia and 
87 measurements during 0.5% halothane administration. The individual 
flow results are given in Tables App. 2 and App. 3. 
The mean values derived from these results are given in Table 7 and 
illustrated in Figure 4. From Table 7 it will be seen that the mean 
value for cortical flow during the administration of 0.5% halothane was 
not significantly different from that under unsupplemented nitrous oxide - 
oxygen anaesthesia. These comparisons were made at virtually the same 
arterial Pco2 but the mean blood pressure fell by 11%. If, however, one 
considers only the first 20 minutes of 0.5% halothane, then there was a 
significant increase of 16 in cortical blood flow, at unchanged Paco2 and 
with a 6; fall in mean blood pressure. The flows measured during the 
more prolonged halothane administration (i.e. over 60 minutes) were not 
significantly different from the nitrous oxide controls but were 
significantly lower than the early (i.e. up to 20 minutes) halothane flows 
as shown in Table 8. Cerebrovascular resistance was markedly reduced by 
0.5% halothane (see Table 9 and Fig. 5), the reduction being greater in the 
first 20 minutes of administration. 
0.5% halothane in nitrous oxide -oxygen therefore caused an increase in 
cerebral cortical flow which was not maintained since flow returned to the 
previous control level after about 20 minutes of administration. 
The other measurements made, i.e. arterial oxygen 
saturation,(Ao2) 
58. 
N20 + 02 0.5% Halothane 
A02 97.3 95.5 
±2.9 ±3.0 
Art. pH 7.30 
7.28 
±0.06 ±0.06 
Pa 38.9 39.9 
14.2 14.0 
Table 10. Mean values for arterial oxygen saturation, arterial 
pH and Pa during nitrous oxide - oxygen anaesthesia 
o2 
and during anaesthesia with 0.5% halothane. 
(Arterial oxygen saturation (Ao2) in percentage 
and Paco2 in mm.Hg.) 
77 




0 + 0 
2 
2% Halothane 
with B.P. greater 
than 90 mm.Hg. 
** 
Blood 0.79 0.98* 0.79 
Flow ±0.19 ±0.36 ±0.20 ±0.36 
Mean 138 
* ** 
97 139 110 * ** 
B.P. ±19 ±21 ±18 ±17 
Pa 
cot 
39.2 39.3 39.5 40.1 
+3.4 ±3.6 ±3.3 ±3.2 
Table 11. The effect of 2ó halothane on blood flow through the cerebral 
cortex. 
(* = p < .05; ** = P < .Ol; * ** = p < .001) 
(Blood flow results (mis. /Gdmin.) are mean values based on 34 
nitrous oxide measurements and 26 halothane measurements in 9 dogs. 
In the group with blood pressures above 90 mm.Hg. there were 30 nitrous 
oxide measurements and 14 halothane measurements in 7 dogs. B.P. and 
Paco2 in mm.Hg.) 
OU. 
N20 + 02 2% Halothane N20 + 02 4% Halothane 
C.V.R. 
1.84 1.05*** 1.56 0.80*** 
+0.52 ±0.32 ±0.37 ±0.34 
Mean 138 97*** 143 62*** 
B.P. ±19 ±21 ±19 ±20 
Table 12. The effect of 2% and 4% halothane on cerebrovascular 
resistance and mean blood pressure. 
(* = p ` . 05; ** = p < .Ol; *** = p ( .001) 
(Mean values based in the 2% halothane group on 34 nitrous oxide 
measurements and 26 halothane measurements in 9 dogs and in the 4% 
halothane group on 19 nitrous oxide and 10 halothane measurements in 
5 dogs.) 




Art. pH 7.30 
7.29 
-0.03 -0.04 
Pa 39.2 39.3 
13.4 1-3.6 
Table 13. Arterial oxygen saturation, arterial pH and Paco 
2 
during nitrous oxide - oxygen anaesthesia and during 
anaesthesia with 2% halothane. 
(Arterial oxygen saturation (Ao2) in percentage 
and Paco2 in mm.Hg.) 
62. 
N20 + 02 4% Halothane 
Blood Flow 0.95 
0.82 
±0.16 ±0.22 







Table 14. The effect of 4% halothane on blood flow through 
the cerebral cortex. 
( * = P <.05; * * = P (.01; ***= P <.001) 
(Blood flow results (mis. /G. /min.) are mean values based on 
19 nitrous oxide and 10 halothane measurements in 5 dogs. B.P. 
and Paco2 in mm.Hg.) 
b;3. 
arterial pH and arterial Pco2, are displayed for each flow measurement in 
Table App. 4 with mean values in Table 10. There were no significant 
differences in these parameters between the nitrous oxide -oxygen 
measurements and the halothane measurements. 
2;' Halothane 
The effects of 2% halothane on cortical flow is shown in Table 11, 
Table App. 5 and Fig. 4 . 34 control (nitrous oxide- oxygen) and 26 
halothane measurements were made in 9 dogs. Cerebral cortical flow 
increased by 24% during the administration of 2% halothane despite a fall 
of 30% in mean blood pressure. If one considers only those flows which 
were measured when the mean blood pressure was above 90 mm.Hg. then the 
increase in cerebral cortical flow with 2% halothane was 36 %. The 
cerebrovascular resistance fell by 45% (Table 12 and Fig. 5). 
Other measurements are displayed in Table 13 and Table App. 6; 
there was no significant difference between the mean values for Ao2, pH 
or Paco2 between the two groups. 
4% Halothane 
The results obtained with 4% halothane will be found in Table App. 7 
and Table 14. There were 19 control and 10 halothane measurements in 
5 dogs. Flow during the administration of 4% halothane was not 
significantly different from that under unsupplemented nitrous oxide- oxygen 
anaesthesia. However 4% halothane reduced the mean blood pressure from 
143 ±19 mm.Hg. under nitrous oxide -oxygen anaesthesia to 62 ±20 mm.Hg. The 
cerebrovascular resistance fell from 1.56±0.37 units to 0.80 ±0.34 units, a 
highly significant decrease (Table 12 and Fig. 5). 
Arterial oxygen saturation and arterial pH and Po2 did not alter between 








Pa 39.5 39.1 
CO2 
-2.5 ±3.8 
Table 15 Arterial oxygen saturation, arterial pH and Pa during 
2 
nitrous oxide -oxygen anaesthesia and during anaesthesia 
with 4 halothane. 
(Arterial oxygen saturation (Ao2) in percentage 









N20 + 02 0.79 157 2.01 40 
4% Hal. 0.63 75 1.19 37 
4% Hal. 
+ Hypertensin 
0.99 118 1.18 43 
Table 16. Cerebral cortical blood flow and cerebrovascular resistance 
in one animal (23/11/64) during anaesthesia with nitrous 
oxide -oxygen, then with 4% halothane and finally with 
4% halothane together with hypertensin. 








A Blood Flow 
Blood Pressure 
4 % Halothane 
4 % Halothane + I.V. Hypertensin 
Figure 6 The effect of 4% halothane on blood flow prior to and during 
intravenous infusion of hypertensin. In this animal blood flow during 
4% halothane administration was 20% below the value pertaining during 
unsupplemented nitrous oxide - oxygen anaesthesia while mean blood pressure 
was reduced by 50%. When the systemic hypotension was partially 
corrected by intravenous hypertensin infusion blood flow during 4% 











0.80 1.00 0.95 
0.5% 0.99 0.99 0.87 
0.5% 0.74 0.83 
0.5% 0.85 0.78 
9/8/64 2% 0.93 0.93 
2% 1.20 0.93 
2% 1.09 1.13 








0.5% 1.06 0.91 
Means 1.08 ± 0.24 1.07 ± 0.25 
Table 17. Blood flow through different areas of cerebral cortex during 
halothane anaesthesia. 
(Blood flow in mls./G./min.) 
v 
control and 4% halothane measurements (Table 15 and Table App. 8). 
In one animal during 4% halothane anaesthesia the vasopressor agent, 
hypertensin, was infused intravenously at a rate sufficient to raise the 
mean blood pressure above 100 mmHg. When this was done blood flow 
through the cerebral cortex was 25% above the control value (Table 1684 Fig.6; 
Furthermore the infusion of hypertensin in this animal, although it raised 
the arterial blood pressure did not alter the cerebrovascular resistance 
which remained at only 60%, of the control value. 
Blood Flow in Different Cortical Areas during Halothane Anaesthesia 
A study of the relationship between flows in different areas of cortex 
during anaesthesia with halothane was carried out. Measurements during 
0.5% halothane administration were made in 3 dogs and during 2% halothane 
in one animal. The results are given in Table 17 mudjBlami from which 
it can be seen that there was a close correlation between flows in 
different cortical areas. This table provides evidence that flow is 
fairly uniform over the cortical surface during halothane anaesthesia. 
L L 
N20+02 
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9mins. 2% HALOTHANE 
13 mins. 2% HALOTHANE 
Figure 7 The E.E.G. of the dog during anaesthesia with 0.5% halothane 
and with 2% halothane. 
 
(d) Results 
Effect of Halothane on the E.E.G., Oxygen Uptake, Cerebral Venous 
Oxygenation and Cerebral Arterio-venous Differences 
All the preceding studies have dealt with cerebral cortical blood flow. 
However, as noted in the methodology section, cerebral venous blood was 
obtained in some of the experiments from the superior sagittal sinus. 
Using this blood, it was possible to determine the arterio -venous oxygen 
difference across the cerebral cortex and, knowing the cerebral cortical 
blood flow, to calculate the oxygen uptake of the cerebral cortex. This 
has been done during anaesthesia with 0.5% halothane and with 2% halothane 
and the results compared with the values existing under unsupplemented 
nitrous oxide -oxygen anaesthesia. The units of oxygen uptake used through- 
out were mis. of oxygen /G. of cerebral cortex /minute. 
The E.E.G. activity present during anaesthesia with these two concen- 
trations of halothane is shown in Figure 7. During 0.5% halothane theta 
waves appeared in the E.E.G. and on these was superimposed the fast activity 
seen during unsupplemented nitrous oxide -oxygen anaesthesia. This pattern 
resembles Level II of Gain & Paletz' (1957) classification of E.E.G. changes 
with halothane. 2f halothane produced a characteristic picture of high 
amplitude fast beta activity. This pattern was not recorded in man by Gain 
& Paletz (1957). With more prolonged administration of 2¡ halothane under- 
lying delta waves appeared as in Level IV of Gain & Paletz' classification 
but the high amplitude beta persisted. 
0.5;" Halothane 
There were 52 determinations of oxygen uptake under nitrous oxide - 
oxygen anaesthesia and 44 during anaesthesia with 0.5 halothane in nitrous 
N20 + 02 0.5% Halothane 
** 
Oxygen 0.066 0.057 
Uptake -0.014 -0.016 
Pharyngeal 38.4 38.2 
Temperature -0.6 -0.9 
Table 18. The effect of 0.% halothane on the oxygen uptake 
of the cerebral cortex. 
(* = P <.05; ** = p < .01; 
xxx = p < .001) 
(Oxygen uptake results (mls./G./min.) are mean values based on 
52 measurements under nitrous oxide - oxygen and 44 measurements 
during anaesthesia with 0.5% halothane in 15 dogs. Pharyngeal 
temperature in °C.) 
CEREBRAL VENOUS OXYGEN SATURATION 
N20 + 02 Halothane 
0.5% Halo thane 58.3% 62.2%* 
All Measurements -9.1% -9.1% 
0.5% Halothane 58.7% 64.6%* 
First 20 minutes -9.1% -9.2% 
2% Halothane 58.1% 
75. 
±7.4% ±3.0 
Table 19. Values for oxygen saturation of cerebral venous blood 
during nitrous oxide - oxygen anaesthesia and during 
anaesthesia with 0.5% and 2% halothane. 






N20 Hal. N20 Hal. N20 Hal. 
20- 
All 0.5% Halothane Early 0.5% Halothane 2 % Halothane 
Figure 8 The effect of halothane on the oxygen saturation of cerebral 
venous blood as sampled from the superior sagittal sinus. Also indicated 













































































































































































































































































































































































































































































































N20 + 02 2% Halothane 
Oxygen 0.060 0.040 * ** 
Uptake -0.015 -0.011 
Pharyngeal 38.4 38.3 
Temperature -0.6 -0.5 
L 
Table 21. The effect of 2% halothane on the oxygen uptake of 
the cerebral cortex. 
(x = p < .05; ** = p < .01; 
* ** = p < .001) 
(Oxygen uptake results (mls./G./min.) are mean values 
based on 17 measurements under nitrous oxide - oxygen 
and 12 measurements during anaesthesia with 2% halothane 
in 6 dogs. Pharyngeal temperature in °C.) 
oxide -oxygen in 15 dogs after thiopentone induction of anaesthesia. The 
results are shown in Table 18, Table App. 9 and Fig. 4. 
0.5% halothane reduced the oxygen uptake of the cerebral cortex by 
14% compared with the value under unsupplemented nitrous oxide -oxygen 
anaesthesia (.01> p> .001). 
The results for cerebral venous oxygen saturation, cerebral arterio- 
venous oxygen saturation difference, arterial and cerebral venous Pco2 and 
cerebral arterio -venous Pco2 difference, arterial and cerebral venous pH 
and arterio- venous pH difference are displayed in Tables 19 and 20 and in 
Table App. l0A and B. 0.5% halothane produced a significant increase in 
the oxygen saturation of the cerebral venous blood from 58.3 -9.1% to 
62.2 ±9.1% (see Table 19 and Fig. 8). During the first 20 minutes of 0.5% 
halothane administration the increase in cerebral venous saturation was 
greater, from 58.7 ±9.1.% to 64.6 ±9.2% -. Since arterial oxygen saturation 
remained constant these increases in cerebral venous oxygen saturation led 
to narrowing of the cerebral arterio- venous oxygen saturation difference, as 
shown in Table 20. 
The arterio- venous difference for Pco2 was 13.2 ±3.8 mm.Hg. under 
nitrous oxide -oxygen anaesthesia; this narrowed to 10.8 ±4.3 mm.Hg. during 
0.5 halothane. Similarly the arteriovenous pH difference fell signifi- 
cantly from 0.062 -0.023 to 0.045±0.027 pH units during 0.5% halothane 
(Table 20). 
2% Halothane 
17 control measurements and 12 measurements of oxygen uptake under 2% 
halothane were made in 6 animals, the results being given in Table 21, Table 
App. 11 and Fig. 4. 
 
2 halothane produced a highly significant fall in the oxygen uptake 
of the cerebral cortex, averaging 33%, when compared with the value under 
unsupplemented nitrous oxide- oxygen anaesthesia. 
The individual values for cerebral arterio - venous differences are 
shown in Table App. 12A and B and the mean values in Tables 19 and 20. 
There was a highly significant increase in the oxygen saturation of the 
cerebral venous blood from 58.1 -7.4 to 75.0 ±3.0% during 2 halothane 
anaesthesia (see also Fig 8). A corresponding fall in the arterio- venous 
oxygen saturation difference occurred. The arterio- venous difference for 
Pco2 was 13.6 -4.3 mm.Hg. under nitrous oxide anaesthesia and 8.9 ±4.1 mm.Hg. 
under 2% halothane, a highly significant fall. The arterio- venous pH 
difference fell from 0.063±0.035 to 0.045±0.029 pH units but this difference 
did not reach statistical significance. 
(e) Discussion 
1. The Influence of Halothane on Cerebral Cortical Blood Flow 
These studies have shown that certain concentrations of halothane 
increase the blood flow through the cerebral cortex of the dog. Since in 
these experiments there was no rise in blood pressure, but in fact a fall, 
this increase in flow must indicate that halothane acts as a vasodilator of 
the cerebral cortical circulation. 
With 0.51,,halothane the increase was relatively small and of short 
duration but with a higher concentration (2%) the blood flow increase was 
considerable and sustained, except that flow began to fall as the blood 
pressure fell below 90 mm.Hg. With 4% halothane, however, cerebral cortical 
presumably 
perfusion was not increased above control values /because the mean blood 
pressure fell by more than 50%. In the experiment in which a vasopressor 
drug was administered during anaesthesia with 4% halothane (Table 16 and 
Fig. 6), blood flow rose above control values indicating vasodilatation by 
4. halothane in the presence of an adequate perfusion pressure. The 
vasopressor employed, hypertensin, has been shown not by itself to have 
1961; 
any direct action on the cerebral vessels (Bohr, Goulet & Taquini, /Agnoli, 
Ballistini, Bozzao & Fieschi, 1965). This spectrum of alterations in 
cerebral cortical flow with increasing concentration of halothane has been 
illustrated in Figure 4 which shows mean values for cerebral cortical blood 
flow during administration of 0.5 %, 2¡ and 4% halothane. The greater 
increase in flow in the first 20 minutes of 0.5% administration is also 
shown in this figure. 
At each concentration of halothane there was a highly significant 
fall in cerebrovascular resistance. However halothane also reduced the 
mean blood pressure and it is well established that the cerebral 
circulation compensates for reductions in perfusion pressure by lowering 
its vascular resistance (Forbes, Nason, Wortman, 1937; Fog, 1938; McCall, 
1953; Carlyle & Grayson, 1955; Rapela, Machowicz & Freeman, 1963; 
Haggendal & Johansson, 1965; Harper, 1966). It is not therefore 
justifiable to consider that these falls in cerebrovascular resistance 
provide independent evidence of cerebral vasodilatation by halothane. It 
is the flow increases with 0.5% and 2% halothane which indicate that the 
falls in cerebrovascular resistance produced by halothane were in excess of 
those required to compensate for the changes in perfusion pressure. The 
mean blood pressure was reduced by 421, halothane to 62 mm.Hg., and at this 
level of hypotension the cerebral circulation in the dog is known to have 
exceeded its maximum range of compensation. Flow at these low levels of 
perfusion pressure is pressure dependant (Harper, 1966) and therefore with 
4% halothane flow was at or rather below control values. However when the 
blood pressure was raised by means of a vasopressor, the underlying cerebral 
vasodilatatory action of 4r halothane was revealed. Indeed the fact that 
cerebrovascular resistance did not increase when the blood pressure was 
raised from 75 to 118 mm.Hg. suggests that 4 halothane 
producing near maximal vasodilatation. 
The conclusion that halothane is a cerebral vasodilator has also been 
reached by others, though this relationship between concentration of 
halothane and flow has not previously been demonstrated. 
Galindo and Baldwin (1963) measured flow in the internal carotid 
artery of the dog with an electromagnetic flowmeter, after clamping the 
external carotid during the administration of unknown concentrations of 
halothane (they were using an uncalibrated vaporiser). They found that 
was itself 
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carotid blood flow increased at first and then fell with falling blood 
pressure, flow becoming equal to the control value when the mean blood 
pressure was 40.7% below the control level. 
There are however two criticisms of tLds study. Firstly, measurement 
of flow in the internal carotid artery of the dog is not a valid measure 
anastomoses 
of cerebral blood flow because of the extensive mmtxxxcemx which exist 
between the internal and external carotid systems so that an unknown 
proportion of the blood in the internal carotid artery is destined for 
extracranial structures. De La Torre, Netsky & Meschan (1959) have not 
only demonstrated anatomically the existence of these astomoses but, by dye 
injection studies, have proved their functional importance in the dog. 
Galindo and Baldwin attempted to avoid this difficulty by clamping the 
external carotid artery but De La Torre and co- workers (1959) had previously 
demonstrated that this procedure considerably increased the proportion of 
extracerebral blood carried by the internal carotid artery. 
Galindo and Baldwin justify the acceptance of their carotid flow 
measurements as indicators of cerebral blood flow on three grounds (1) 
that the carotid artery is one of the three main vessels to the dog's brain, 
(2) that the c.s.f. pressure moved in the same direction as the flow 
measurements and (3) that the administration of CO2 increased carotid blood 
flow. Argument (1) for the reasons given above is hardly conclusive. 
The fact that when the carotid blood flow increased the pressure of the 
cerebrospinal fluid also rose, in the absence of changes in central venous 
pressure, is a more weighty argument. Ilowever from the results given the 
mean c.s.f. pressure rose by an average of 79.2% on giving halothane yet 
this result was far from being statistically significant (p < .3). This 
naturally makes one wonder how many observations of c.s.f. pressure were 
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in fact made (no tables of the individual results are given in this paper). 
The 3rd argument was that administration of CO2 always led to an increase in 
carotid flow. Since CO2 dilates the cerebral vessels and constricts muscle 
vessels, the inference is that carotid flow can be accepted as a measure of 
cerebral flow. However CO2 is a very potent dilator of cerebral vessels 
and therefore the net effect of an increase in C.B.F. and a decrease in 
extracranial flow may be to increase carotid flow during CO2 administration; 
halothane is on the other hand a potent dilator of skin and subcutaneous 
vessels (Black & McArdle, 1962; Lindgren, Westermark & Wahlin, 1964) and 
the resultant increase in non - cerebral blood flow in the carotid artery 
might dictate an increase in total blood flow in the carotid artery whatever 
was happening to the cerebral vessels. 
The second criticism of this study, is that the reported increase in 
carotid blood flow did not in fact reach statistical significance. 
Consequently these authors had to rely heavily on their demonstration of a 
large fall in carotid vascular resistance with halothane, a result which 
was statistically highly significant. The reasons for discounting changes 
in cerebrovascular resistance as evidence of direct vasodilatation by 
halothane have been cited above. Galindo and Baldwin themselves point out 
"it was difficult to differentiate between the effects of hypotension or 
halothane itself on the internal carotid vascular resistance ". 
Williams (1964) also concluded that halothane in unknown concentrations 
was a cerebral vasodilator. He perfused one common carotid artery in the 
dog by means of a pump oxygenator after cross clamping both vertebral and 
the opposite common carotid artery during a study of the increase in 
carotid vascular resistance produced when cold blood is infused into the 
carotid artery. He reported that if halothane was administered during 
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the infusion of cold blood carotid flow was increased by 37% though he did 
not state what the "anaesthetic gases" were for the control measurements. 
As these experiments were performed in dogs, the objections to the use of 
carotid flow measurement as an indicator of cerebral flow are the same as 
those discussed above in relation to the work of Galindo and Baldwin. 
Indeed the author ascribes the absence of an increase in carotid flow 
during CO2 administration to vasoconstriction produced by CO2 in the muscle 
bed perfused by carotid blood. Consequently the increase in flow with 
halothane could equally be ascribed to halothane induced vasodilatation in 
the skin and subcutaneous tissues. 
Schmahl (1965) has measured the effect of halothane on the blood flow 
through the thalamus and hypothalamus using the thermoelectric heat 
clearance technique of flow measurement. This is a non -quantitative 
technique of measurement. He found that 1.9% halothane markedly elevated 
blood flow despite a 30 mm.Hg. reduction in mean blood pressure. However 
Schmahl made his measurements in spontaneously breathing cats during the 
administration of 1.9% halothane. This concentration must have produced 
severe respiratory depression since Beaton (1959) has shown that 2.5% 
halothane actually causes respiratory arrest in cats. The consequent 
hypercapnia in Schmahl's study must have contributed to and may even have 
accounted for the rise in cerebral blood flow found. 
Woliman, Alexander, Cohen, Chase, Melman & Behar (1964) have employed 
the technique of Lassen and Munck (1955) to measure cerebral blood flow in 
man during halothane anaesthesia. This technique is a modification of the 
Kety - Schmidt (1948) method and uses radioactive krypton as the inert gas 
in place of the original nitrous oxide. It therefore, like the Kety - 
Schmidt technique, measures total cerebral blood flow. Wollman and 
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co- workers anaesthetised healthy volunteers with 1.2`¡ halothane in oxygen 
and controlled ventilation, usually after obtaining muscular paralysis with 
tubocurarine. Measurements of cerebral blood flow were made after at least 
90 minutes of anaesthesia with 1.2% halothane and the results were assessed 
by comparison with the values obtained in the same laboratory by the same 
technique in another group of conscious healthy volunteers. Assessed in 
this way, this concentration of halothane caused a 15% increase in total 
cerebral blood flow despite a fall in mean perfusion pressure to 56 mm.Hg. 
The authors state that this increase in flow was statistically significant 
but their criteria for significance appear to be different from the 
the 
conventional limits since p value given was <.1. The only other 
reservation that one might have about this carefully conducted study is some 
misgiving about the use of control values from a different group of 
subjects not studied at the same time, especially since there was in this 
study as in most others a considerable variation between individuals in 
cerebral blood flow under identical conditions. In the present thesis the 
influence of variation between the individual animals has been minimised 
by always comparing observations in the same animal. 
The results of Wollman et al. appear to be very much in line with the 
results of the present study, i.e. they obtained an increase in flow of 15% 
with 1.2% halothane while in the present study flow increased 24% with 2% 
halothane. However the similarity cannot be pressed tooclosely for 4 
reasons (1) possible species differences, (2) Wollman et al. measured total 
cerebral flow while the present study was concerned only with cerebral 
cortical flow, (3) in the study of Wollman et al. the mean arterial Pco2 
was 4 mm.Hg. lower in the halothane group as compared with the conscious 
group, and (4) their control values were of flow during consciousness while 
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in this study the control values were obtained under light anaesthesia with 
nitrous oxide. 
An almost identical study was subsequently published by McHenry, 
Slocum, Bivens, Mayes & Hayes (1965). These workers found that 1.Q;ß 
halothane in nitrous oxide -oxygen was associated with a value for total 
C.B.F. as determined by the technique of Lassen and Munck which was 55% 
greater than that in a group of conscious subjects studied concomitantly. 
This rise is very much greater than one would expect from the finding in 
the present study of a rise of 24 with 2% halothane. 
McHenry et al. were measuring total cerebral flow while 
cortical flow was measured in the present studies would 
The fact that 
only cerebral 
seem unlikely to 
account for the difference since it is difficult to believe that the non- 
cortical components, which are largely white matter with only a fifth of 
grey matter flow, could increase their perfusion enough to produce so great 
a total rise. This 55'. increase was also greatly in excess of the 15% 
rise obtained by Wollman et al. with an almost identical concentration of 
halothane. The fact that McHenry et al. used nitrous oxide as the carrier 
for the halothane while Wollman et al. (1964) used oxygen cannot explain 
the discrepancy since it has been demonstrated (Wollman et al., 1965) that 
nitrous oxide anaesthesia does not alter cerebral perfusion from the 
conscious level. McHenry et al. explain the discrepancy by pointing out 
that the mean blood pressure in their series was higher than that in the 
group studied by Wollman et al. (76 mm.Hg. compared with 56 mm.Hg.) and also 
that the methods of calculating the C.B.F. differed somewhat. The 
difference in blood pressure between the two groups would certainly account 
for part of the discrepancy but the difference in calculating the flows 
would have just the opposite effect to that claimed by the authors. These 
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workers used, without later mathematical correction, an equilibration 
period of krypton inhalation of only 10 minutes although it has been 
clearly established by Lassen and Munck (1955) that even at 14 minutes 
equilibration between blood and brain for krypton is not complete. There 
is in fact good evidence of incomplete equilibration of the brain in the 
paper itself for in the two "typical" clearance curves illustrated, the 
arterial radioactivity at the start of washout was higher than the jugular 
venous activity. The error introduced by failure to reach equilibration 
between blood and brain concentration of krypton will be greater the lower 
the C.B.F. The control value for flow will therefore be higher than the 
true control value, as pointed out by the authors. However, given that 
halothane increases flow, the error will be less during halothane 
administration and therefore the halothane and control values will be 
closer than the true relationship, not the reverse as suggested in the 
paper. 
A more likely explanation of the greater increase in flow is the fact 
that the mean arterial Pco2 in the anaesthetised patients was 47 mmHg. 
while the control flows during consciousness were presumably measured at 
Pco2 values within or below the normal range. Fortunately, however, a 
graph is given in the original paper relating flow under halothane anaesthesi 
to arterial Pco2. From this one can calculate that at a Paco2 of 40 mmHg. 
cerebral blood flow would have been about 71 ccs. /100 G. /min. under 
halothane anaesthesia, a rise of 25 ¡,. This order of flow increase would 
certainly be in keeping with the results presented in the studies reported 
here. 
On the other hand, there are two studies reporting decreases in cerebral 
blood flow with halothane. In the first recorded study of the effects of 
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alothane on cerebral blood flow which came from this laboratory (McDowall, 
Harper & Jacobson, 1963), a fall in both the blood flow and the oxygen 
uptake of the cerebral cortex was observed with this anaesthetic drug. In 
those experiments however very low concentrations of halothane were used 
(less than 0.5;x) and the drug was vaporised in air or oxygen. Consequently 
the level of anaesthesia was very light and the situation was not comparable 
with the present studies in which clinical concentrations of halothane in 
nitrous oxide have been employed. That earlier study did however 
demonstrate that very low concentrations of halothane in air produce 
reductions in blood flow in certain cortical areas. The reasons for 
believing that the flow reduction was regional is that if the measured flow 
is multiplied by the whole cortex arterio- venous oxygen difference the 
figure obtained for oxygen uptake is half that existing under nitrous oxide 
anaesthesia. Since, as we have seen, 2 halothane only reduced oxygen 
uptake by 33' it is almost inconceivable that less than 0.5% should cause a 
fall of 50%. The error in this calculation must therefore be that the 
localised flow measured was not representative of the rest of the cortex 
during anaesthesia with less than 0.5% halothane. This conclusion appears 
obvious now but was not so before the present studies on cerebral metabolism 
under different concentrations of halothane were performed. In the present 
work it has been shown that with 0.5. and 2% halothane flow over the cortical 
surface is fairly uniform and therefore valid calculations of oxygen uptake 
can be made from the localised flow determinations. There are several other 
factors which may have been active in producing the decrease in flow with 
halothane observed in this study. Firstly, this was a very early study 
and technical experience in making the surgical preparation was limited. 
Consequently it is likely that the exposed area of brain had been subjected 
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to more trauma than in later studies. It has been pointed out that after 
such brain trauma cerebral blood flow become dependent on perfusion 
pressure, i.e. autoregulation is lost (Harper 1965). Since halothane 
administration in these experiments lowered the blood pressure, the 
observed fall in flow may have been partly due to this. 
Secondly, because the surgical preparation was slower in these 
early studies, the total dose of thiopentone administered was greater than 
in later work. Consequently although time was allowed for the E.E.G. to 
recover from thiopentone depression, the plasma levels of barbiturate must 
have been higher than in later studies. Under such circumstances Betz, 
Oehmig and Wunnerberg (1965) have shown that halothane reduces rather than 
increases cerebral blood flow. 
Several factors were therefore at work in leading to this first result 
that halothane was a cerebral vasoconstrictor. Unfortunately their 
influence could not have been foreseen on the basis of the information 
available at that time. 
Christensen, Hoedt- Rasmussen & Lassen (1965) used a radioactive gas 
clearance technique ZSIEMbeelaCCOMOC±CECOMar with external counting to measure 
cerebral blood flow ( Hoedt- Rasmussen, 1965) during anaesthesia with 1% 
halothane in oxygen in man. They reported that halothane reduced the 
cerebral blood flow by 21 compared with the value obtained in the same 
four patients during consciousness. Both groups of observations were made 
at a Paco2 of 40 mm.Hg. It is very difficult to see why this study yielded 
this result which is contrary to the studies reported above and contrary to 
the work of Wollman et al. (1964) and of McHenry et al. (1965). The mean 
blood pressure in these patients certainly dropped dramatically during 
halothane anaesthesia (mean = 60 mm.Hg.) but no more than in the study of 
ö(. 
Wolluran et al. (mean = 56 mm.Hg.). Induction of anaesthesia in both 
studies was with halothane in unpremeditated patients, in both studies the 
drug was administered in 100; oxygen and in both studies muscular paralysis 
was achieved with tubocurarine. The only apparent difference is that 
Christensen et al. were studying patients of a chronic mental institution 
while s,ollman et al. made their measurements on healthy volunteers. At 
present nothing is known of the possible variability of the cerebral 
circulatory response to halothane in mental disease. 
In summary, the experiments reported here indicate that halothane is 
a cerebral vasodilator, the effect being small and short lived with 0.5% 
halothane but well marked with higher concentrations. With very high 
concentrations the fall in cerebral perfusion pressure prevents any rise 
in flow despite markedly decreased cerebrovascular resistance. 
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Table 22A Oxygen uptake of the cerebral cortex during anaesthesia 
with 0.5% halothane expressed as percentages of the oxygen 




with 2 Halothane 
as % of Control 












Table 22B Oxygen uptakes of the cerebral cortex during anaesthesia with 
2% halothane expressed as percentages of the oxygen uptake 
during nitrous oxide -oxygen anaesthesia in the same animal. 
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(e) Discussion 
2. Effect of Halothane on the Oxygen Uptake of the Cerebral Cortex 
The validity of the above measurements of cerebral cortical oxygen 
uptake rests on two assumptions: (1) that flow in the monitored area is 
representative of all areas of cortex draining into the sagittal sinus 
anterior at the point of sampling and (2) that the venous blood in the sinus 
has drained mainly from the cerebral cortex. Assumption (1) has been 
verified by the demonstration that blood flow over the cerebral cortex is 
fairly uniform during halothane anaesthesia (Table 17). The evidence for 
accepting assumption (2) has been given in the main methodology section. 
These studies have demonstrated that halothane reduced the oxygen 
uptake of the cerebral cortex below the level existing under light nitrous 
oxide -oxygen anaesthesia. The reduction in oxygen uptake appears to be 
dependent on the concentration of halothane administered, 0.5% producing a 
fall of 14%, 2% halothane reducing uptake by 33 %. To test whether this 
reduction with 2% halothane was significantly different from that with 0.5% 
the individual results were recalculated as percentage changes on the control 
value in the same animal and the statistical significance of the differences 
between these two groups of percentage changes calculated (see Table 22A and 
B). In this way the statistical effect of the variability of the control 
value for oxygen uptake under nitrous oxide- oxygen anaesthesia between 
individual animals was reduced. These calculations showed that 0.5% 
halothane reduced the oxygen uptake of the cerebral cortex to 88% of the 
value existing under nitrous oxide -oxygen while 2% halothane caused a fall to 
70% of the nitrous oxide -oxygen value; the difference between these two 
results being highly significant (p <,.001). Increasing concentrations of 
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halothane therefore cause progressively greater depression of the metabolic 
activity of the cerebral cortex during general anaesthesia. The E.E.G. 
patterns which were associated with these two levels of depressed cerebral 
oxygen uptake have been shown in Figure 7. 
There have been no other studies of the oxygen uptake of the cerebral 
cortex with which to compare the above results. Wollman et al. (1964) 
measured the oxygen uptake of the whole brain during anaesthesia with 1.2% 
halothane in oxygen. They reported that during halothane anaesthesia the 
oxygen uptake was 15% below that of conscious man. However the oesophageal 
temperature of their anaesthetised subjects was 36 °C and they concluded that 
"most of the 15% depression of C.M.R.o2 seen in this study results from the 
lowered body temperature of the subject. A small reduction of C.M.R.o2 
by the anaesthetic agent itself cannot be ruled out ". 
In the study by McHenry et al. in which 1% halothane in nitrous oxide - 
oxygen was used, a fall of 27% in cerebral metabolic rate below conscious 
values was found. This result with 1% halothane in nitrous oxide is 
compatible with the present finding of a 14% reduction with 0.5% halothane 
and a 33% fall with 2% halothane in nitrous oxide. In McHenry et al.'s 
patients, as in the present study, induction of anaesthesia was with 
thiopentone. The correlation improves even further when one remembers that 
this 27% reduction is probably an overestimate of the true fall in cerebral 
metabolic rate because of the already mentioned methodological criticisms 
of their study. These criticisms imply that the control flow results and 
therefore the control values for C.M.R.o2 were too high while the halothane 
results were less in error. It is very surprising to find these authors 
commenting that the depression in cerebral metabolic rate which they 
demonstrated with halothane "is similar to the depression noted with other 
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anaesthetic agents ". Their reference for this statement is to Sokoloff 
(1959) who in reviewing the literature found no evidence as to the effect 
of volatile anaesthetic drugs other than an unpublished report by Kety 
that ether caused an unspecified depression of C.M.R.o2. The barbiturates 
of course lower cerebral metabolic rate but there is not a priorireason for 
assuming that the volatile agents will do the same. 
A general discussion of the relationship between flow and metabolic 




3. Arterio- venous Differences for Oxygen, Hydrogen Ion Concentration 
and Carbon Dioxide Tension across the Cerebral Cortex under Halothane 
Anaesthesia 
The observed narrowing of the arteriovenous differences for oxygen, 
pH and Pco2 with the administration of 0.5 must be entirely ascribed to the 
fall in metabolic activity of the cortex since the mean blood flow did not 
change. The higher venous oxygen saturation in the first 20 minutes of 
halothane administration, however, was in part due to the increased flow 
noted at this time. With 27, halothane the elevation of cerebral cortical 
flow and the further depression of oxygen uptake together produced a very 
large rise in the saturation of the cerebral venous blood and a greater 
narrowing of the A -V differences. 
One may also consider these results from the viewpoint of changes 
produced in cerebral tissue oxygenation during halothane anaesthesia. The 
mean venous oxygen saturation under nitrous oxide -oxygen was 58.3% and 
58.7% in the two halothane studies (Table 19). From the dog's oxyhaemo- 
globin disassociation curve (Rossing & Cain, 1966) one can calculate venous 
Po 
2 
from these values and the simultaneously determined venous pH (7.23 
and 7.25). The corresponding venous oxygen tensions are 40 mm.Hg. and 
39 mm.Hg. The mean haemoglobin concentration for these animals was 
16.1 ±6.7gm. /100 cc. blood and therefore the mean arterio - venous oxygen 
content difference can be calculated to have been 8.5cc. /100cc. blood. If 
one assumes that oxygen is extracted from the blood as it moves along the 
brain capillaries at a constant rate and that pH falls uniformly then one 
can calculate that the mean capillary Po2 under these circumstances would 
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have been 63mm.Hg. (using an 11 stage integration). 
Kety (1957) has produced a mathematical derivation of mean tissue Po2 
from mean capillary Po2 in the following form: - 
P. = Po -A (mR2 /4d) 
where p is the mean tissue Po2 
po is the mean capillary Po2 
A is a factor relating to the geometry of the model; in this case 
a simple cylindrical capillary tissue model is assumed with capillary 
flow running parallel in the same direction. In calculating A, the 
radius of the capillary has been assumed to be 3.5 u and the radius 
of the tissue cylinder served by the capillary to be 30 u ( Horstmann, 
1960; Lierse & Horstmann, 1965; Lubbers D.W. - personal 
communication). This yields a value of 2.73 for A (Kety, 1957). 
m is the oxygen consumption of the tissue which of course is known 
from the above results. The assumption is made that the specific 
gravity of cerebral cortex is unity. 
R is the intercapillary distance. For the cerebral cortex this is 
known to be of the order of 30 u (Horstmann, 1960), i.e. half the 
usual capillary distance for the cerebral cortex (Lubbers - personal 
communication). 
d is the diffusion coefficient of oxygen in tissue: Kety's value of 
2.1x10 8mis.02 /cm.2 /min. / mm.Hg. has been used. 
In this way it can be calculated that the mean cerebral cortical 
tissue Po2 under nitrous oxide anaesthesia was 44 mmHg. 
When 0.5 halothane was administered the cerebral venous oxygen 
saturation rose to 62.22. At the observed venous pH of 7.22 the 
calculated venous Po2 was therefore 43 mm.Hg., the calculated moan 
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capillary Po2 was 64 mmHg. and the calculated mean tissue Po2 was 47 mm.Hg. 
With 2¡ halothane the same calculations have been performed taking into 
account the change in oxygen consumption of the brain. The values are: 
under 2¡. halothane, cerebral venous oxygen saturation = 75.0% 
cerebral venous pH = 7.25 
cerebral venous Po2 = 52 mmHg. 
mean capillary Po2 = 76 mm.Hg. 
and mean tissue Po2 = 64 mm.Hg. 
It is clear therefore that 0.5 %. halothane produces little alteration 
in cerebral tissue oxygenation but that higher concentrations produce 
marked increases. 
There are no values in the literature for venous oxygen saturation of 
the superior sagittal sinus under halothane anaest,esia with which to 
compare the present findings. Wollman et al. (1964) measured a venous Po2 
of 53.7 mm.Hg. in blood drawn from the jugular bulb; this is equivalent at 
their observed venous pH to a saturation of 87f. However this result 
cannot be closely compared with the present findings because the arterial 
Po2 was much higher (566 mm.Hg. compared with 120 -150 mm.Hg. in this work) 
and because the drainage territory of the jugular bulb includes the whole 
brain while the superior sagittal sinus drains almost entirely from cortical 
grey matter. 
It is a simple matter to calculate mean tissue Pco2 for the cerebral 
cortex from the measured values of blood Pco2 since Ponten and Siesjo 
(1966) have shown that:- 
Pvco2 - Paco 
mean tissue Pco2 = Pa + ( 
2 
)+ 0.5 mm.Hg. 
2 
96. 
Using this formula it can readily be shown that mean cerebral cortical 
tissue Pco2 fell by about 0.5 mm.Hg. during administration of 0.5% 
halothane. With 2n: halothane, tissue Pco2 fell from 45 to 44 mmHg. 
despite a small increase in arterial Pco2 from 38 to 39 mm.Hg. 
Similar calculations of tissue pH from mean cortical and cerebral 
venous pH values are not possible because active transport mechanisms are 
involved which tend to stabilise tissue pH and make it partially independent 
of blood pH (De Bersaques & Leusen, 1954; Robin, Whaley, Crump, Bickelmann 
& Travis, 1958; Manfredi, 1962; Mitchell, Bainton, Severinghaus & Edelist, 
1964; Severinghaus, 1965). 
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CHAPTER 4 
The Influence of Trichloroethylene on the Blood Flow 
and Oxygen Uptake of the Cerebral Cortex 
(a) Introduction 
It was considered important to study trichloroethylene because it, 
like halothane, is commonly employed in neurosurgical anaesthesia in the 
belief that it has no adverse influence on surgical operating conditions 
(gyre, 1944; Brittain, 1948; Hunter, 1948; Woringer, Brogly & Schneider, 
1951; Ballantine & Jackson, 1954). 
The chemical formula of trichloroethylene is:- 
Cl Cl 
I I 
C = C 
( I 
H Cl 
It has a blood : gas partition coefficient of 9.15 and so is approximately 
four times more soluble in blood than in halothane. The rate of increase 
of arterial concentration is therefore slower than that of halothane. In 
fact Mapleson (1963) has shown that, because trichloroethylene is 
metabolised, its arterial concentration never exceeds 20% of the inspired 
concentration and at 10 minutes is only 10% of the inspired. The rate of 
increase of arterial concentration is so slow between 10 minutes and 24 hours 
of administration that the anaesthetic depth remains virtually constant 
(Mapleson, 1963). 
In clinical practice it is usually used as a supplement to nitrous oxide 
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oxygen anaesthesia and is said to be administered in concentrations ranging 
from 0.5 to 2% (Wood -Smith & Stewart, 1964). In fact the administered 
concentrations are in the lower part of this concentration range because 
tachypnoea readily occurs with the higher concentrations (Lee & Atkinson, 
1964) and because, with the usual system of administration (the Boyle 
bottle), concentrations over l% are rarely obtained (Mapleson, 1957). The 
concentration range which was studied in the following experiments was 
therefore 0.3 - 0.9%. 
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(b) Methodoloa 
This drug was studied in the same way as was halothane. After the 
control measurements of flow had been made under nitrous oxide -oxygen 
anaesthesia, trichloroethylene was added to the anaesthetic gases from a 
Fluotec II vaporiser. The vaporiser was set at the 1.0%, 1.5%, 3.0% or the 
4.0¡ settings and at these settings, the vaporiser delivered 0.3, 0.5, 0.7 
and 0.9% trichloroethylene respectively as was determined by refractometry. 
All the results to be cited therefore relate to trichloroethylene 
concentrations of less than 15. 
As with the halothane study, it was decided to make a special study of 
the first 20 minutes of trichloroethylene administration and this was done 
in a second group of experiments, designated Study IB. The methodology in 
this subgroup was the same as described for short halothane administrations. 
Controlled ventilation under paralysis with suxamethonium chloride was 
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Figure 9 All individual values for cerebral cortical blood flow during 
trichloroethylene anaesthesia as compared with the control values during 
unsupplemented nitrous oxide oxygen anaesthesia. The vasodilatatory 
action of trichloroethylene during the first 20 minutes of its adminis- 
tration is clearly seen. Dog no. 4 of this series (20/6/63) behaved 
atypically, showing a decrease in flow throughout trichloroethylene 
administration. 
101. 
N 0+ 0 
2 2 (PROLONGED 
ADMINISTRATION) 
N 0+ 0 
2 2 
(lst 20 MINUTES) 
Blood 0.76 0.72 0.83 1.11 ** 
Flow -0.11 ±0.15 -0.20 ±0.37 
Mean 151 147 155 157 
B.P. -27 -22 -24 -20 
Pa 35.9 35.3 39.5 39.4 
-2.6 -2.5 14.4 13.8 
0 
Table 23. The effect of trichloroethylene on blood flow through the 
cerebral cortex. 
(* = p < 05; ** = p < .01; *** = p < .001) 
(The blood flow results (mls./G./min.) are mean values based, in the 
study of prolonged administration of trichloroethylene, on 18 nitrous 
oxide measurements and 31 trichloroethylene measurements in 6 dogs. 
In the study of the first 20 minutes of administration, there were 49 blood 
flow measurements under nitrous oxide - oxygen and 21 measurements during 
trichloroethylene administration in 11 dogs. B.P. and Paco2 in mm.Hg.) 
102. 
N 0+ 0 
2 2 
Trichloroethylene 
N 0+ 0 
2 
2 2 1st 20 minutes 
C.V.R. 
2.03 2.08 1.97 1.55 ** 
±0.67 ±0.60 ±0.60 ±0.56 
Mean 151 147 155 157 
B.P. ±27 ±22 ±24 ±20 
Table 24. The effect of trichloroethylene on cerebrovascular 
resistance and mean blood pressure. 
(* = p < 05; ** = P < .01; * ** = p < .001) 
(B.P. in mm.Hg.) 
103. 
N20 + 02 PROLONGED 
TRICHLOROETHYLENE 
A02 97.7% 98.4% 
-2.3% ±1.6% 
Art. pH 7.31 7.31 
-0.03 -0.04 
Pa 35.9 35.3 
±2.6 ±2.5 
Table 25 Mean values for arterial oxygen saturation, arterial 
pH and Pa during nitrous oxide - oxygen anaesthesia 
o2 
and during prolonged anaesthesia with trichloroethylene 
(Arterial oxygen saturation (Ao2) in percentage 
and Paco2 in mm.Hg.) 
104. . 
(c) Effect of Trichloroethylene on Blood Flow through the Cerebral Cortex 
Study lA - Prolonged Administration of Trichloroethylene 
Six experiments were performed in which trichloroethylene was 
administered for a prolonged period of time (up to 3 hours) and flow 
measurements made repeatedly. The individual results are in Table App. 13 
and Figure 9 and the mean results are given in Table 23. It will be seen 
that mean cerebral cortical flow under trichloroethylene was not 
significantly different from mean flow under unsupplemented nitrous oxide - 
oxygen anaesthesia at the same carbon dioxide tension. One animal however 
showed an atypical decrease in flow of about 25% throughout trichloroe- 
thylene anaesthesia (indicated distinctively in Figure 9). All the mean 
results given include the measurements made in this animal but even if it is 
excluded the mean cerebral cortical flow under trichloroethylene in the 
other five experiments was still not significantly different from the mean 
nitrous oxide value. 
The mean blood pressure during trichloroethylene anaesthesia was not 
significantly different from that during nitrous oxide anaesthesia nor was 
there any significant difference in the mean values for cerebrovascular 
resistance (Table 24). 
No difference was detected between the mean values for arterial oxygen 
saturation, arterial pH, or arterial carbon dioxide tension between the two 
groups of observations (Table 25 and Table App. 14) 
105. 






Art. ph 7.28 
7.28 
-0.06 -0.07 
Pa 39.5 39.4 
14.4 ±3.8 
Table 26 Mean values for arterial oxygen saturation, arterial 
pH and Pa during nitrous oxide - oxygen anaesthesia 
2 
and during the 1st 20 minutes of anaesthesia with 
trichloroethylene. 
(Arterial oxygen saturation (Ao2) in percentage 
and Paco2 in mm.Hg.) 
106. 
(c) Effect of Trichloroethylene on Blood Flow through the Cerebral Cortex 
Study 1B - 1st 20 minutes of Trichloroethylene Administration 
These results were obtained during short administration (up to 20 
minutes) of trichloroethylene in concentrations of less than 1%. The 
results obtained in Study lA during the first 20 minutes of administration 
have been also included in this section. There were 21 measurements of 
cerebral cortical flow in 11 animals during the first 20 minutes of 
trichloroethylene; individual results on Table App. 15 and Figure 9 and 
mean results are on Table 24. 
During the first 20 minutes of trichloroethylene anaesthesia there was 
a pronounced and highly significant increase in cerebral cortical flow 
( +34 %; p < .001). Since there was no change in mean blood pressure, the 
cerebrovascular resistance fell significantly (Table 24). 
The values for arterial oxygen saturation, arterial pH and arterial 
Pco2 were virtually identical between control and trichloroethylene groups 
(see Table 26 and Table App. 16). 
8mins. 09% TRICHLOROETHYLENE 
13 mins. 09% TRICHLOROETHYLENE 
30mins. 0-9x TRICHLOROETHYLENE 
Figure 10 The E.E.G. of the dog during anaesthesia with 0.9% trichloro- 
ethylene. 
108. 
N20 + 02 TRICHLOROETHYLENE 
* 
Oxygen 0.061 0.053 
Uptake -0.018 ±0.019 
** 
Pharyngeal 38.3 37.8 
Temperature -0.6 -0.8 
Table 27 The effect of trichloroethylene on the oxygen uptake 
of the cerebral cortex. 
(* = p < .05; ** = P ..01; *x* = p < .001) 
(Oxygen uptake results (mls./G./min.) are mean values based on 
41 measurements under nitrous oxide -oxygen and 38 measurements during 
anaesthesia with trichloroethylene in 9 dogs. Pharyngeal temperature 
in °C.) 
CEREBRAL VENOUS OXYGEN SATURATION 
N20 + 02 TRICHLOROETHYLENE 
* 
Prolonged 54.5 61.0 
Trichloroethylene +4.2 +7.7 
*** 
1st 20 minutes 64.3 78.0 
Trichloroethylene -10.3 -11.1 
Table 28 Values for oxygen saturation of cerebral venous blood 
during nitrous oxide anaesthesia and during trichloro- 
ethylene anaesthesia (both prolonged administration and 
administration for less than 20 minutes). 


























































































































































































































































































































































































































































































































































































































(d) Effect of Trichloroethylene on E.E.G., Oxycen Uptakes Cerebral Venous 
Oxygenation and Cerebral Arterio- venous Differences 
The effect of increasing duration of administration of 0.9% trichloroe- 
thylene on the E.E.G. in the dog is shown in Figure 10. It can be seen 
that despite the high blood solubility of the drug, obvious changes were 
produced in the electrical activity of the brain within 8 minutes of the 
commencement of trichloroethylene. These changes consisted of the 
appearance of theta waves on which was superimposed the same fast activity 
present before trichloroethylene. After 13 minutes the record was 
dominated by high amplitude delta waves together with some theta activity. 
There was no great change in the E.E.G. pattern between 13 and 30 minutes 
of administration which is in accord with Mapleson's prediction (1963) that 
arterial trichloroethylene concentration will remain virtually constant 
after the first 10 minutes of administration. These E.E.G. changes are 
similar to those found in man (Faulconer & Bickford, 1960). 
The administration of trichloroethylene produced a significant 
reduction of l3; in the oxygen uptake of the cortex; individual results 
Table App. 17, mean values Table 27. The mean oesophageal temperature was 
0.5(6 lower in the trichloroethylene measurements. 
The values for arterial and cerebral venous oxygen saturation, for 
cerebral arterio- venous oxygen difference, for arterial and cerebral -venous 
Pco2 and cerebral arterio- venous Pco2 difference and for arterial and 
cerebral venous pH and cerebral arterio- venous pH differences are given 
individually in Table App. 18A and B and the mean values are in Tables 28 
and 29. The mean cerebral venous oxygen saturation was higher during 
prolonged trichloroethylene administration than during nitrous oxide 
112. 
anaesthesia; 61.0% cf. 54.5%) and this result was statistically significant 
(Table 28). During the first 20 minutes of trichloroethylene administratio 
the saturation of the cerebral venous blood was very greatly increased on 
the nitrous oxide value (78% cf. 64%); this result was highly significant 
(p < .001) (Table 28). Similarly, during this early period of trichloroe- 
thylene anaesthesia the cerebral arterio- venous difference for oxygen was 
lower (21% cf. 34%; p < .001). The arterio- venous Pco2 difference was 
also significantly smaller (5.7 mmHg. cf. 10.6 mm.Hg.).(Table 29). 
The lower cerebral venous oxygen saturation under nitrous oxide -oxygen 
anaesthesia in Study lA as compared with the corresponding value under 
nitrous oxide -oxygen in Study 1B was due to the lower arterial Pco2 in 
the former study (36 mm.Hg. cf.40 mm.Hg.). 










Ihr. 2 hrs. 
Figure 11 Changes in cerebral cortical blood flow with trichloroethylene 
in one animal. On administration of 0.0 trichloroethylene there was a 
marked increase in blood flow but this was not maintained with time. 
When the concentration of trichloroethylene was increased to 0.9%, there 
was a second short lived increase in blood flow. 
114. 
(e) Discussion 
1. The Influence of Trichloroethylene on Blood Flow through the 
Cerebral Cortex 
These results demonstrate that trichloroethylene when added to nitrous 
oxide -oxygen in concentration of less than 1J produces a marked increase in 
cerebral cortical blood flow during the first 20 minutes of its administ- 
ration. The cerebrovascular resistance falls considerably at this time and, 
since blood pressure is not affected, this must indicate cerebral vaso- 
dilatation. After this initial phase both flow and cerebrovascular 
resistance return to their previous control levels despite continuing 
trichloroethylene administration. These conclusions are reached on the 
basis of the statistically analysed mean data given above. To illustrate 
these changes each measurement of blood flow during trichloroethylene 
anaesthesia has been plotted against the duration of trichloroethylene 
administration in Figure 9. This figure demonstrates clearly the early but 
short -lived increase in cerebral blood flow which occurs with this drug. 
In Figure 11 the results from one animal have been plotted against time. 
When trichloroethylene was first administered to this animal, there was a 
large increase in cerebral cortical flow. This increase fell away quite 
rapidly so that after 20 minutes of administration the cortical flow was not 
different from the control value. At this point the trichloroethylene 
concentration was abruptly increased when there was another, though less 
marked, increase in flow but again this was not maintained. One may 
conclude then that when the cerebral cortical vessels are first exposed to 
trichloroethylene, they dilate but tacbyphylaxis to this effect of trichlor- 
oethylene quickly develops and the vessels return to their previous diameter. 
115. 
The only other reference to the effect of trichloroethylene on 
cerebral blood flow is a brief account in an article by Nowill, Stephen 
and Searles (1953) which states that trichloroethylene causes an increase 
in cerebral blood flow which is less than that which follows administration 
of 5 002. This conclusion was based on measurements in rabbits and one 
monkey using the thermoelectric probe technique of flow measurement. Since 
these workers give no details of their measurement technique nor of their 
actual results it is impossible to assess the validity of their conclusions. 
They do not state the circumstances under which the control measurements 
were made, nor do they indicate the site of the brain in which flow was 
measured nor do they report the arterial carbon dioxide tension, the blood 
pressure or the body temperature of their experimental animals. 
116. 
(e) Discussion 
(2) Effect of Trichloroethylene on the Oxygen Uptake of the 
Cerebral Cortex 
Trichloroethylene in concentrations of less than 1% reduced the oxygen 
uptake of the cerebral cortex by 13% below the level existing during 
unsupplemented nitrous oxide -oxygen anaesthesia. Unfortunately the mean 
oesophageal temperature during the trichloroethylene measurements was 0.5 °C. 
lower than during the nitrous oxide measurements. It is well recognised 
that cerebral oxygen consumption is reduced when the body temperature falls. 
Rosomoff and Holaday (1954) have studied the relationship between tempera- 
ture and cerebral oxygen uptake in the dog and found that oxygen uptake 
falls by 6 -7% per °C. Using this data one can see that of the 13, fall in 
oxygen uptake of the cerebral cortex found during trichloroethylene 
anaesthesia approximately 3% was due to the 0.5 °C. fall in temperature. 
It is clear therefore that trichloroethylene was itself responsible for the 
greater part of the observed reduction in oxygen uptake during its 
administration.and that the fall in cerebral oxygen uptake during light 
trichloroethylene anaesthesia was similar to that during light halothane 
anaesthesia. 
There is no other information in the literature on the oxygen uptake 
of the brain during trichloroethylene anaesthesia with which to compare 
this result. 
The observed reduction in oxygen uptake together with the increase in 
flow during the first 20 minutes of trichloroethylene administration 
produced a marked increase in the oxygen saturation of the cerebral venous 
blood (Table 28). Substituting the measured values in Kety's 
equation, 
117. 
which was fully discussed in the halothane section, one can calculate that 
during early trichloroethylene anaesthesia the mean cerebral tissue oxygen 
tension rose from 52 mmHg. to 65 mm.Hg. 
118. 
CHAPTER 5 
The Influence of Chloroform on the Blood Flow and Oxygen Uptake 
of the Cerebral Cortex 
(a) Introduction 
Chloroform is a volatile anaesthetic drug which clinically resembles 
halothane in a number of respects but is probably slightly more potent 
(Mg'rch & Jobgen, 1959; Dobkin, Harland & Fedoruk, 1961; McReynolds, 
Thorogood & Morris, 1963). It has largely fallen into disuse because of 
alleged hepatotoxicity and because it is said to predispose to cardiac 
arrhythmias(ood -Smith & Stewart, 1964). However attempts have recently 
been made to reawaken clinical interest in the drug since several authoritie 
believe that its dangers have been seriously exaggerated (Waters, 1951; 
Griffiths & Ozguc, 1964; Davidson, 1965). It was decided to include 
chloroform in the present study because the drug differs chemically from 
the other two halogenated hydrocarbons studied in that it has only a single 
carbon atom. It was felt that a study of chloroform might determine 
whether a relationship between chemical structure and cerebrovascular effect 
existed. 






Its blood : gas partition coefficient is 8.4 and its 
brain : blood 
119. 
coefficient is 1.0. The rate of rise of its arterial concentration 
therefore is greater than that of trichloroethylene but less than that of 
halothane. 
The concentration of chloroform required for maintenance of anaesthesia 
is 0.5 - 1.5% (Wood -Smith & Stewart, 1964) and therefore in these studies 
the concentration administered was 1.0%. 
120. 
(b) Methodology 
After the control measurements had been made in the usual manner, 
during unsuppleimented nitrous oxide -oxygen anaesthesia, chloroform was 
introduced from a Chlorotec vaporiser. The vaporiser was adjusted to the 
IN setting, it having previously been ascertained, by refractometry, that 
at this setting the particular vaporiser used delivered 1.03 chloroform. 
121. 
N20 + 02 i% Chloroform 
* ** 
Blood Flow 0.79 0.94 
-0.19 -0.21 
*** 




Pa 36.3 37.1 
±4.0 ±5.4 
Table 30 The effect of 1% chloroform on blood flow through 
the cerebral cortex. 
(* = p \ .05; ** = p < .01; *** = p < .001) 
(The blood flow results (mis. /G. /min.) are mean values based 
on 35 measurements under nitrous oxide - oxygen and 32 measurements 
during 1% chloroform administration in 12 dogs. B.P. and Paco2 
in mm.Hg.) 
12 2. 






Mean 158 142 
B.P. -12 
Table 31 The effect of 1% chloroform on cerebrovascular 
resistance and on blood pressure. 
(* = P <,.05; ** = P < .01; * ** = p .001) 
(B.P. in mm.Hg.) 
123A 






Art. pH 7.328 
7.285 
-0.039 -0.059 
Paco 36.3 37.1 
2 
+4.0 15.4 
Table 32 Mean values for arterial oxygen saturation, arterial 
pH and Pa during nitrous oxide - oxygen anaesthesia 
o2 
and during anaesthesia with 1% chloroform. 
(* = p < .05; ** = p <.01; 
* ** = p <.001) 
(Arterial oxygen saturation (Ao2) in percentage 
and Paco2 in mm.Hg.) 
124. 
(c) Results 
Effect of Chloroform on Blood Flow through the Cerebral Cortex 
32 measurements of cerebral cortical blood flow were made in 12 
animals during anaesthesia with 1¡ chloroform in nitrous oxide -oxygen. The 
individual results are given in Table App. 19 and the mean results in Table 
30. 
1% chloroform caused a mean increase in cerebral cortical blood flow 
of 24% (p < .001). Of the 32 separate measurements flow increased on 25 
occasions, stayed the same once and fell on 6 occasions. The range of 
individual flow measurements was from -19% to +62%. The longest period of 
administration studied was 12 hours at which time there was no evidence of 
flow returning to the control value. 
With this concentration of chloroform, the mean blood pressure fell 
from 158 to 142 mm.Hg. The cerebrovascular resistance fell very much more 
than could be accounted for by the observed drop in B.P. thus indicating 
cerebral vasodilatation by the chloroform (Table 31). 
The values for arterial oxygen saturation, arterial carbon dioxide 
tension and arterial pH are given in Table 32 and Table App. 20. Arterial 
oxygen saturation and Pco2 were virtually identical in the two groups of 
results but a metabolic acidosis, evidenced by a fall in arterial pH at 
constant arterial Pco2, developed during chloroform anaesthesia in these 
dogs. 
N20 + 02 
15 min. 1% CHLOROFORM 
Figure 12 The E.E.G. of the dog during anaesthesia with i% chloroform. 
126. 
N20 + 02 1% Chloroform 
Oxygen 0.060 0.055 
Uptake -0.013 -0.010 
Pharyngeal 38.0 38.2 
Temperature ±1.3 -1.1 
Table 33 The effect of 1% chloroform on the oxygen uptake of 
the cerebral cortex. 
(Oxygen uptake results (mis. /G. /min.) are mean values 
based on 17 measurements under nitrous oxide - oxygen 
and 14 measurements during anaesthesia with 1% chloroform 










1% Chloroform 71.7 
25.0 
±4.4 ±5.5 
Table 34 The effect of i% chloroform on cerebral venous oxygenation 
and cerebral arterio- venous oxygen saturation difference. 
(* = p <.05; ** = p <.01; *** = p <.001) 
128. 
(d) Results 
The Effect of Chloroform on the E.E.G., Oxygen Uptake, Cerebral Venous 
Oxygenation and Cerebral arterio- venous Differences 
Figure 12 shows the changes in the E.E.G. produced by the administration 
of 15 chloroform. It will be seen that during 15 chloroform, the pattern 
was of delta activity with some superimposed faster theta waves. This 
pattern of electrical activity corresponds exactly with Level V of the 
classification of Pearcy, Knott, Pittinger & Keasling (1957) for the E.E.G. 
changes produced by chloroform in dogs. These workers considered that 
levels III and IV of their classification were indicative of full surgical 
anaesthesia and therefore the cerebral blood flow and oxygen uptake results 
reported in this thesis are those associated with a fairly deep plane of 
surgical anaesthesia. 
14 measurements of cerebral oxygen uptake during chloroform 
administration were made in 6 animals (Table 33 and Table App. 21). The 
observed fall in oxygen uptake of 8n did not reach statistical significance. 
The mean cerebral venous oxygen saturation rose markedly from 61% to 727 
during chloroform administration (Table 34 and Table App. 22). There was 
also a highly significant fall in the arterio -cerebral venous difference for 
oxygen (Table 34 and Table App. 22). Calculation of mean cerebral tissue 
oxygen tension is not possible in this group because at the 
time of these 
studies venous pH was not being measured. 
129. 
(e) Discussion 
These results show that chloroform is a dilator of the cerebral 
vasculature leading to marked increases in cerebral cortical blood flow 
despite small falls in blood pressure. There is one feature that renders 
these chloroform results different from the results with the other volatile 
anaesthetics studied and that is the metabolic acidosis which occurred 
during chloroform administration. The development of metabolic acidosis 
during chloroform anaesthesia in dogs has been noted before by Dobkin, 
Harland & Fedoruk (1961). This acidosis could not, however, have been 
responsible for the observed increase in cerebral blood flow since it has 
been shown that alterations in blood pH, other than those due to changes in 
Paco2, do not affect cerebral blood flow (Harper & Bell, 1963). 
Since chloroform has been in use as a general anaesthetic for well 
over a century one might expect to find a considerable volume of literature 
dealing with its action of cerebral haemodynamics and metabolism. In fact 
there appears to have been only one previous study of the subject. 
Finesinger & Cobb (1935) studied the action of drugs on the cerebral 
circulation by measuring changes produced in the diameter of the cerebral 
cortical vessels lying in the pia mater. They noted that the administration 
of chloroform to cats produced increases in pial artery diameter which 
ranged from 5 to 30yß. They further observed that pial artery dilatation 
was greater in deeper chloroform anaesthesia. The evaluation of these 
findings is difficult because it is clear from their data that many of 
their animals were grossly hypotensive during chloroform administration, 
mean arterial pressures as low as 30 mm.Hg. being recorded. It was not 
until three years after this study that Fog (1938) 
showed that hypotension 
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itself produces increases in pial artery diameter. Fog interpreted these 
changes as evidence of an autoregulatory mechanism tending to maintain flow 
constant despite falling cerebral perfusion pressure - an interpretation 
which has been supported by much recent work (Noell & Schneider, 1944; 
Carlyle & Grayson, 1955; Rapela, Machowicz & Freeman, 1963; Schneider, 
1963; Haggendal & Johansson, 1965; Harper, 1966). Therefore it is not 
possible to be confident that the changes in pial artery diameter noted by 
Finesinger and Cobb during chloroform anaesthesia were produced by the drug 
itself and not by the associated hypotension. Furthermore, the authors 
fail to state how many of their animals were studied under controlled 
ventilation, a vital point since chloroform is a potent respiratory 
depressant (Wood -Smith & Stewart, 1964) and leads to hypercapnia in the 
spontaneously ventilating animal or patient. Finally since the chloroform 
was vaporised in air, and during spontaneous ventilation in some of the 
animals, it is probable that respiratory depression and increased venous 
admixture produced significant hypoxaemia in some of their animals. When 
the arterial oxygen tension falls below 60 mm.Hg. increases in cerebral flow 
occur (McDowell, 1966 quoting unpublished work by Harper, McDowell & 
Jacobson) and therefore part of the observed cerebral vasodilatation may 




,Q, Blood Flow 
.Q Blood Flow 
1120 + 02 
HALOTHANE 39 4 30 - 30% - 13% 
TRICHLOROETFYLEENE 36 4 22 - 24% - 27% 
CHLOROFORM 39 28 - 18% - 15% 
Table 35 Percentage reductions in blood flow through the 
cerebral cortex produced by hypocapnia during anaesthesia 
with halothane, trichloroethylene or chloroform. Also 
shown are the changes in blood flow which are known to 
occur when Pa is lowered to the same degree under 
o2 




Q Blood Flow Q Blood Flow 
Iá20 + 02 
HALOTHARE 43 4 69 + 69% + 41% 
TRICHLOROETHYLENE 36 4 82 + 150¡ + 102¡ 
CHLOROFORM 40 4 63 + 715 + 36% 
Table 36 Percentage increases in blood flow through the cerebral 
cortex produced by hypercapnia during anaesthesia with 
halothane, trichloroethylene or chloroform. Also shown 
are the changes in blood flow which are known to occur 
when Pa is raised to the same degree under unsupplemented 
o2 
nitrous oxide -oxygen anaesthesia. 
133. 
CHAPTER 6 
The Influence of H1ypocapnia and of Hypercapnia on Blood Flow 
through the Cerebral Cortex durin Anaesthesia with 
Halothane, Trichloroethylene and Chloroform 
(a) Introduction 
It was decided to test in several animals the responsiveness of the 
cerebral cortical vessels to changes in arterial Pco2 during anaesthesia 
with these drugs in order to determine whether normal cerebrovascular control 
mechanisms are inactivated by these volatile anaesthetic agents. 
(b) Methodology 
In some animals after measuring flow during the administration of 
halothane, trichloroethylene or chloroform the arterial Pco2 was altered and 
further measurements made. Hypocapnia was induced by increasing the tidal 
volume of the ventilator and hypercapnia by adding CO2 to the inspired gases. 
(c) Results 
The individual' results are shown in Tables App. 23, 24, 25, 26, 27 and 
28. The mean results, expressed as percentage changes are given in Tables 
35 and 36. Included in these tables are the percentage changes in blood 
flow through the cerebral cortex which would occur if Paco2 were altered to 
the same extent under unsupplemented nitrous oxide -oxygen anaesthesia 
(these latter changes being calculated from the results of Harper and 
Glass, 
1965). For example, from Table 35 it can be seen that when 
Paco2 islowered 
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from 36 to 22 mm.Hg. during trichloroethylene anaesthesia, blood flow 
through the cerebral cortex falls by 24 while the same change in Paco2 
during unsupplemented nitrous oxide -oxygen anaesthesia would reduce flow by 
27%. 
(d) Discussion 
These results demonstrate that the cerebral blood vessels retain their 
responsiveness to changes in arterial Pco2 during anaesthesia with these 
volatile anaesthetic drugs. 
During anaesthesia with halothane or chloroform, the mean blood pressure 
was below the values existing under unsupplemented nitrous oxide -oxygen 
anaesthesia. Haggendal & Johansson (1965) and Harper & Glass (1965) have 
shown that the influence of changes in Paco2 on cerebral cortical blood flow 
becomes less as the mean blood pressure is reduced until at a mean B.P. of 
50 mm.Hg. no response to alterations in arterial Pco2 occurs. In order to 
obtain the most meaningful comparisons of CO2 effects during anaesthesia with 
halothane and chloroform, the percentage changes in flow observed have been 
compared with the changes which would have occurred under nitrous oxide - 
oxygen anaesthesia at the same reduced blood pressure. (No significant 
hypotension was present during the trichloroethylene measurements) The 
lowering of blood pressure during nitrous oxide -oxygen anaesthesia in the 
study of Harper and Glass (1965) was achieved by controlled haemorrhage 
while in the present studies hypotension was presumably the result of drug 
induced peripheral vasodilatation and reduced cardiac output. None the 
less, because the cerebral circulation appears to be unaffected by 
(Lassen, 195 
sympathetic vasoconstriction affecting other parts of the body it is 
reasonable to compare results obtained at the same perfusion pressure 
even 
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although the mechanism of hypotension is different in the two situations. 
When the percentage changes in flow with alterations in Paco2 during 
anaesthesia with these drugs are compared with the changes under unsupple- 
mented nitrous oxide -oxygen anaesthesia at the same blood pressure it is 
clear that blood flow is at least as sensitive to changes in Paco2 during 
halothane, trichioroethylene and chloroform anaesthesia. Similar cerebro- 
vascular sensitivity to Paco2 changes during halothane anaesthesia has been 
reported by Alexander, Wollman, Cohen, Chase & Behar (1964) and by McHenry 
et al (1965) but has not previously been described with either 
trichioroethylene or chloroform. 
136. 
CHAPTER 7 
General Discussion of the Results of Part I 
This thesis compares the effects of three volatile anaesthetic drugs, 
halothane, trichloroethylene and chloroform on the cerebral circulation and 
metabolism. The E.E.G. records presented show that the concentrations of 
these drugs administered produced definite changes in the electrical 
activity of the brain indicative of depression of cerebral activity. In 
addition, there is evidence in the literature which allows a comparative 
assessment of the depth of anaesthesia associated with the concentrations 
of these drugs used. 
Dobkin, Harland and Fedoruk (1962) have found that an inspired 
concentration of 1% trichloroethylene produces a depth of anaesthesia in 
dogs similar to that due to 2ó halothane. Dobkin, Harland and Fedoruk 
(1961) and McReynolds et al. (1963) believe that chloroform is slightly 
more potent than halothane at the same inspired concentration though 
MOrch and Jobgen (1959) disagree. In this study therefore 1.% chloroform 
can be considered to fall in anaesthetic potency between 0.5 and 2% 
halothane, being closer to the latter. The increase in cerebral cortical 
blood flow with 1% chloroform was in fact the same as that with b halothane 
The lesser fall in oxygen uptake with chloroform was due to an anomalous 
increase in oxygen uptake found in one animal with this drug, to the 
somewhat lighter anaesthetic depth and to the greater blood solubility of 
chloroform. This last point is relevant because with the greater blood 
solubility the arterial concentration of chloroform rises more slowly and 
so anaesthesia deepens more gradually than is the case with halothane (see 
below). 
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Trichloroethylene in the concentrations administered in this study 
(0.3 to 0.9%) is equivalent to 0.6 to 1.8% halothane (or to slightly 
lower concentrations of chloroform). The depression of oxygen uptake 
produced by trichloroethylene was similar to that produced by 0.5 halothane 
since the majority of the trichloroethylene measurements were made with the 
lower concentrations of trichloroethylene. 
In discussing the anaesthetic concentrations referred to in this thesis 
it is necessary to stress that these were inspired and not alveolar or 
arterial concentrations. On account of the high blood solubility of these 
drugs, the alveolar and arterial concentrations will have been much lower 
than the inspired concentrations in all these studies, the effect being 
greatest with trichloroethylene and least with halothane (Eger & Larson, 
1964). In the case of halothane, Mapleson (1963) has shown that the 
arterial concentration equals 40% of the inspired after 10 minutes of 
administration and 60;% of the inspired.at 60 minutes. The great majority 
of the measurements reported here were obtained after between 10 and 60 
minutes of halothane administration. The comparable figures for chloroform 
are that the arterial concentration equals 20% of the inspired at 10 minutes 
and 40;:', at 60 minutes. With trichloroethylene, the arterial concentration 
is about 10% of the inspired at 10 minutes and does not exceed 20% even after 
many hours of administration.(Mapleson, 1963). The reason for discussing 
the results in terms of inspired concentrations is to allow ready 
correlation with clinical practice and experience since it is invariably 
inspired concentrations which are used clinically. 
Of course if the results presented in this thesis are to be correlated 
with clinical practice then it is necessary to know what the equivalent 
anaesthetic concentrations of these drugs are for 
man and for dog. 
0.5% Halothane 2% Halothane <1 %Trichloroethylene 1% Chloroform 
o0 
+40 - B.P. > 90 
+30- / / /B.P.<90 
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Figure 13 Changes in blood flow and oxygen uptake of the cerebral cortex 
during administration of halothane, chloroform and trichloroethylene. 
With halothane and trichloroethylene, blood flow changes during the first 
20 minutes of administration are indicated by the first block and the 
overall changes by the second block of the respective blood flow columns. 
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Fortunately these equipotent concentrations are rather precisely known from 
the work of Eger, Brandstater, Saidman, Regan, Severinghaus and Munson 
(1965). These workers found that surgical anaesthesia in the dog required 
an alveolar concentration of 0.87% halothane while in man the figure was 
0.74 %. As the surgical stimulus used to test anaesthesia was rather less 
severe in man, these workers concluded that equipotent anaesthetic 
concentrationsof halothane for man and dog are virtually identical. Eger 
et al. did not study either trichloroethylene or chloroform but it seems 
probable from their work that species differences between man and dog in 
sensitivity to the volatile anaesthetics do not exist. 
To turn now to the blood flow results, it is clear from these studies 
that halothane, trichloroethylene and chloroform when administered in 
clinical concentrations act as vasodilators of the cerebral vasculature 
(see Figure 13). Detailed study of the action of different concentrations 
of halothane has further shown that the degree of cerebral vasodilatation 
is related to the concentration of the drug administered. The question 
which therefore arises is why should these drugs which vary considerably in 
chemical structure all act in the same way on the cerebral vasculature. 
The first approach to this problem is to consider what are the other 
pharmacological actions of these drugs which they share in common. Most 
obvious of these is the fact that all are general anaesthetics. However 
the present imperfect understanding of the mechanism of drug action in the 
production of general anaesthesia limits the value of this approach. In 
the studies reported here it has been established that general anaesthesia 
with these drugs is associated with a reduction in the oxygen uptake of the 
cerebral cortex; in other words aerobic cellular metabolism is depressed. 
Is therefore the observed cerebral vasodilatation imatxxict linked in some 
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way to the metabolic depression of the brain produced by these anaesthetics? 
There is a considerable body of evidence against this suggestion. It 
has been shown that in many different situations depression of cerebral 
metabolic rate is associated with a reduction in cerebral blood flow. For 
example general anaesthesia produced by the barbiturate group of drugs 
results in a fall in both cerebral blood flow and in cerebral metabolic 
rate (I'Iimwich et al., 1947; Pierce et al., 1962). Furthermore, Gleichman 
et al. (1962) found that the reduction in cerebral cortical blood flow under 
barbiturate anaesthesia was proportional to the associated depression of 
cerebral metabolic rate. Similar proportionate reductions in cerebral 
metabolic rate and cerebral blood flow have also been demonstrated in 
hypothermia (Rosomoff & Holaday, 1954; Bering, Taren, McMurrey & Bernhard, 
1956). This evidence has led to the formulation of the hypothesis that, in 
the brain, blood flow is regulated to meet metabolic requirements. The 
concept is that flow is controlled by the local tissue tension of carbon 
dioxide so that if metabolism decreases, tissue Pco2 tends to fall and this 
produces an increase in local cerebrovascular resistance and a consequent 
fall in cerebral blood flow. The net result is that tissue Pco2 is 
maintained constant over a range of metabolic rates by adjustment of cerebral 
perfusion. A recent slight modification to this hypothesis has been the 
suggestion that the controlling mechanism is not tissue Pco2 itself but 
tissue pH, which is of course partly dependent on tissue Pco2 (Betz & Kozak, 
1967; Lassen, 1966). 
As has been pointed out, the present results show that the volatile 
anaesthetic drugs, halothane and trichloroethylene depress cerebral 
metabolic rate (the depression of C.M.R.o2 with chloroform just failed to 
reach statistical significance). In the terms of the above hypothesis 
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CEREBRAL VENOUS OXYGEN SATURATION 
BEFORE DURING CHANGE 
0.5 Halothane 58.3% 62.2% 
+3.9` %* 
All results -9.1p ±9.1% 
0.5% Halothane 58.7% 64.6¡ * 
1st 20 mins. +a .1w 
+9.2" +5.9. 
2% Halothane 58.1% 75.0;,. * ** 
+7.4% +3.0;. 
+16.9íi 
< 1;. Trichloroethylene 







<12, Trichloroethylene 54.5% 61.0% * 
Prolonged Administration ±7.7: 
+ 5` 
1, Chloroform 61.1% 71.7% ** 
+5.4% ±4, +10.6% 
Table 37 Comparison of the changes in cerebral venous oxygen saturation 
produced by the various volatile anaesthetics studied. 
(* = p <05; ** = p <O1; *** = p <001) 
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flow therefore should fall. However the converse was the case; flow 
increased while metabolic rate fell and the higher the concentration of drug 
the wider became the discrepancy. Cerebral blood flow during anaesthesia 
with these drugs was therefore "inappropriate" to the level of metabolic 
demand. As a result the oxygen saturation of cerebral venous blood rose 
(results summarised in Table 37) and cerebral venous Pco2 fell, indicating 
changes in the same directions of tissue Po2 and tissue Pco2. 
Do the "inappropriate" increases in cerebral blood flow with these 
drugs imply that the normal controlling mechanisms have been either 
inactivated or depressed? This cannot be the case since flow responsive- 
ness to alterations in Paco2 has been shown to be unimpaired during 
anaesthesia with these volatile drugs. 
One must conclude then that the changes in cerebral blood flow 
produced are in the opposite direction to those predicted by the hypothesis 
of flow regulation to metabolic demand despite the fact that the mechanism 
of metabolic control of flow via tissue Pco2 appears to be functioning 
normally. 
What other pharmacological actions are common to these three drugs? 
halothane and chloroform 
The mean blood pressure fell with xiskximixilimm but this could hardly account 
for an INCREASE in flow. Similarly any depression in cardiac output which 
they caused would if anything affect cerebral perfusion in the opposite 
direction. 
Chloroform produces a sympathomimetic response marked by elevation of 
plasma catechol amine levels (Richardson, Woods & Richardson, 1957) while 
halothane reduces sympathetic nervous activity (Price, Linde & Morse, 1963). 
The common cerebral vasodilatation produced by these two drugs cannot 
therefore be ascribed to changes in sympathetic activity. In any case 
the 
143. 
cerebral circulation is peculiarly unresponsive to changes in autonomic tone 
(Hamel, Hafkenschiel, Austin, Crumpton & Kety, 1949; Sokoloff, 1959). 
Cerebral vasoconstriction however has been shown to accompany intravenous 
infusions of catechol amines in normotensive dogs maintained at constant 
blood pressure (Haggendal, 1965). The cerebral vasodilatation seen with 
chloroform therefore occurred despite and not because of the elevation in 
plasma catechol amines. 
In the absence of any correlation with the known common pharmacological 
actions of these drugs, it becomes necessary to postulate that each of them 
produces vasodilatation "directly" that is by relaxing the tone of the 
smooth muscle of the cerebral arterioles. In this connection the obser- 
vations of Smith and Vane (1966) may be relevant. These workers studied 
the effect on vascular smooth muscle of perfusing isolated strips of artery 
with perfusion fluids of different oxygen tensions. They showed that the 
higher the Fog of the perfusate the greater was the smooth muscle tone, i.e. 
that high oxygen tensions caused "direct" vasoconstriction. From these 
observations they postulated that the tone of vascular smooth muscle is 
dependent upon the enzymatic supply of energy and that this enzymatic 
reaction is oxygen limited so that if the rate of oxygen supply is increased 
then more energy is produced and smooth muscle tone thereby increases. The 
observations reported in this thesis could readily be explained if the 
volatile anaesthetics studied depressed the enzymatic reaction from which 
the energy for smooth muscle contraction is derived. Unfortunately no 
studies have been reported in the literature on the responses of isolated 
vessels to exposure to volatile anaesthetic drugs. Burns and Epstein (1959) 
were able to show that when one dog's hind limb is perfused with blood from 
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Figure 14 Schematic representation of the "shift to the left" in the 
blood flow - Paco2 curve produced by administration of the volatile 
anaesthetics studied (the blood flow - Paco2 relationship under nitrous 
oxide - oxygen anaesthesia is from the work of Harper & Glass, 1965). 
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perfused limb, suggesting a direct action of halothane on the vessel wall. 
This direct response of peripheral vessels to halothane cannot however be 
translated to the cerebral vessels since these latter are known to respond 
differently to humoral and chemical agents even when directly applied 
(Bohr, Goulet and Taquini, 1961). 
It does seem at least possible that drugs which act as depressants of 
cellular metabolism might well depress the rate of the reaction responsible 
for smooth muscle tone and that such depression would be common to all these 
volatile anaesthetics. The fact that the barbiturates which also depress 
cerebral metabolism do not produce cerebral vasodilatation could readily be 
ascribed to failure of such drugs to penetrate the arteriolar wall. 
The observation that the responsiveness of cerebral blood flow to 
changes in Pco2 is not reduced by these drugs means that, although the 
"resting tone" of the cerebral vessels may be lowered, the normal mechanisms 
of control are still active. Figure 14 is a diagrammatic representation of 
this concept. The flow -Paco2 curve produced by Harper & Glass (1965) is 
shown as a continuous line while the dotted line indicates the shift to the 
left produced by the vasodilatatory action of these anaesthetic drugs. It 
will be seen that the flow -Pco2 curves are separated only in the middle 
range of Pco2 values for at very high and at very low Pco2 values it is 
likely that maximum vasodilatation or constriction will have been effected by 
the CO2 level and that the influence of the anaesthetic will be small. 
Besides this interaction between the influence of Pco2 and of volatile 
anaesthetics, there is a relationship between drug effect and mean arterial 
blood pressure. Under nitrous oxide - oxygen anaesthesia in the dog it has 
been demonstrated by Harper (1966) that reducing the mean blood pressure 
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Figure 15 The effects of 0.5%, 2% and 4% halothane on blood flow as 
compared with the blood flow present at similar levels of hypotension 
during nitrous oxide - oxygen anaesthesia (the nitrous oxide - oxygen results 
were obtained from the work of Harper (1966) ). 
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that with reductions below 80 mm.Hg. flow falls proportionately with mean 
perfusion pressure. In addition Harper & Glass (1965) have shown that 
raising the arterial Pco2 has more effect on flow at normal and at high blood 
pressures than it has at low pressures. Indeed at a mean pressure of 50 
mm.Hg. these workers found that arterial Pco2 had no influence on cerebral 
blood flow. The same is likely to be true of these anaesthetic drugs and 
it has been shown in this thesis that 2 halothane is a more potent cerebral 
va.odilator when the mean blood pressure is above 90 mmHg. In Figure 15 
therefore the halothane findings have been superimposed on the flow pressure 
diagram of Harper (1966). This figure illustrates the important point 
that at any blood pressure above that at which flow becomes entirely pressure 
dependent, the administration of halothane increases flow above the level 
which would exist during unsupplemented nitrous oxide -oxygen anaesthesia at 
the same reduced blood pressure. 
From the results presented and the literature reviewed it is now 
possible to describe a composite picture of cerebral haemodynamics and 
metabolism during the course of clinical anaesthesia. Induction of 
anaesthesia in clinical practice in this country is normally accomplished 
with a small dose of barbiturate (0.2 - 0.5 G. in the adult)'sufficient only 
to produce light unconsciousness. Light anaesthesia with barbiturates 
reduces the cerebral oxygen uptake by 36 (Wechsler, Dripps & Kety, 1951) 
and therefore the depression produced by the smaller doses used for induction 
of anaesthesia will be less than this. Concomitantly with the fall in 
oxygen uptake a proportionate fall in cerebral blood flow will occur 
(Gleichmann et al., 1962). Anaesthesia is then often continued with nitrous 
oxide -oxygen together with either halothane or trichloroethylene. From the 
work presented here, it can be stated that the introduction of either of the 
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agents into the anaesthetic mixture will produce a wave of cerebral vaso- 
dilatation and a further reduction in cerebral metabolic rate so that the 
brain will appear more vascular and the colour of the blood in the cerebral 
veins will become lighter as the cerebral venous oxygen saturation rises. 
Any further increase in the concentration of the volatile drug will produce 
a further increase in flow and a deeper fall in cerebral metabolic rate. 
What happens to arterial Pco2 depends on whether ventilation is spontaneous 
or controlled. If spontaneous, then respiratory depression will lead to a 
rise in arterial Pco2 and to a further increase in cerebral blood flow. If 
ventilation is controlled and the patient is hyperventilated then the 
influence of the volatile drug on flow will become less as the arterial Pco2 
falls. The volatile agent will however still produce appreciable cerebral 
metabolic depression so that the saturation of the cerebral venous blood 
and therefore the local tissue Pot will be higher during hypocapnia than 
would otherwise be the case. 
A similar relationship exists for cerebral perfusion pressure. If the 
anaesthetic technique is associated with hypotension then the influence of 
the volatile drug on flow will become progressively less as the mean B.P. 
falls until a level is reached at which flow has become entirely dependent 
on perfusion pressure and will be uninfluenced by the anaesthetic. None 
the less, the volatile anaesthetic will still produce a depression of 
cerebral metabolic rate, so that cerebral tissue oxygen tension will be 
higher during hypotension than if no volatile agent wei administered. 
Clinical Significance of the Results of Part 1 
There would appear to be two main clinical implications of the findings 
of this Part of the thesis. These are:- 
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(1) the possibility that the cerebral vasodilatation seen during the 
administration of these drugs might seriously elevate intracranial 
pressure 
and (2) the possibility that the increased cerebral blood flow and reduced 
cerebral oxygen requirements which accompany administration of these 
drugs might increase the tolerance of the brain to periods of 
circulatory insufficiency. 
The first of these two possibilities forms the basis of Part II of this 
thesis and so need not be considered further here. 
In considering cerebral protection against ischaemia, the anaesthetist 
thinks in terms of four main groups of patients. Firstly there are those 
patients who are presented for surgery with pre -existing cerebral arterio- 
sclerosis. The concern in this group is that anaesthesia may, by lowering 
cerebral perfusion pressure, lead to acute regional ischaemia within the 
supply area of the atheromatous vessel. Secondly there are those patients 
whose perfusion pressure is to be deliberately lowered by drug induced 
hypotension in order to improve surgical operating conditions. The third 
group consists of neurosurgical cases in whom, for surgical reasons, it is 
necessary to temporarily occlude one of the vessels of supply to the brain, 
e.g. the internal carotid artery during carotid disobliteration. Finally 
there is the group of patients who are to undergo elective total circulatory 
arrest in order to allow the performance of cardiac or neurosurgical 
operative procedures. 
From the physiological point of view there are three ways in which 
protection of the brain might be afforded to such patients: - 
(1) the collateral blood supply to an ischaemic area might be improved 
(2) the quantity of oxygen stored in the brain prior to circulatory 
arrest might be increased 
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and (3) the rate of oxygen consumption by the brain might be reduced. 
As regards the collateral blood supply to an ischaemic area, it might 
be held that, because halothane, early trichloroethylene and chloroform 
increase cerebral blood flow, more blood might reach ischaemic areas during 
anaesthesia with these agents. Such an increase of blood flow would be of 
value to patients with pre -existing cerebral arteriosclerosis and to patient 
undergoing procedures requiring regional interruption of the cerebral 
circulation. Of course a more potent cerebral vasodilator than the 
volatile anaesthetics is carbon dioxide and indeed hypercapnia has been used 
as a means of protecting the brain during internal carotid occlusion by Homi, 
Humphries, Young, Beven and Smart (1966) who claimed that this procedure 
reduced the incidence of postsurgical neurological deficit. However, 
Wylie (1966) in discussing this paper by Homi et al. pointed out that only a 
few patients fail to tolerate temporary unilateral carotid occlusion and 
that if one was careful to select only these "at risk" cases it could be 
shown that hypercapnia offered no protection against ischaemic neurological 
damage during carotid occlusion. There are also sound theoretical grounds 
for doubting whether vasodilator drugs could be of any possible benefit 
in this clinical situation because the cerebral vessels in an area of 
ischaemia are already dilated by tissue hypoxia. Administration of a 
cerebral vasodilator under these circumstances may merely divert blood away 
from the ischaemic area because of the consequent reduction in cerebro- 
vascular resistance in non -ischaemic areas. 
It should be noted in this connection that measurement of the oxygen 
content of cerebral venous blood in order to determine the adequacy of 
regional cerebral oxygenation, as has been done during anaesthesia 
by several 
groups of workers (Lyons, Clark, McDowell/ & McArthur, 
1964; Viancos, 
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Sechzer, Keats & DeBakey, 1966) may be fallacious because an increase in 
cerebral venous oxygen content may only indicate diversion of blood by the 
vasodilator away from the ischaemic area. After all, the highest cerebral 
venous oxygenation will occur when the ischaemic area is not perfused at all. 
It is therefore most unlikely that cerebral vasodilatation produced by 
volatile anaesthetics will be of any clinical value in improving the 
perfusion of an area of regional ischaemia in the brain. Indeed the 
converse may occur. 
The possibility of increased cerebral oxygen storage during administ- 
ration of volatile anaesthetic drugs may be quickly dismissed. It is true 
that this thesis has shown that these drugs do elevate mean cerebral tissue 
Po2 but the amount of the increase is small, being of the order of only 
20 mmHg. This together with the low solubility of oxygen in tissue 
establishes the point that the consequent increase in cerebral oxygen storage 
could have only a marginal effect on the safe duration of cerebral circulato 
arrest. However the combined use of hyperbaric oxygen and volatile 
anaesthetic drugs may elevate mean tissue Po2 sufficiently to significantly 
affect cerebral oxygen storage (McDowell, Jennett, Bloor & Ledingham, 1966). 
The finding which has the greatest likelihood of being clinically 
important is the observed reduction in cerebral oxygen consumption with 
halothane and trichloroethylene. The fall in oxygen consumption has been 
shown to be related to the concentration of halothane administered and 
therefore to the depth of anaesthesia. The possibility arises therefore 
that this reduced oxygen requirement of the brain, particularly during deep 
anaesthesia, may prolong the period of cerebral circulatory arrest compatible 
with full neurological recovery. 
Unfortunately there has been no controlled experimental study on this 
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point but since hypothermia also reduces cerebral oxygen requirements 
(Field, Fuhrman & Martin, 1944; Rosomoff & Holaday, 1954; Adams, Elliot, 
Sutherland, Wylie & Dunbar, 1956; Bering, Taren, McMurrey & Bernhard, 1956) 
it is relevant to point out that hypothermia certainly prolongs the period of 
cerebral ischaemia or hypoxia compatible with neuronal survival (Loughheed & 
Kahn, 1955; Owens, Sawyers & Ward, 1956; Rosomoff, 1956; Jacobson & Lawson 
1963; Campkin, 1965). It may be therefore that anaesthesia with these 
volatile anaesthetics will confer a degree of protection to the brain during 
ischaemia and hypoxia in the same way and for the same reason as does hypo- 
thermia. Indeed some quantitative predictions may be made on the basis of 
the data presented in this thesis and the equivalent data from the literature 
on hyopthermia. General body hypothermia to 28 -30 °C. appears to reduce 
cerebral oxygen uptake by 50% (Rosomoff & Holaday, 1954; Adams et al., 1956) 
while 2 halothane reduces oxygen uptake by 335ß. Since hypothermia to 28 °C. 
increases the safe duration of circulatory arrest in dogs by a factor of 3 
(Smith, Ledingham, Norman, Douglas, Bates & Lee, 1963) it may be that 2¡0 
halothane will approximately double the duration of safe circulatory arrest 
at normothermia. Since it has been shown that the degree of depression of 
cerebral oxygen uptake is a function of halothane concentration it is likely 
that 4'¡ halothane will provide even greater protection. 
Although throughout the above discussion, the protection afforded to 
rain by halothane on account of depressed cerebral oxygen consumption 
as been considered in terms of total circulatory arrest, similar protection 
ould be expected also in patients with regional ischaemia due to surgical 
interruption of the cerebral circulation or to pre -existing cerebral arterio- 
sclerosis. In the case of deliberate drug induced hypotension, it 
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is known that the great majority of patients tolerate the reduction in 
/ pressure 
cerebral perfusions without neuronal damage because of the efficiency of 
cerebral autoregulation (Enderby, 1961; Eckenhoff, Enderby, Larson, Davies 
& Judevine, 1963). However tragedies occasionally occur and it is likely 
that anaesthesia with halothane would provide an extra margin of safety. 
During the time that the work for this thesis has been in progress, 
two reports have appeared in which it has been suggested that general 
anaesthesia with volatile anaesthetic drugs protects the brain from regional 
ischaemia during elective temporary occlusion of the internal carotid artery 
(Wells, Keats & Cooley, 1963; Lyons et al., 1964). After the presentation 
of the second of these papers, Spencer (1964) commented "I would seriously 
doubt that the oxygen metabolism of the brain is changed (by general 
anaesthesia) and have not seen any data to prove this concept ". The present 
thesis provides the necessary evidence to substantiate this clinical approach 
to the problem of temporary cerebral ischaemia. 
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AUTHOR' S WORK 
PART II 
Studies of the Influence of Volatile Anaesthetic Drugs 
on Cerebrospinal and Cerebral Venous Pressures 
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CHAPTER 1 
Introduction to Part II of Thesis 
In Part I, it was shown that halothane, trichloroethylene (during the 
first 20 minutes of its administration) and chloroform increase cerebral 
cortical blood flow and it was suggested that one clinically relevant 
consequence of this blood flow increase might be that cerebrospinal fluid 
pressure would be elevated. A search of the literature at the time of 
starting these investigations revealed that it was generally believed that 
anaesthetic agents did not appreciably affect cerebrospinal fluid pressure 
(Bozza, Maspes & Rossanda, 1961) though some authorities excluded ether 
from this generalisation (iirgantanzpri,9214 Woringer, Brogly & Dorgler, 1954; 
Lundberg, Kjallquist & Bien, 1959). 
As regards the anaesthetic agents which are to be examined in this 
thesis, trichloroethylene was generally thought to be without effect on 
c.s.f. pressure (Woringer, Brogly & Schneider, 1951; Sondergard, 1961) 
though Hunter (1964) disagreed with this view. There was some evidence, 
fully reviewed subsequently, that halothane increased c.s.f. pressure though 
the amount of the increase and its mechanism were disputed. From the 
clinical point of view, Brindle, Gilbert & Millar (1957) had advocated the 
use of halothane in neurosurgery because of its "freedom from increases in 
cerebrovenous and cerebrospinal fluid pressures ". One of the surprising 
features of all the previous literature was the absence of any attempt to 
differentiate between the effects of these drugs in patients with intra- 
cranial tumours from the effects in patients without intracranial pathology. 
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Some of the studies did indeed study patients of both groups but the results 
were not separately considered. Finally with respect to chloroform, there 
had been no recent study of the influence of this drug on c.s.f. pressure 
and most of the older evidence was difficult to interpret because of the 
hypotension, hypercapnia and hypoxia which accompanied the administration of 
this drug in air to spontaneously breathing animals. 
The investigations of this Part of the thesis fall into three parts: - 
(1) an initial study on the effects of halothane and chloroform in dogs 
(2) an investigation of the influence of halothane and trichloroethylene 
on c.s.f. pressure in patients without intracranial pathology 




The Influence of Halothane and Chloroform on Cerebrospinal Fluid, 
Cerebral Venous and Central Venous Pressures in Dogs 
(a) Methodology 
Eight unpremedicated, mongrel dogs were studied; in 3 of these the 
study was abandoned for technical reasons (see Table App. 29). Anaesthesia 
was induced with a sleep dose of thiopentone and maintained with 70% nitrous 
oxide and 30% oxygen. Orotrachael intubation was performed and ventilation 
was controlled using an automatic ventilator. To allow control of 
ventilation, muscular paralysis was produced with suxamethonium chloride 
administered as required intravenously diluted in saline to a concentration 
of 1 mg. /cc. 
A catheter was inserted into one femoral artery and advanced until its 
tip lay in the abdominal aorta; this catheter was employed for the 
measurement of mean arterial blood pressure with a damped mercury manometer 
and for the sampling of arterial blood. 
A flexible plastic catheter was placed in the cisterna magna. This 
catheter was of the type which consists of a central metal needle and an 
outer plastic cannula ( "Branula "). The dog's head was fully flexed, a 
short incision was made in the skin at the back of the neck and the 
ombined needle and cannula inserted into the cisterna magna through the 
tlanto occipital membrane. The central needle was then withdrawn leaving 
my the flexible catheter in the cisterna magna. Slowly the dog's neck 
as extended to return the head to its normal position. 
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In 2 animals (dogs nos. 8 & 9) after reflection of skin and muscle, a 
hole 
midline trephine was made in the skull overlying the superior sagittal 
sinus near its midpoint. A metal cannula was inserted into the sagittal 
sinus to allow measurement of the venous pressure within this vessel; this 
pressure will hereafter be referred to as the cerebral venous pressure. 
In experiments 2, 5 and 8 central venous pressure was measured via a 
catheter passed via one external jugular vein into the great veins of the 
thorax. 
In experiments 1, 2 and 5 measurement of c.s.f. and central venous 
pressures was accomplished with simple narrow bore saline manometers. In 
experiments 8 and 9, c.s.f., cerebral venous and central venous pressures 
were measured with pressure transducers (Statham gauges) connected to 
suitable amplifiers (Devices) and thence to an ultraviolet recorder (SE 
Laboratories Ltd.). Calibration of the pressure records was performed at 
the beginning and at intervals of half an hour during the experiment by 
reference to a water manometer. Subsequently the UV record was plotted onto 
arithmetical graph paper and it is these plots which are shown in the 
accompanying illustrative figures. 
Once the surgical preparations had been completed no measurements were 
made until a time of 3 hours had elapsed since the induction dose of 
thiopentone. During this time ventilation was adjusted to produce an 
arterial Pco2 of near 40 mm.Hg., as measured by the technique of Andersen 
et al. (1960). The environmental temperature of the animal was adjusted so 
that the pharyngeal temperature of the dog was close to 38 °C. 
Control measurements of all parameters (i.e. during nitrous oxide -oxygen 
anaesthesia, suxamethonium paralysis and controlled ventilation) were made. 
Then either halothane (Experiments 2, 5, 8 & 9) or chloroform (Experiments 
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1 and 2) was introduced into the anaesthetic gases from the same calibrated 
vaporisers as those used in the blood flow studies. The subsequent changes 
in c.s.f., cerebral venous and central venous pressures were followed and 
recorded. Halothane or chloroform administration was then discontinued 
and further pressure measurements made. The exact protocol differed from 
experiment to experiment and will be described as each experiment is 
discussed. 
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(b) Detailed Description of Methodology 
Much of the methodology of these experiments was the same as that used 
for the cerebral blood flow experiments and so has already been discussed 
in detail. The additional features of these pressure studies were the use 
of sagittal sinus pressure measurements as an index of cerebral venous 
pressure, the measurement of c.s.f. pressure in the cisterna magna and the 
measurement of central venous pressure. 
The insertion of a cannula in the sagittal sinus might have altered the 
venous pressure by producing partial obstruction to the blood flow within the 
sinus. Although narrow cannulae were employed it cannot be denied that the 
presence of the cannula in the relatively rigid sinus must have to a degree 
impeded flow. However the elevation in venous pressure produced must have 
been small because in experiment 9, c.s.f. pressure was measured prior to 
and subsequent to placement of the sagittal sinus cannula and no detectable 
alteration in 'c.s.f. pressure occurred. Since elevating cerebral 
venous pressure increases c.s.f. pressure (Becht, 1920) this lack of change 
in c.s.f. pressure indicates negligible change in cerebral venous pressure as 
a result of the placement of the sagittal sinus cannula. Bedford (1935) 
agrees that a cannula in the superior sagittal sinus of the dog is unlikely 
to produce significant venous obstruction. 
The bone overlying the sagittal sinus was removed to allow exposure of 
the sinus. It is very unlikely that this altered the venous pressure 
within the sinus or the intracranial pressure because the diameter of the 
trephine used was only 1 cm. and because the superior wall of the sinus in 
the dog is so fibrous and non -elastic. To exclude this possibility, 
however, in dog 9 the skull defect over the sagittal sinus was closed with 
101. 
dental cement. 
The cannula in the cisterna magna would not be expected to alter 
intracranial dynamics unless c.s.f. escaped around or through the cannula 
or unless the cannula produced bleeding into the c.s.f. Leakage of c.s.f. 
was considered to be likely if the cannula, having once been in the 
cisterna magna became dislodged and hence one experiment was abandoned 
(dog.No. 4) when the cannula came out of the sinus during manipulation of 
the animal's head. Great care was taken at the time of connecting the 
c.s.f. cannula to the pressure measuring circuit that c.s.f. was not lost 
from the skull. This was done by filling the dead space of all catheters 
and taps with saline prior to connection to the cisterna magna catheter. 
At the end of each experiment, 1 cc. of c.s.f. was aspirated to determine 
whether bleeding had occurred into the c.s.f.; this was not found in any 
of these experiments. 
The measurement of central venous pressure via a catheter passed into 


































































































































































































































































































































































































































DOG 1 DOG2 
Figure 16 The increases in c.s.f. pressure produced by 0.5% and 2% 
halothane and by 1%o chloroform in dogs. 2% halothane caused a greater 
rise in c.s.f. pressure than did 0.5% in the 2 animals in which both 




ALOTHAF IICREASE IN 
C.S.F. PRESSURE 
INCREASE IN 
CEREBRAL VENOUS PRESSURE 
8 0.5% + 4o - 
8 2.0% + 90 + 120 
8 0.5% + 59 + 6o 
8 2.0% + 80 + 8o 
9 0.5% + 105 - 
9 2.0% + 158 + 14o 
Table 39 The effects of 0.5 and 2.0 halothane on c.s.f. and 
cerebral venous pressures (mm. H20) in dogs. 
HAL 
0.5% 
1 HAL 1 HAL ',HALO - 
0.5% 2% 4% - - 
0 10 20 




20 30 0 10 20 30 minutes 
Figure 17 c.s.f. and cerebral venous pressure records from Dog 8. Both 
0.5% and 2% halothane increased c.s.f. and cerebral venous pressures but 
the increases were greater with the higher halothane concentration. The 












0 10 20 0 10 20 30 MINUTES 
Figure 18 c.s.f. and cerebral venous pressure records from Dog 9. 
Halothane administration produced relatively short lived increases in 
these pressures. The small increase in both c.s.f. and cerebral venous 




(1) The Effect of Halothane on c.s.f., Cerebral Venous and 
Central Venous Pressures 
Table 38 gives the values for c.s.f. pressure before, during and after 
administration of 0.5 halothane. It will be seen that in each experiment 
there was an increase in c.s.f. pressure during halothane administration 
(see also Figure 16) and that the pressure fell again on stopping the drug. 
The mean control value for c.s.f. pressure was 144 - 35 mms.H20 and the 
mean increase with 0.5 halothane was of 78 ± 27 mms.H20. 
These results were obtained at arterial Pco2 values within the normal 
range. However in dog 2, Paco2 was subsequently lowered from 37 mm.Hg. 
to 27 mm.Hg. by hyperventilation. With the reduction in Paco2, c.s.f. 
pressure during nitrous oxide -oxygen anaesthesia fell from a mean of 
139 mm.H20 to a mean of 76 mm.H20. When 0.5 halothane was administered 
under these circumstances, c.s.f. pressure rose by only 18 mm.H20 as 
compared with a rise of 73 mm.H20 during normocapnia. 
In dogs 8 and 9, the effects of 0.5 and 2¡ halothane on c.s.f. and 
cerebral venous pressure were measured and compared. The results are 
presented in Table 39. It will be seen that both c.s.f. and cerebral 
venous pressure rose when halothane was administered and that the rise of 
both pressures was greater with the higher concentration of the drug (see 
also Figs. 17 & 18). From Table 39 it can also be clearly seen that the 
increases in c.s.f. pressure were very similar in magnitude to the increases 
in cerebral venous pressure during halothane administration. 
Individual records of these two experiments are shown in Figures 17 
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- 80 - 
- 100 - 
HALOTHANE. INT: HALOTHANE. 
O Iihr. 2hrs. 
CONTROL 
LEVEL. 
i 3 hrs. 
DOG NO. 5. 
c.s.f. pressure changes with prolonged 0.5% halothane 
administration in Dog 5. The increase in c.s.f. pressure produced by 
halothane was not maintained since c.s.f. pressure returned to control 
values after 52 minutes of halothane administration. Withdrawal of 








































































































































































































































































































that the increases in c.s.f. and in cerebral venous pressures were not 
well maintained. With both pressures, the peak increase occurred at 
between 3 and 5 minutes and was followed by a gradual fall towards baseline 
values. dith 2¡ halothaneasimilar tendency for c.s.f. and cerebral venous 
pressures to rise to a peak and then to fall despite continuing halothane 
administration can be discerned. In Table 40 the time relationships of 
the c.s.f. pressure changes with halothane are given for each experiment; 
it will be seen that with only one exception, the halothane induced rise in 
c.s.f. pressure was not maintained beyond 3 - 9 minutes after the commence- 
ment of halothane. 
This point was further studied in dog 5 in which 0.5% halothane was 
administered for 1 hour and 40 minutes (see Figure 19). The peak pressure 
in this animal was attained after 9 minutes of halothane; thereafter a 
slow fall in c.s.f. pressure occurred so that the pressure had returned to 
control values after 52 minutes of halothane administration. Withdrawal 
of halothane caused an abrupt fall in c.s.f. pressure even although at this 
time pressure was back to control values. 
In the two dogs in which central venous pressure was measured (dogs 
2 and 5) no significant change occurred with administration of 0.5% 
halothane. 
(2) The Effect of Chloroform on c.s.f. and Central Venous Pressures 
In experiments 1 and 2, the administration of l% chloroform elevated 
c.s.f. pressure (see Table 41 and Fig. 16). Central venous pressure in 
experiment 2 rose by 7 mm.H20 during chloroform anaesthesia but at this 
time the increase in c.s.f. pressure was 67 mm.H20. 
CHAPTER 3 
The Influence of Halothane, Trichloroethylene and Chloroform on 
Cerebral and Central Venous Pressure in Dogs with Open Dura 
(a) Methodology 
In addition to the above experiments in which a specific study was 
made of the relationship between c.s.f. and cerebral venous pressure, a 
number of animals in the blood flow series of experiments also had cerebral 
venous pressure measured. It should be emphasised that in these animals 
the dura had been opened. Consequently, due to the escape of c.s.f., both 
c.s.f. and cerebral venous pressures were reduced below their normal values. 
Furthermore since any rise in cerebral venous pressure would tend to be 
cushioned by displacement of c.s.f. out through the open dura these 
measurements, unlike those just described above, can only be considered 
to indicate in a qualitative fashion the direction of change in cerebral 
















4 5 FLOW MEASUREMENTS 
30 60 90 120 150 180 
MINUTES 
Figure 20 0.5% halothane administration in this dog produced a brief 
rise in cerebral venous pressure. Cerebral cortical blood flow was 
measured when the venous pressure increase was subsiding and was found to 
be not different from control values. (The figures at the foot of the 
record indicate the times of measurement of cerebral cortical blood flow). 
Halothane 0.5% Halothane 204 
mm. 











1 2 3 4 5 6 MEASUREMENTS 
I I 1 I I I I I 
0 30 60 
MINUTES 
90 120 
Figure 21 The rise in cerebral venous pressure with 0.5% halothane in 
this animal was accompanied by a marked increase in cerebral cortical 
blood flow. 2% halothane increased cerebral venous pressure further but 
this was probably related to the concomitant increase in central venous 
pressure since there was no further alteration in cerebral blood flow. 
(The figures at the foot of the record indicate the times of measurement 
of cerebral cortical blood flow). 
175. 
(b) Results in Animals with Open Dura 
Halothane 
Measurements of cerebral venous and central venous pressures were made 
in two animals (1/3/65 and 17/3/65) prior to and during halothane 
administration. The results are shown in Figures 20 and 21. 
In the first of these (Figure 20) there was a short -lived increase in 
cerebral venous pressure with the introduction of 0.5% halothane into the 
anaesthetic mixture at a time when there was no alteration in central venous 
pressure. The first measurement of cerebral cortical blood flow under 
halothane in this animal was not made until 6 minutes after the commence- 
ment of halothane administration by which time cerebral venous pressure was 
already falling from its peak value and in fact this flow measurement showed 
no significant change on control values 
In the other animal (Fig. 21) there was also a quick increase in 
cerebral venous pressure with halothane and a concomitant flow measurement 
showed that flow was above control values. When 2% halothane was 
administered cerebral blood flow did not increase further in this particular 
animal but cerebral venous pressure increased again. However measurement 
of central venous pressure showed that it also had risen and in fact the 
increase in central venous pressure ( +50 mm.H2O) almost certainly accounted 
for the change in cerebral venous pressure ( +57 mm.H2O) in this animal. 
Trichloroethylene 
Cerebral venous pressure was measured in 5 animals during cerebral 
blood flow studies. The results of these measurements are given in Table 
176. 
DATE 










0.74 7.0 1.11 12.0 
0.79 4.0 0.87 10.0 
0.67 4.0 0.71 7.0 















0.71 10.0 0.77 8.0 
0.82 10.0 0.79 7.0 
13/5/63 0.80 8.o 0.70 7.o 
0.80 8.o 
0.76 7.0 
0.84 4.0 0.58 4.0 
0.76 3.0 0.54 3.o 








0.53 4.0 0.59 5.o 
0.57 5.o 0.54 6.o 
27/6/63 0.58 5.o 0.58 6.o 
0.61 6.o 
0.53 6.0 









Table 42 Cerebral cortical blood flow (mis. /G /min.) and cerebral venous 
pressure (cm. H2O) during nitrous oxide -oxygen anaesthesia and during 
anaesthesia with trichloroethylene in nitrous oxide- oxygen in dogs. 
EXPERIMENT 
DATE 











0.64 6.o 1.00 9.0 
11/10/63 0.61 5.0 0.86 16.0 
0.82 16.0 
0.54 5.o 0.64 11.0 
18/10/63 0.54 5.0 0.69 14.0 
0.56 7.0 


















0.67 7.5 1.01 * ** 14.2 * ** 
MEANS ±2.5 -0.26 ±2.9 
Table 43 Cerebral cortical blood flow (mis. /G /min.) and cerebral 
venous pressure (cms. H2O) during nitrous oxide- oxygen 
anaesthesia and during anaesthesia with 1% chloroform in 
nitrous oxide -oxygen in dogs. 
( * = P < .05; ** = P < .01; 
* ** = p .001) 
178. 
42 from which it can be seen that marked increases in cerebral venous 
pressure occurred in the 2 animals which exhibited the greatest flow 
increases in the early period of trichloroethylene administration (7/5/63 
and 9/5/63). However the mean cerebral venous pressure during trichloroe- 
thylene anaesthesia (6.3 
± 
1.9 cms.H20) was not significantly different from 
the mean cerebral venous pressure during nitrous oxide -oxygen anaesthesia 
(5.4 2.3 cms.H20). There was no significant change in cerebral cortical 
blood flow in this group of animals either (Table 42). 
Chloroform 
Measurements of cerebral venous pressure during the administration of 
1% chloroform were made in 4 animals. In every case the administration of 
chloroform produced a marked rise in cerebral venous pressure which 
paralleled the increases in cerebral blood flow simultaneously measured (see 
Table 43). The mean cerebral venous pressure during chloroform anaesthesia 
was 14.2 ± 2.9 cms.H20, while the mean control value was 7.5 ± 2.5 cms.H20; 
this increase with chloroform was highly significant (p < .001). 
CHAPTER 4 
Summary of Main Findings of Studies of Cerebrospinal Fluid 
Cerebral Venous and Central Venous Pressures in Dogs 
Discussion of these animal results will be deferred so that they may 
be considered along with the investigations in man to be described below. 
At this point the findings will only be summarised thus:- 
(1) halothane and chloroform elevate c.s.f. pressure in anaesthetised dogs 
at constant Paco2 
(2) in the case of halothane the increase in c.s.f. pressure has been 
shown to be dependent upon the concentration of halothane administered 
and the existing arterial Pco2. 
(3) halothane, chloroform and early trichloroethylene elevate cerebral 
venous pressure and the changes appear normally to be related to 
changes in measured blood flow through the cerebral cortex. However 
in one instance the increase in cerebral venous pressure during 2`¡ 
halothane was due to a rise in central venous pressure. 
(4) with halothane it has been shown that the elevations in c.s.f. and in 
cerebral venous pressure produced by halothane are very similar in 
magnitude. 
(5) the increases in c.s.f. and cerebral venous pressures with halothane 
are not maintained with time but tend to return to their control 
values despite continuing halothane administration. 
180. 
CHAPTER 5 
The Influence of Halothane and Trichloroethylene on Cerebrospinal 
Fluid Pressure in Patients without Intracranial Pathology 
(a) Methodology 
The effect of halothane (0.5 or 1%) or of trichloroethylene (0.) on 
lumbar c.s.f. pressure and on central venous pressure was studied in 35 
patients anaesthetised for surgical treatment of lumbar disc lesions. All 
patients studied had given their free consent to the investigation. Of 
these 35 patients, the records from 11 patients were discarded for the 
reasons stated in Table App. 30. Details of the remaining 24 patients as 
regards age, sex and investigation performed are given in Table App. 31. 
The patients were premedicated with 100 mgs. of pethidine and 0.6 mg. 
of atropine one hour before operation. Induction of anaesthesia was 
performed with a dose of thiopentone just sufficient to produce sleep. 
Suxamethonium chloride was administered and, under the resultant muscular 
paralysis, orotracheal intubation with a flexometalic cuffed tube was 
performed. A thermocouple lead was passed into the oesophagus for the 
measurement of mid oesophageal temperature. Ventilation was controlled 
using an automatic ventilator ( "Barnet ") and anaesthesia maintained with 
70% nitrous oxide and 302 oxygen. When recovery of muscle tone from the 
effects of suxamethonium was seen, a dose of tubocurarine between 35 and 
55 mgs. according to the size of the patient was administered to produce 
prolonged muscular paralysis. A plastic catheter was inserted into an 
antecubital vein and advanced until its tip was within the subclavian vein 
t 
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Figure 22 Photograph of record of c.s.f. pressure as obtained with Stathan 
pressure transducer and ultraviolet recorder. 
_LOG 
as judged by measurement and by examination of the venous pressure record. 
This site was chosen as the most distal likely to give a true measurement of 
central venous pressure. 
The patient was then turned into the lateral position and, under full 
aseptic precautions, a lumbar puncture needle was inserted into the lumbar 
subarachnoid space, great care being taken to avoid loss of more than a few 
drops of c.s.f. All measurements were made with the patient in the lateral 
position. 
The minute volume of ventilation was adjusted according to an estimate 
of the patients weight and on most occasions a Paco2 of between 35 and 
45 mm.Hg. was attained. Time limitations prevented subsequent alterations 
in minute volume. However in some of the later investigations an infra red 
analyser allowed measurement of end tidal Pco2 and so facilitated the 
correct setting of minute volume. An electric blanket was placed over the 
patient to reduce the fall in body temperature which tended to occur under 
anaesthesia. 
C.s.f. and central venous pressures were measured in the early studies 
with simple saline manometers but latterly with electronic pressure 
transducers, amplifiers and recorders. Those results based on measurements 
with saline manometers are marked distinctively in the detailed Appendix 
Tables. The zero reference for all pressure measurements was taken as 
the midline of the back with the patient in the lateral position. The 
records of c.s.f. pressure showed pulsations at the same rate as the heart 
beat and also slower variations in time with the respiratory phases of the 
ventilator. An example of the record obtained from the ultraviolet 
recorder is shown in Figure 22. When analysing these results c.s.f. 
pressures at both systole and diastole were plotted during the expiratory 
183. 
pause of the ventilator. Mean c.s.f. pressure was calculated as being 
equal to the diastolic c.s.f. pressure plus one third of the pulse pressure 
of the c.s.f. 
Capillary blood samples were taken from the finger tip before and 
after the 10 minute period of administration of the volatile anaesthetic 
and were measured for pH and Pco2 by the technique of Andersen et al.(1960). 
The results were corrected for the difference in temperature between the 
patient and the pH electrode by application of Rosenthal's (1948) factor. 
The mean oesophageal temperature during the period of pressure measurement 
was 35.7 0.8 °C (range 34.2 - 37.3 °C). Systolic blood pressure was 
measured intermittently by upper arm sphgmomamometry. 
Measurements of c.s.f., central venous and systolic blood pressure 
were made during unsupplemented nitrous oxide -oxygen anaesthesia. The 
volatile agent under study, either halothane or trichloroethylene, was then 
introduced from a calibrated vapouriser (Fluotec Mk II) and the changes in 
these pressures followed, for lO minutes. The volatile drug was then 




































































































































































































































































































































































































































































Halothane 05 % Halothane 1 % Halothane 0.5 % 
+ Hypocapnia 
6 14 16 17 32 38* 40 43 10 38* 68 69 
PATIENT NUMBER 
8 12 31 33 34 39 
Figure 23 The increases in lumbar c.s.f. pressure produced by halothane 
in patients. In the one patient to whom both concentrations of halothane 
were administered, 1% halothane caused a greater rise than 0.5%. The 
administration of halothane during hypocapnia produced only small increases 














o 5 10 
MINUTES 
15 20 
Figure 24 A typical plot from one patient of the c.s.f. pressure changes 
produced by 0.5% halothane administration at constant Paco2. 
187. 
(b) Results 
The Influence of Halothane on c.s.f. Pressure in Man 
(1) 0.5% Halothane during Normocapnia 
The influence of 0.5 halothane during normocapnia on c.s.f. pressure 
was studied in 8 patients and, in 4, central venous pressure was also 
measured. The detailed results of all measurements are given in Table 
App. 32. The arterial Pco2 in these patients ranged from 37 to 46 mm.Hg. 
with a mean value of 41.0 
± 
3.3 mm.Hg. The mean c.s.f. pressure before, 
during and after 0.5% halothane administration for each patient is given 
in Table 44, from which it will be seen that the administration of 0.5% 
halothane increased lumbar c.s.f. pressure in every patient studied (see 
also Figure 23). The mean control c.s.f. pressure in this group was 
123 60 mm.H20 with a range from 21 to 214 mm.H20. During administration 
of 0.5% halothane the mean c.s.f. pressure was 186 ± 64 mm.H20 with a 
range from 73 to 270 mm.H20. halothane therefore caused a mean 
increase of 64 
± 
29 mm.H20 (range + 39 + 126 mm.H20). In 6 of these 8 
cases c.s.f. pressure was also measured after stopping halothane and there 
was a fall to near control values in every case. A typical graph of the 
c.s.f. pressure changes with 0.5 halothane is shown in Figure 24. 
The increase in c.s.f. pressure occurred very quickly after 
introducing the halothane into the anaesthetic gases - within one minute in 
5 cases and within 2 minutes in the other 3. The time to reach peak 
pressure was very variable (from 3 to 16 minutes) while the return to the 
baseline occurred within 3 to 10 minutes of discontinuing the halothane. 
In an attempt to assess whether the halothane induced rise in c.s.f. 




PULSATIONS OF C.S.F. 
BEFORE 0.5% HAL. AFTER 
14 4 16 6 
17 38 77 37 
32 53 74 - 
38 90 go 80 
40 25 42 25 
43 64 92 86 
Amplitude of pulsations of c.s.f. pressure (mm. Iï20) 
before, during and after the administration of 0.5% 
halothane in patients. 
189. 
than 10 minutes (maximum 20 minutes)(Nos. 6, 14 
40 
/and 43). In 2 of these 
patients c.s.f. pressure reached a peak value and then began to fall despite 
continuing halothane administration. In the other 2, the halothane induced 
rise was maintained throughout the 15 and 20 minutes respectively of 
halothane administration. 
As was pointed out in the methodology section, the c.s.f. pressure 
showed fluctuations at the same rate as the pulse. The magnitude of these 
fluctuations was measured during unsupplemented nitrous oxide -oxygen 
anaesthesia and during 0.5c7, halothane administration; the results are 
given in Table 45. Patients whose c.s.f. pressure was measured with 
saline manometers have been excluded from this Table because the heavy 
damping of this system made the results meaningless except for assessing 
mean pressure. In addition one patient whose c.s.f. pressure was measured 
electronically had a "damped" record, probably due to an undetected air 
bubble in the connecting catheter. Of the remaining 6 patients, the size 
of the arterial pulsations of the c.s.f. increased with halothane 
administration in 5; in the 6th there was no change. 
Of the 4 patients receiving 0.5, halothane whose central venous 
pressure was also measured, no change in this pressure occurred in 3. In 
the 4th central venous pressure rose by 8 mm.H20 at a time when c.s.f. 
pressure had increased by 80 mm.H20. 
(2) 1% Halothane during Normocapnia 
The effect of 1 halothane on c.s.f. pressure was determined in 4 
patients and in 3 central venous pressure was also measured. Paco2 was 
in the range 38 to 45 mm.Hg. Detailed results are presented in Table App. 
33. 1`,' halothane increased c.s.f. pressure in 




































































































































































































































































































































































PULSATIONS OF C.S.F. 
PATIENT 
BEFORE 1,' HAL. AFTER 
38 90 112 80 
68 62 106 69 
69 37 113 45 
Table 47 Amplitude of pulsations of c.s.f. pressure (mm. H20) 
before, during and after the administration of 









































































































































































































































































































































































































(see Table 46 and Figure 23). The mean increase was 93 
± 
23 mm.H20 
(range +65 to +115 mm.H20). After 1% halothane was discontinued, c.s.f. 
pressure quickly returned to control values. One of these patients was 
studied immediately after the administration of 0.55 halothane (Case No. 38) 
With 0.5; halothane c.s.f. pressure rose from 190 mm.H20 to 270 mm.H20; 
when the concentration of halothane was increased to 1% c.s.f. pressure rose 
further to reach 305 mm.H20. 
All 3 patients given lÇ halothane whose c.s.f. pressures were 
measured electronically showed an increase in the amplitude of c.s.f. 
pulsations during halothane administration. (Table 47). Central venous 
pressure was measured in thesethree cases; in 2 there was no change with 
halothane and in the third there was a 1 mm.H2O rise. 
(3) 0.5% Halothane during Hypocapnia 
In 6 patients the influence of 0.5% halothane on c.s.f. pressure was 
assessed during hypocapnia (Paco2 < 35 mm.Hg.). In 4 of these patients 
central venous pressure was also measured. The detailed results are given 
in Table App. 34 and the mean results in Table 48. The mean Paco2 was 
29.2 
± 
4.8 mm.Hg. The control level of c.s.f. pressure under nitrous 
oxide- oxygen anaesthesia was considerably lower in this hypocapnic group 
than in the normocapnic group (18 - 16 mm.H20 cf. 123 
± 
60 mm.H20). 
When 0.55 halothane was administered there was in each case a rise in c.s.f. 
pressure but this was much smaller than the increase found during normo- 
capnia (see also Figure 23). The mean increase was 18 
± 
13 mm.H20 at a 
Paco2 of 29.2 mm.Hg. as compared with a mean increase during normocapnia 
of 64 ± 29 mm.H2O. 
Central venous pressure did not change in 2 cases while it rose by +4 
and +9 mm.H20 in 2 other instances (cases 31 and 33). The increase in 
central venous pressure could have entirely accounted for the observed 
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PATIENT NUMBER 
Figure 25 The increases in lumbar c.s.f. pressure produced by 0.9% 
trichloroethylene administration to patients. 
PATI] NT 
PULSATIONS OF C.S.F. 
BEFORE 0.9% T.C.J. AFTER 
18 8 14 9 
21 24 48 18 
22 20 40 20 
24 8 10 11 
25 13 17 21 
Table 50 Amplitude of pulsations of c.s.f. pressure 
(mm. H20) before, during and after the 
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MINUTES 
Figure 26 A typical plot from one patient of the c.s.f. pressure changes 
produced by 0.9% trichloroethylene administration at constant Paco2. 
 
The Influence of Trichloroeth lene on c.s.f. Pressure in Man 
The influence of trichloroethylene on c.s.f. pressure was studied in 
5 cases. In 3 cases central venous pressure was measured prior to and 
during trichloroethylene administration. All the detailed results are 
presented in Table App. 35 and the changes in mean pressure in Table 49. 
O.9 trichloroethylene produced a rise in c.s.f. pressure in every 
patient studied. The mean control value for c.s.f. pressure in this group 
was 109 ± 32 mm.H20. During trichloroethylene the mean c.s.f. pressure 
rose to 215 ± 78 mm.H20, representing an increase of 105 ± 46 mm.H20 (see 
Table 49 and Figure 25). All patients were studied during normocapnia; 
the mean arterial Fco2 being 38.6 ± 2.1 mm.Hg. As with halothane, there 
was an increase in the amplitude of c.s.f. pulsations when trichloroethylene 
was administered (Table 50). In 1 case however the amplitude of pulsation 
remained elevated after discontinuance of the trichloroethylene and in 
another patient the amplitude actually increased at this stage. This 
latter patient was however breathing against the ventilator at this time 
and this may well have accounted for this anomalous result. 
A typical record of c.s.f. pressure changes with trichloroethylene 
administration is shown in Figure 26. 
CHAPTER 6 
Discussion of c.s.f. Pressure Chantes in Man and Exerimental Animals 
These studies have shown that the administration of either halothane or 
trichloroethylene during nitrous oxide -oxygen anaesthesia leads to definite 
increases in c.s.f. pressure in man at constant arterial carbon dioxide 
tension in the norrnocapnic range and that halothane and chloroform increase 
c.s.f. pressure in the dog. In man c.s.f. pressure was measured in the 
lumbar subarachnoid space while in the dog measurement was made in the 
cisterna magna. However in the horizontal position there is no difference 
between mean lumbar c.s.f. pressure and mean intracranial pressure (Evans, 
1956) though the amplitude of c.s.f. pulsations is lower in the lumbar 
theca (Bering, 1955). Consequently the changes in mean c.s.f. pressure 
recorded from the lumbar subarachnoid space in these patients can be 
considered to indicate the changes produced by halothane and by trichloroe- 
thylene in intracranial pressure. 
The extent of the rise in c.s.f. pressure produced by these drugs was 
very variable between individual patients or animals and was not related to 
either the initial control value for c.s.f. pressure or arterial Pco2 
provided these control values were within the normal range. The increase 
in c.s.f. pressure produced by halothane was related to the concentration 
of the drug administered in any individual patient or animal. 
The increased amplitude of c.s.f. pulsations noted during the 
administration of halothane and trichloroethylene can be attributed 
to the 
rise in mean c.s.f. pressure for similarly amplified pulsations 
are seen 
whenever c.s.f. pressure is elevated (Ryder, Espey, 
Kimbell, Penka,Rosenauer, 
Podolsky & Evans, 
201. 
1952. Part of the increase may however have resulted from increased 
intracranial arterial pulsations consequent upon the cerebral vasodilatation 
produced by halothane and early trichloroethylene (see Part I). 
When patients were atiattrammicedgc hyperventilated, c.s.f. pressure fell 
although the initial level was normal. The administration of halothane at 
this stage caused only minor elevations in c.s.f. pressure. This is in 
agreement with previous evidence that the influence of any cerebral vaso- 
dilator on c.s.f. pressure is less when that pressure is low (Ryder, Espey, 
Kimbell, Penka, Rosenauer, Podolsky & Evans, 1952B). 
There have been several previous studies of the influence of anaesthet 
drugs on cerebrospinal fluid pressure. Stephen, Woodhall, Golden, Martin 
& Nowill (1954) concluded after such a study that "it is doubtful whether 
anaesthetic drugs per se with the possible exception of avertin, are 
capable of increasing cerebrospinal fluid pressure ". Unfortunately it is 
not clear from the article whether trichloroethylene or chloroform were 
studied (halothane was not available at the time). Furthermore these 
workers made their measurements during the induction of anaesthesia when 
many factors operate to confuse the picture, e.g. straining and struggling 
during the excitement stage of anaesthesia. It is therefore not 
surprising that they failed to detect the relatively small changes in c.s.f. 
pressure which these anaesthetic drugs have now been shown to produce. 
Woringer, Brogly and Schneider (1951) have also stated that trichloroe- 
thylene has no effect on c.s.f. pressure. Sondergard (1961) found that 
administration of trichloroethylene produced a rise in c.s.f. pressure in 
spontaneously breathing patients. However c.s.f. pressure promptly fell 
"with the re- establishment of a clear airway" and Sondergard therefore 
concluded that trichloroethylene per se had no effect on c.s.f. pressure. 
GVG 
These findings are interesting in that his observation of an initial rise 
in c.s.f. pressure with trichloroethylene followed by a fall fits well with 
the initial but transient increase in cerebral blood flow which has been 
shown (in Part I) to occur with this drug. Despite these reports, Hunter 
(1964) in his review of this subject writes "the addition of trichloroe- 
thylene to a nitrous oxide - oxygen mixture will cause an immediate small 
increase in intracranial pressure" and the results reported here fully 
support his conclusion. 
Sondergard also studied the effects of halothane on c.s.f. pressure 
and he concluded that this agent did increase c.s.f. pressure. Unfortun- 
ately his measurements were made on spontaneous breathing patients so that 
they are obscured by the respiratory depression and consequent hypercapnia 
which occurs with halothane. It is true that Sondergard measured end 
tidal Pco2 but it is difficult to know how much of his observed increases 
in c.s.f. pressure were due to halothane itself and how much to concomi- 
tantly measured increases in end tidal Pco2. 
There have been two reports of the effect of halothane on c.s.f. 
pressure during controlled ventilation at constant arterial Pco2. The 
work of Marx, Andrews & Orkin (1962) performed in this way indicated that 
halothane increased c.s.f. pressure and that the extent of the rise was 
related to the concentration of halothane administered. Superficially 
their results appear to be in agreement with those presented here but in 
fact the extent of the increase found by them was much smaller, averaging 
only 17 mm.H20 during 0.5;L halothane. These workers also measured "venous 
pressure" via a catheter introduced into an antecubital vein and this they 
found to be elevated by halothane by percentage increments similar to the 
percentage increases in c.s.f. pressure. They therefore concluded "the 
increases in cerebrospinal fluid pressure due to halothane per se are 
related solely to increases in systemic venous pressure ". However their 
mean value for venous pressure of 126 mm.H20 in spontaneously breathing 
unanaesthetised patients suggest either a falsely low zero reference point 
or that the venous pressure measured was greatly in excess of central 
venous pressure. In fact the site of measurement is not specified beyond 
the information that a catheter was introduced via an antecubital vein. 
From the high control values quoted it would seem likely that peripheral 
venous pressure of the arm was monitored. Changes in this pressure may of 
course be due to changes in central venous pressure but they can equally well 
result from halothane induced vasodilatation of skin vessels producing 
increased limb blood flow. Furthermore the expression of changes in 
pressure as percentages by these authors artificially magnifies any actual 
increase in venous pressure when compared with c.s.f. pressure since the 
absolute level of the former is so much less than that of the latter. For 
these reasons the demonstration of Marx et al. that equal percentage 
increases in c.s.f. and venous pressure occur with halothane need not imply 
that the rise in c.s.f. pressure is secondary to a primary rise in venous 
pressure. In the results reported in this thesis 0.5% and 1¡ halothane 
and up to 0.9% trichloroethylene produced either no change in central venous 
pressure or only small increases. 2 halothane was shown in one animal 
(Figure 21) to produce a steady and progressive rise in central venous 
pressure and when this occurred the expected equal and parallel rise in 
cerebral venous pressure followed. This was the only occasion in all these 
studies when a change in cerebral venous or c.s.f. pressure appeared to be 
the result of a primary alteration in central venous pressure. With lower 
concentrations of halothane and with trichloroethylene administered during 
eu4. 
normocapnia, the alterations in central venous pressure did not exceed 10% 
of the increases in cerebral venous or c.s.f. pressure. 
(1964) 
Hunte± has published a record of the changes in intracranial pressure 
produced in one patient by the intermittent administration of 1% halothane 
during controlled ventilation. The changes shown closely resemble the 
pattern observed in the present study. 
As regards chloroform, Finesinger and Cobb (1935) noted that the 
administration of this drug to cats caused increases in c.s.f. pressure. 
This paper has already been discussed in Part I when it was pointed out 
that the animals on which these observations were made were certainly 
hypotensive and possibly hypoxic. Unlike the changes in pial artery 
diameter, hypotension could not have been the cause of the c.s.f. pressure 
increases though of course the possible presence of hypoxia could have done 
so. Koopmans (1939) noted that the administration of chloroform increased 
the pressure inside a balloon placed under the dura in cats and dogs. 
Since the pressure inside such a balloon must equal intracranial pressure, 
this finding indicates that the drug increased c.s.f. pressure. However, 
like much work carried out at this time, arterial Pco2 was not controlled 
in these experiments and therefore the reported change in intracranial 
pressure could have been due to hypercapnia consequent upon respiratory 
depression. 
205 
Causes of the Pressure Changes 
The c.s.f. pressure tends to rise whenever the volume of the intra- 
cranial contents increases; this is because, as pointed out by Monro (1783) 
and by Kellie (1824) the intracranial and spinal theca are relatively rigid 
or, expressed in other terms, have a low compliance. Therefore changes in 
the volume of the intracranial contents produce very large changes in intra- 
cranial pressure. 
The intracranial contents are: - 
(1) blood which constitutes about 2 of the intracranial volume 
(Rosomoff, 1961) 
(2) cerebrospinal fluid comprising about of the intracranial volume 
(Rosomoff, 1961) 
(3) the brain itself which consists almost entirely of cellular elements, 
either neuronal or glial, and with only a small interstitial space 
(de Robertis, 1963). The fluid in this extracellular space is in 
free communication with the c.s.f. so that changes in extracellular 
brain volume can be considered together with changes in c.s.f. 
volume. Therefore in the subsequent discussion the term "brain 
volume" is used to indicate intracellular brain volume. 
The question of what causes c.s.f. pressure to rise during halothane 
or trichloroethylene administration therefore becomes "do halothane and 
trichloroethylene increase the volume of the blood or of the c.s.f. or of 
the brain within the skull ?" 
One of the features of the pressure recordings obtained in the present 
study was the rapidity with which c.s.f. pressure rose on starting 
halothane or trichloroethylene administration and the equal rapidity with 
which the pressure fell again when the drug was stopped. Changes in 
LUb. 
intracellular volume could scarcely occur with such rapidity. 
Changes in c.s.f. volume can be produced by either an increase in the 
rate of c.s.f. production or a fall in the rate of c.s.f. reabsorption. 
However when changes in c.s.f. volume are the cause of increases in c.s.f. 
pressure then there are no associated changes in cerebral venous pressure 
as measured in the sagittal sinus (Becht, 1920; Weed & Flexner, 1933; 
Greenfield & Tindall, 1965). This is quite contrary to the situation 
which has been shown in these experiments to arise when volatile 
anaesthetic drugs are administered for then both c.s.f. and cerebral venous 
increase. In the 2 animal experiments described above and illustrated in 
Figures 17 and 18 when halothane was administered both cerebral venous and 
c.s.f. pressure rose together and when halothane was withdrawn both pressures 
fell in parallel. It has also been shown that chloroform and early 
trichloroethylene increase cerebral venous pressure in dogs. Since 
primary changes in c.s.f. pressure do not produce secondary changes in 
cerebral venous pressure these observations must mean that the venous 
pressure changes were primary and that the c.s.f. changes were the result 
of increases in cerebral venous pressure. This in turn indicates that 
the effect of halothane on c.s.f. pressure was not the result of an increase 
in c.s.f. volume. 
Since expansion of either the c.s.f. compartment or of the cerebral 
intracellular compartment has been excluded the expansion must have been 
in the intracranial blood volume. The results of the two Parts of this 
thesis thus become mutually corroborative. When either halothane or 
trichloroethylene is administered the cerebral arterioles relax and more 
blood flows through the cerebral circulation, as was shown in Part I. 
With the increased volume of blood flowing along the venous sinuses the 
207. 
pressure in these sinuses rises as was shown to occur with halothane, 
chloroform and early trichloroethylene. The increased venous pressure 
distends the cerebral veins and this expansion in volume raises the intra- 
cranial pressure as demonstrated by the c.s.f. pressure measurements made 
in the cisterna magna of dogs and in the lumbar subarachnoid space of 
patients. The volume of the cerebral arterioles is of course also 
elevated by the vasodilatory action of these drugs but this contributes 
little to the increase in intracranial volume since the volume of the 
arterioles is small by comparison with the high capacity of the venous 
side of the circulation. 
In Part I it was shown that the increases in cerebral blood flow 
produced by halothane were related to the concentration of the drug 
administered while in this Part the c.s.f. pressure rise has been found also 
to be related to halothane concentration. 
In studying the animal c.s.f. pressure records it has already been 
pointed out that there was a tendency, during 0.5;x. halothane administration, 
for c.s.f. pressure to rise to a peak and then to fall slowly towards the 
base -line. This late fall in c.s.f. pressure correlates closely with the 
flow results in which 0.5. halothane was shown to produce an increase in 
flow at the beginning of its administration with a subsequent return to 
control values. This may however not be the whole explanation for this 
pattern of c.s.f. pressure because Draper and Whithead (1944) have 
demonstrated that a similar rise and subsequent fall in c.s.f. pressure is 
also seen during hypercapnia although the increase in blood flow is 
well maintained. Bedford (1935) observed the same sequence of changes in 
c.s.f. pressure during prolonged venous occlusion in the neck. The 
probable explanation is that elevation of c.s.f. pressure activates a 
¿Ob. 
regulatory mechanism which operates by increasing the rate of c.s.f. 
reabsorption. Therefore the end result is that the expansion of the 
intracranial blood volume is balanced by a reduction in c.s.f. volume and 
c.s.f. pressure is returned to normal values. Direct evidence of this 
hypothesis is lacking but Rosomoff (1963) has shown that when cerebral 
blood flow is reduced by hyperventilation, c.s.f. volume increases; the 
converse is therefore feasible. Figure 19 tends also to corroborate the 
hypothesis; in the experiment illustrated in this Figure, halothane was 
administered for 1 hour and 40 minutes and the c.s.f. pressure rose to a 
peak and then subsided towards the control value.. The important point to 
the present discussion is however that c.s.f. pressure fell below the 
initial control value when the halothane was discontinued. This suggests 
that the volume of c.s.f. had fallen during the period of halothane 
administration. 
In patients the peak increase in c.s.f. pressure was not reached as 
quickly as in the animal studies and this may indicate either that the 
increase in cerebral blood flow produced by 0.5 halothane was more 
prolonged than in the dogs or alternatively that compensatory adjustments 
of c.s.f. volume are more slowly accomplished in man. 
209. 
Clinical Significance of c.s.f. Pressure Changes 
Although both halothane and trichloroethylene increased c.s.f. pressure 
in these investigations, the clinical significance of these findings would 
appear to be slight. There are two reasons for this view. In the first 
place the rise in c.s.f. produced by these anaesthetic drugs was small (i.e. 
of the order of 100 mm.H20 or 7 mm.Hg.) and would scarcely produce a 
detectable increase in dural tension during neurosurgery. Secondly, 
particularly with the lower concentration of halothane, the increase in 
c.s.f. pressure was not sustained so that if halothane were administered 
from the start of anaesthesia, the c.s.f. pressure would have returned to 
normal before the surgeon had exposed the dura. These two points almost 
certainly explain the failure of Bozza, Maspes & Rossandra (1961) to detect 
any obvious difference in dural tension between patients without intra- 
cranial space occupying lesions anaesthetised with different anaesthetic 
agents. 
It should be remembered that although the c.s.f. pressure tends to 
return to control values during prolonged halothane administration this is 
probably partly due to reduction in c.s.f. volume. Therefore the surgeon 
will find the brain itself rather more "engorged" or "swollen" due to the 
increased brain blood volume while the gap between the pia -arachnoid and 
the dura will be narrowed by the lowered c.s.f. volume. These theoretical 
predictions are well borne out by clinical observation. 
These are, tommyftm, points of little or arguable clinical significance. 
There is however one group of patients in whom even small elevations in 
intracranial pressure may be harmful and this group comprises patients who 
have raised intracranial pressure as a result of the presence of space 
occupying lesions within the skull. It was decided therefore as a final 
part of this study to assess the effect of halothane anaesthesia on patients 
with intracranial tumours. 
211. 
CHAPTER 7 
The Influence of Halothane on Cerebrospinal Fluid Pressure 
in Patients with Intracranial Tumours 
Methodology 
Four patients with intracranial tumours and clinical signs of intra- 
cranial hypertension were studied; relevant clinical details are given for 
each patient below. 
Premedication was with pethidine 50 mgs. and atropine 0.6 mg. in every 
case except A.D. who received atropine 0.6 mg. alone. The technique of 
anaesthesia was identical to that described in the preceeding study. A 
metal cannula was inserted into one of the lateral ventricles through a burr 
hole made as part of the normal surgical procedure. Intracranial pressure 
was measured via this cannula by means of suitable pressure transducers and 
amplifiers and was recorded with an ultraviolet recorder. All measurements 
were completed before a bone flap was reflected. The patient was lying in 
the supine position with the operating table level and the zero reference 
point was taken as the mid axillary line. 
Blood Pco2 was held constant by controlling ventilation and was 
measured on capillary blood by the technique of Andersen et al. (1960) 
immediately before administering halothane and at the end of the period of 
administration. The values were corrected for the temperature difference 
between the patient and the pH electrode by applying Rosenthal's (1948) factor. 
Systolic blood pressure was measured every minute during halothane 
administration by upper arm sphygmomanometry and pulse rate by palpation. 
Control measurements of intracranial pressure were obtained during 
unsupplemented nitrous oxide -oxygen anaesthesia with muscular relaxation 
obtained with tubocurarine. The effect of the addition of 0.5 or 1% 
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- Halothane 1 70--- 
Figure 27 The effect of halothane on mean c.s.f. pressure in patients 
with intracranial tumours compared with the changes found previously in 
patients without intracranial pathology. 
Results 
Table App. 36 records the detailed results while Table 51 shows the 
changes in mean intracranial pressure produced by halothane in these 
patients. It will be seen that, as with the patients without intracranial 
pathology, halothane administration in every case resulted in a rise in 
c.s.f. pressure. The difference in the present group is in the magnitude 
of the rise induced by halothane which wa6 2 to 8 times greater than that in 
the "normal" patients. This point is illustrated graphically in Figure 27 
which shows the pressure increases in these patients with intracranial 
tumours alongside these obtained from the patients without intracranial 
pathology. 
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Figure 28 The c.s.f. pressure record in patient A.D. 
217. 
Individual Results 
Patient A.D. (48 years) 
Pathology: cerebellar metastatic tumour 
Clinical Evidence of Intracranial Hypertension: early papilloedema 
Ventriculogram demonstrated symmetrical hydrocephalus. 
Pressure Study: 
In this patient a burr hole was made under local anaesthesia to 
allow air ventriculography. Later the same morning the patient was brought 
to theatre and was anaesthetised in the standard way already described. 
Figure 28 is the c.s.f. pressure record from this patient. The c.s.f. 
pressure, as measured in the lateral ventricle was 180 /160 mm.H20 during 
unsupplemented nitrous oxide - oxygen anaesthesia and at an arterial Pco2 of 
38 mm.Hg. His systolic blood pressure at this time was 110 mm.Hg. The 
administration of 0.5% halothane produced a progressive rise in intracranial 
pressure which showed no sign of levelling off during the 13 minutes of 
administration. Indeed after discontinuing the halothane, c.s.f. pressure 
continued to rise for a further minute reaching a peak value of 520/460 mm. 
H2O. Thereafter the c.s.f. pressure dropped sharply towards the pre - 









Figure 29 The c.s.f. pressure record in patient A.McN. 
Patient A. MeN (36 years) 
Pathology: Anaplastic astrocytoma of the left frontal lobe. 
Clinical Evidence of Intracranial Hypertension: Marked papilloedema. 
Pressure Study: 
Figure 29 is the c.s.f. pressure record from this patient. The 
anaesthetic technique and the placement of the ventricular cannula were as 
described in the general methodology section. During unsupplemented nitrou' 
oxide -oxygen anaesthesia the c.s.f. pressure was 155/130 mm.H20, the arteri. 
Pco2 was 34 mm.Hg., systolic blood pressure 130 mm.Hg., and the pulse rate 
94 /minute. The administration of 1:, halothane caused a precipitous rise 
in intracranial pressure, so great indeed that halothane administration was 
discontinued after only 7 minutes. Intracranial pressure continued to 
rise for one further minute reaching a peak value of 800/620 mm.H20 at which 
time systolic blood pressure was down to 100 mm.Hg. and pulse rate was 
86 /minute. The intracranial pressure then fell rapidly and regained control 
values 4 minutes after the end of halothane administration. 
The minute volume of ventilation was then increased from 6 litres /minute 
to 9 litres /minute and this produced a fall in Paco2 to 21 mm.Hg. Hyper- 
ventilation did not in this patient lower the c.s.f. pressure during 
nitrous oxide -oxygen anaesthesia which remained at 170 /140 mm.H20; however 
the administration of le;:, halothane now caused a much lower increase in c.s.f. 
pressure which reached a peak of 530/440 mm.H20 and then fell despite 
continuing halothane administration to a level of only 340/290 mm.H20. On 
discontinuing halothane administration intracranial pressure fell to control 














Figure 30 The c.s.f. pressure record in patient H.T. 
GG1 
Patient H.T. (47 years) 
Pathology: Astrocytoma in left frontal region. 
Clinical Evidence of Intracranial Hypertension: Early papilloedema and 
X -ray evidence of erosion of dorsum sellae. 
Pressure Study: 
The record from this patient is shown in Figure 30. During unsupple- 
mented nitrous oxide -oxygen anaesthesia, c.s.f. pressure was 168/108 mm.H20, 
arterial Pco2 50 mm.Hg., systolic blood pressure 120 mm.Hg., and pulse rate 
92 /minute. 1;T, halothane for 11 minutes produced a rise in intracranial 
pressure which reached a peak value of 537/281 mm.H20. Intracranial 
pressure returned to control values 5 minutes after the cessation of 
halothane. During halothane administration systolic blood pressure fell 














Figure 31 The c.s.f. pressure record in patient M.J. 
223. 
Patient M.J. (62 years) 
Pathology: Glioblastoma left temporal lobe. 
Clinical Evidence of Intracranial Hypertension: Angiographic lateral 
displacement of the anterior cerebral arteries. 
Pressure Study: 
Figure 31 is the c.s.f. pressure record from this patient. Pre - 
halothane values were as follows:- c.s.f. pressure 382/232 mm.H20; 
arterial Pco2 39 mm.Hg., systolic blood pressure 100 mm.Hg., and pulse 
rate 84 /minute. 
The administration of 1% halothane at first produced the usual marked 
rise in intracranial pressure which reached 690/455 at the 4th minute. 
There then occurred a progressive fall in intracranial pressure which had 
reached 600 /400 mm.H20 at the 8th minute when halothane was discontinued. 
The other unusual feature in this case, which will be discussed in detail 
subsequently, was that when halothane was stopped intracranial pressure 
rose for 3 minutes before beginning to fall towards the control value. 
Halothane reduced the systolic blood pressure to 75 mm.Hg; there was no 
significant alteration in pulse rate. 
224. 
Discussion of c.s.f. Pressure Chan es in Patients with Intracranial Tumours 
Without exception, the c.s.f. pressure increases in these patients with 
intracranial tumours were greater than the increases produced in normal 
subjects. There is no reason to suppose that the cause of the c.s.f. 
other than 
pressure increase was different between the two groups, i.e. was/the result 
of halothane induced cerebral vasodilatation. It would seem unlikely that 
the greater pressure rise in the tumour group was the result of greater 
cerebral vasodilatation by halothane in this group though the possibility 
cannot readily be ruled out. However a more likely explanation would 
appear to be that the increase in intracranial blood volume produced by 
halothane in both groups caused a greater pressure rise in the patients with 
intracranial tumours because the intracranial contents were already 
compressed by the growth of the tumour. In normal subjects when a sudden 
increase in intracranial blood volume occurs the consequent rise in intra- 
cranial pressure is modified by a compensatory movement of c.s.f. out from 
the skull. In patients with cerebral tumours such compensatory mechanisms 
are progressively exhausted by expansion of the tumour and so, when a sudden 
expansion in intracranial blood volume occurs, intracranial pressure rises 
precipitously. Lundberg (1960) has demonstrated that in such patients 
"Plateau waves" of intracranial pressure arise in response to trigger 
stimuli which act by producing sudden changes in intracranial blood volume. 
Halothane, because of its cerebral vasodilatatory action, would appear to be 
such a "trigger ". 
These results are in direct contradiction to the conclusion of Bozza 
et al. (1961) that anaesthetic drugs have negligible influence on 
c.s.f. 
pressure. However this statement was based upon a comparison 
of anaestheti 
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drugs in patients without intracranial space occupying lesions (patients 
of Class I of Bozza et al.'s paper) and therefore should not have been 
extended, as it was, to all neurosurgical patients. 
Hunter in 1948 when discussing volatile anaesthetic drugs stated, 
"During operation on patients with supratentorial tumours even a slight 
rise in intracranial tension adds to the difficulties of those whose 
intracranial pressure is already raised. ". The present results confirm 
the truth of this warning but reveal that the situation is not that the 
volatile anaesthetics produce a small increase in intracranial pressure on 
top of a high resting level but that these drugs produce very great 
elevations in intracranial pressure from values which may be only slightly 
above normal values of intracranial pressure. 
The next problem is to decide whether these large changes in intra- 
cranial pressure are actually hazardous. It must first be stated that 
there was in no instance evidence of clinical deterioration in these 
patients during halothane administration; the pulse rate did not fall 
dramatically nor was systemic hypertension seen. These are, however, 
probably late signs of intracranial hypertension. It should also be 
remembered that halothane administration was stopped in three of the cases 
while the c.s.f. pressure was still rising so that the maximum effect of 
halothane was not allowed to develop. Finally, the clinical signs of 
not 
cerebral ischaemia during anaesthesia have/been adequately studied. 
Allowing then that clinical evidence of cerebral dysfunction was not 
allowed to develop in these patients, is there other evidence that 
halothane administration without careful c.s.f. pressure monitoring might 
be detrimental to the brain? There are basically two ways in which a rise 
226. 
in intracranial pressure can imperil cerebral function. Firstly, an 
increase in pressure localised to one intracranial compartment may produce 
brain shifts, brain distortion or brain herniation. In the present 
studies it was justifiable only to make pressure measurements in the 
compartment which was being exposed for surgical treatment. All the 
pressure measurements were made via a cannula in the lateral ventricle. 
Since the c.s.f. communicating pathways may be obstructed in patients with 
intracranial space occupying lesions it is possible that pressure 
equilisation between different intracranial compartments is slow when 
sudden vasodilatation is produced by halothane. Also because of local 
compression by tumour growth, the intracranial pressure rise produced by 
a cerebral vasodilator like halothane will be greatest in the compartment 
containing the tumour. For these reasons it is likely that halothane 
administration to patients with intracranial tumours may on occasion 
produce differential pressure changes and increase the likelihood of 
brain herniation. 
The other way in which intracranial hypertension may impair cerebral 
function is through reduction of cerebral blood flow. From direct 
measurement in animals it is known that cerebral blood flow begins to fall 
when the intracranial pressure rises to within 30 -40 mm.Hg. of the mean 
arterial blood pressure (Zwetnow, 1967). In the four patients presented 
here systolic and not mean blood pressure was measured but from this a 
close approximation to mean pressure can be calculated by subtracting 
20 mmHg. from the systolic pressure at the reduced blood pressure 
pertaining during halothane anaesthesia, (i.e. assume that the pulse 
pressure was 30 mm.Hg. and calculate mean pressure in the usual way as 
diastolic pressure +* pulse pressure). It can then be seen that at the 
CG ( 
peak values of c.s.f. pressure during halothane administration the differenc 
between mean c.s.f. pressure and mean blood pressure was only 35, 30, 48 and 
16 mmHg. in the four patients studied. It is clear therefore that 
halothane administration to patients with intracranial tumours elevates the 
intracranial ressure to a level at which cerebral erfusion has been shown 
in animals to be impaired. The hypotensive action of halothane obviously 
acts synergistically with its effect on intracranial pressure to produce 
this undesirable situation. It is this systemic hypotension in patients 
anaesthetised with halothane which makes the situation more serious than in 
conscious patients. However even if one leaves the question of hypotension 
out of account for the moment, the level of intracranial hypertension 
reached in 3 of these patients exceeded the value of 450 mm.H20 stated by 
Kety, Shenkin and Schmidt (1948) to be the pressure level at which cerebral 
blood flow begins to fall; all 4 patients exceeded the value of 350 mm.H20 
given by Ferris (1941). It should be noted again that in patients A.D., 
A.McN. and H.T. halothane administration was discontinued before there was 
any sign that the intracranial pressure had reached its zenith; longer 
halothane administration would have yielded even greater values but was felt 
to be clinically contraindicated. 
Greenfield and Tindall (1965) measured in man changes in cerebral blood 
low produced by artificial elevation of c.s.f. pressure produced by the 
intradural infusion of saline. Relating cerebral blood flow to c.s.f. 
pressure is physiologically less meaningful than relating it to cerebral 
perfusion pressure (i.e. mean blood pressure - mean intracranial 
pressure) 
and therefore for the purposes of this discussion 
Greenfield and Tindall's 
results have been recalculated to allow this comparison 
of flow with 
perfusion pressure. In this way it can be 
shown that in Greenfield and 
Tindall's study cerebral blood flow was reduced to 74% of the initial value 
when the cerebral perfusion pressure was down to 25 mmHg. The mean 
perfusion pressure during halothane anaesthesia in the patients reported 
here was 32 mmHg. and was as low as 16 mmHg. in one. 
No direct measurements of cerebral blood flow have been made in these 
patients but there is a suggestion from the c.s.f. pressure record of 
patient M.J. that cerebral blood flow was in fact impaired. In Figure 31 
it will be seen that when halothane administration was started, intra- 
cranial pressure rose steeply in the same way as in the other cases. 
However, after 4 minutes, intracranial pressure began to fall again and 
continued to do so until the halothane was stopped. Such a fall from a 
peak value during halothane administration was not seen in the other patients 
with intracranial tumours. However the feature of greatest interest in the 
pressure record of patient M.J. is that when halothane administration was 
discontinued c.s.f. pressure began to increase again and did so for 2 - 3 
minutes before beginning to fall towards control values. A possible 
interpretation of this unusual pressure pattern is that the fall in c.s.f. 
pressure seen after the 4th minute of halothane administration was due to 
a fall in cerebral perfusion and this becomes all the more probable when one 
notes that the c.s.f. - mean B.P. difference had fallen to only 16 mm.Hg. 
at this point. The increase in c.s.f. pressure when the halothane was 
stopped would then be ascribed to an increase in cerebral perfusion as the 
blood pressure began to recover. At 3 minutes after discontinuing the 
halothane cerebral vasodilatation was passing off and the c.s.f. pressure 
fell. In Figure 31 the dotted line indicates the pattern of c.s.f. 
pressure response to halothane which results in other patients would have 
led us to expect. In this patient therefore not only did the c.s.f. - B.P. 
229. 
difference fall to a value which has been shown to be inadequate to sustain 
cerebral blood flow but the c.s.f. pressure record shows that such a fall 
in cerebral perfusion may actually have occurred. 
One cannot of course infer that because cerebral blood flow may be 
reduced by the fall in perfusion pressure produced by halothane that 
cerebral function is thereby imperilled. After all, cerebral blood flow 
can be halved by hyperventilation without any permanent loss of cerebral 
function. Indeed the patients in the study of Greenfield and Tindall 
(1965) remained fully alert and conscious at a cerebral perfusion pressure 
of only 25 mm.Hg. In considering the question of halothane administration 
to patients with intracranial tumours, however, it should be emphasised 
that, unlike the situation with hypocapnic cerebral vasoconstriction, the 
cerebral arterioles are maximally dilated in an attempt to compensate for 
the raised intracranial pressure (Fog, 1934) and therefore cerebral blood 
flow is impaired at a time when the reserves of cerebrovascular compensation 
are fully extended. The situation is more closely analogous to that 
existing with systemic hypotension which has been carried to the point at 
which the cerebral arterioles are maximally dilated and can compensate no 
further. When halothane is administered to patients with intracranial 
tumours therefore cerebral perfusion pressure may become inadequate to 
support neuronal survival at a systemic blood pressure higher than that 
normally required to maintain adequate cerebral blood flow, the discrepancy 
being due to the elevated intracranial pressure. In clinical terms the 
reserves of compensation normally available to the cerebral circulation are 
exhausted and any further impairment in perfusion pressure, as for example 
may be produced by a sudden haemorrhage, could produce cerebral damage at 
a level of blood pressure which would not normally be considered hazardous. 
¿30. 
It was demonstrated in the preceding chapter of this thesis that, in 
patients without intracranial lesions, prior hyperventilation greatly 
reduced the effect of halothane on c.s.f. pressure. In patient A.McN. of 
this intracranial tumour group the effect of hyperventilation prior to 
halothane administration was assessed. It was found that the extent of the 
halothane induced rise in intracranial pressure was greatly reduced by this 
procedure. This protective effect of hyperventilation is almost certainly 
due to the reduction in cerebral blood flow and intracranial blood volume 
which hypocapnia produces (Rosomoff, 1963). Consequently as suggested 
but not confirmed by Marx et al. (1962) it is wise to hyperventilate patient 
with intracranial space occupying lesions prior to administering halothane. 
It is important however that hyperventilation should not be too long 
continued before halothane is administered for then a compensatory increase 
in c.s.f. volume might negate the protective value of this procedure. 
Patient A.D. differed from the other patients in this group in that he 
underwent air ventriculography prior to anaesthesia and prior to the c.s.f. 
pressure study. Saidman and Eger (1965) have shown that the administration 
of nitrous oxide to a patient with air inside the skull following air 
ventriculography can lead to increases in intracranial pressure. These 
changes are due to the transfer of nitrous oxide to the air bubbles in 
volumes in excess of the volume of nitrogen removed from the bubbles. The 
discrepancy between nitrous oxide entry and nitrogen removal from air 
bubbles is related to the much higher solubility of nitrous oxide in blood 
than that of nitrogen. However, the c.s.f. pressure rise in this patient 
is unlikely to have been caused in this way because nitrous oxide had been 
administered for 30 minutes prior to the study and because a stable value 
for c.s.f. pressure was obtained during the 5 minutes of measurement prior 
231. 
to halothane administration. Furthermore the pressure changes which did 
occur were clearly related in time to the starting and stopping of halothane 
administration. Transfer of halothane to the intraventricular air bubbles 
would have been negligible because of the low administered concentration of 
halothane. By virtue of being compressible the air collections in this 
patient probably "cushioned" the effects of the increase in intracranial 
blood volume produced by halothane and indeed the c.s.f. pressure record 
does show a rather more gentle rise in pressure than that seen in the other 
tumour patients. 
In summary, it has been demonstrated that in patients with intracranial 
space occupying lesions halothane produces much greater elevations in c.s.f. 
pressure than it does in patients without intracranial pathology. The 
increases in pressure in the former group were such that the mean blood 
pressure - c.s.f. pressure difference (which under these circumstances is 
the perfusion pressure of the brain) narrowed to levels which in animals 
are associated with reduction in cerebral perfusion. Prior hyper- 
ventilation has been shown to be protective and.it is likely that the 
current anaesthetic practice of hyperventilating patients during neuro- 
surgery accounts. for the infrequency of clinical deterioration when 
halothane is administered. However, sometimes, and especially during 
cerebral angiography, halothane is administered to patients with intra- 
cranial tumours who are allowed to breathe spontaneously. Since such 
patients usually underventilate intracranial pressure will be elevated both 
by hypercapnia and halothane itself. This practice would appear to be 
potentially hazardous. 
(The full summary of the thesis has been placed, 
as required by the 
regulations, at the beginning immediately after 




DATE 3LOOD FLU!! OXYGEN UPTAKE Paco2 B.P. 
0.96 - 37 150 
1.05 - 37 140 
2/4/65 0.87 -- 40 150 
0.87 - 41 130 
0.83 - 41 130 
1.26 0.062 36 135 
5/4/65 1.22 0.074 40 148 
1.27 0.068 38 130 
1.45 0.072 44 190 
23/4/65 1.40 0.073 44 195 
1.48 - 44 185 
1.28 0.074 50 150 
26/4/65 1.28 0.065 50 145 
1.18 0.070 46 157 
Table Apy. 1. Detailed results for blood flow and oxygen uptake of the 
cerebral cortex and for blood pressure and arterial Pco2 
in four dogs anaesthetised with nitrous oxide -oxygen 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































N20 + 02 
0.5 ¡. Halothane 
Oxygen Uptake Temp. °C . Oxygen Uptake Temp. °C . 
0.060 38 0.059 
0.068 37 0.063 36 











26/2/64 0.100 0.081 
0.098 











0.075 39 0.062 39 
23/11/64 0.066 39 0.045 39 
0.056 39 
0.071 39 0.060 37 
0.075 39 0.041 37 
23/12/64 0.059 38 
0.076 
38 
0.048 39 0.033 39 
0.042 39 0.028 39 







N20 + 02 0.5% Halothane 
Oxygen Uptake Temp. °C, Oxygen Uptake Temp. °C. 
0.077 39 0.065 39 
15/3/65 0.065 39 0.063 39 
0.074 39 0.060 39 
0.057 38 0.074 38 
17/3/65 0.071 38 0.055 38 
0.063 38 0.060 33 
0.060 38 0.046 38 












0.098 39 0.069 39 































N20 t 02 0.5% Halothane 







Table App. 9 Individual results for oxygen uptake of the cerebral 
cortex during nitrous oxide -oxygen anaesthesia and 
during anaesthesia with 0.5% halothane. The pharyngeal 
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N20 + 02 2 Halothane 






0.081 38 0.045 38 
0.073 37 0.046 38 
9/7/65 0.090 38 0.064 38 
0.079 38 
0.059 38 


















0.045 38 0.037 38 
2/8/65 0.056 38 0.033 38 
0.053 38 0.033 38 
Table App. 11 Individual results for oxygen uptake of the cerebral 
cortex during nitrous oxide -oxygen anaesthesia and 
during anaesthesia with 2% halothane. The pharyngeal 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































N20 + 02 Trichloroethylene 
Oxygen Uptake Temp. °C. Oxygen Uptake Temp. °c. 
0.051 37.0 0.044 38.o 
0.055 37.o 0.036 38.o 
0.047 37.o 0.052 38.o 
0.041 37.0 
7/5/63 0.042 37.0 
0.049 36.5 
0.052 36.5 











0.066 38.0 0.060 37.0 
0.089 38.0 0.055 37.0 











27/6/63 0.060 0.040 38.0 
0.034 38.5 
0.042 
0.054 38.5 0.046 38.7 
0.058 38.7 0.059 39.2 
0.064 39.2 0.054 39.o 





N20 + 02 .Trichloroethylene 
Oxygen Uptake Temp. °C. Oxygen Uptake Temp. °C, 
18/2/66 
0.088 39.0 0.097 38.5 
0.099 38.0 0.067 38.5 
0.051 37.5 0.040 38.0 
0.043 38.0 0.043 39.0 
21/2/66 




0.043 38.0 0.011 38.0 
0.029 39.0 0.018 38.0 
0.036 38.0 0.039 38.5 




0.048 38.0 0.049 38.0 
0.048 38.0 0.010 38.0 









Table App. 17 Individual results for oxygen uptake of the cerebral 
cortex during nitrous oxide -oxygen anaesthesia and 
during anaesthesia with trichloroethylene. The 
pharyngeal temperature at the time of the measurement 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































N20 + 02 1% CHLOROFORM 
Oxygen Uptake Temp. °C. Oxygen Uptake Temp. °C, 
0.060 37.o 0.065 37.0 
12/7/63 0.094 36.5 0.061 37.5 
0.073 37.o 
0.052 36.5 0.070 37.o 
11/10/63 0.067 37.0 0.049 37.0 
0.040 37.0 
0.057 - 0.059 - 
18/10/63 0.056 - 0.065 - 
0.072 - 
0.067 - 0.041 - 
26/1o/63 0.056 - 
0.070 - 
0.065 
0.050 39.5 0.048 39.5 
20/1/64 0.045 39.5 0.040 39.5 
0.047 39.0 0.054 39.o 
19/8/64 0.048 39.o 0.059 39.0 
0.049 39o 0.060 39.o 
0.056 39.0 
Table App. 21 Individual results for oxygen uptake of the cerebral 
cortex during nitrous oxide- oxygen anaesthesia and 
during anaesthesia with 1¡% chloroform. The 
pharyngeal temperature at the time of the 
measurement is also displayed. 
289. 
DATE 
Td20 + 02 1% CIiL0R0,?ORvI 
Ao2 Vo2 A-Vo2 Ao2 Vo2 A-Vo2 
92 61 31 99 71 28 
12/7/63 99 52 47 99 67 32 
95 53 42 
92 62 30 93 67 26 
11/1o/63 99 58 41 98 77 21 
97 79 18 
, 
99 61 38 99 66 33 
18/10/63 99 62 37 98 64 34 
99 51 48 


































97 70 27 
Table App. 22 Values for arterial and cerebral venous oxygen 
saturation and for cerebral arterio -venous oxygen 
saturation difference during nitrous -oxygen anaesthesia 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DOG NO. EXPERIMENT PROTOCOL 
1 1% chloroform on c.s.f. pressure. 
2 
0.5% halothane and 1% chloroform separately on 
c.s.f. and central venous pressures. Also 0.5i 
halothane during hyperventilation. 
3 Experiment abandoned because of hypotension. 
4 
Experiment abandoned. Catheter accidentally 
dislodged from cisterna magna. 
Prolonged 0.5% halothane on c.s.f. and cerebral 
venous pressures. 
6 Experiment abandoned because of hypoxic incident. 
Experiment not relevant. Hypothermia on c.s.f. 
pressure. 
8 
0.5% and 2% halothane on c.s.f., cerebral venous 
and central venous pressures. 
9 
0.5% and 2% halothane on c.s.f. and cerebral 
venous pressures. 
Table App. 29 Protocols of individual experiments in animal study of 
influence of volatile anaesthetic drugs on cerebro- 
spinal fluid and cerebral venous pressures. 
PATIENT REASON FOR EXCLUSION 
5 No blood gas results. 
7 Loss of C.S.F. from L.P. needle. 
9 Recorder failure. 
13 No stable control value for c.s.f pressure. 
15 No stable control value for c.s.f. pressure. 
23 Pressure transducer faulty. 
26 No stable control value for c.s.f. pressure. 
28 Pressure transducer faulty. 
29 Pressure transducer faulty. 
30 Pressure transducer faulty. 
42 No stable control value for c.s.f. pressure. 
Table App. 30 Patient studies excluded from results section together 
with reasons for exclusion. 
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PATIENT SEX AGE INVESTIGATION 
6 Li 57 0.5¡ halothane during normocapnia on 
c.s.f. and central venous pressures. 
38 1 = 42 0.5 halothane during normocapnia on 
c.s.f. and central venous pressures. 
40 M 27 0.55 halothane during normocapnia on 
c.s.f. and central venous pressures. 
43 F 47 0.5% halothane during normocapnia on 
c.s.f. and central venous pressures. 
14 f 40 0.5% halothane during normocapnia on 
c.s.f. pressure. 
16 M 37 0.5% halothane during normocapnia on 
c.s.f. pressure. 
17 F 34 0.5% halothane during normocapnia on 
c.s.f. pressure. 
32 M 47 0.5% halothane during normocapnia on 
c.s.f. pressure. 
31 F 50 0.5% halothane during hypocapnia on 
c.s.f. and central venous pressures. 
33 F 22 0.5; halothane during hypocapnia on 
c.s.f. and central venous pressures. 
34 LAI 52 0.5% halothane during hypocapnia on 
c.s.f. and central venous pressures. 
39 F 44 0.5% halothane during hypocapnia on 
c.s.f. and central venous pressures. 
8 L¿ 39 0.55 halothane during hypocapnia on 
c.s.f. pressure. 
12 F 38 0.5' halothane during hypocapnia on 
c.s.f. pressure. 
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PATIENT SEX AGE INVESTIGATION 
38 M 42 1% halothane during normocapnia on 
c.s.f. and central venous pressures. 
68 M 47 l halothane during normocapnia on 
c.s.f. and central venous pressures. 
69 M 25 1% halothane during normocapnia on 
c.s.f. and central venous pressures. 
10 M 37 l`,-, halothane during normocapnia on 
c.s.f. pressure. 
25 M 30 0.9% trichloroethylene during normo- 
capnia on c.s.f. and central venous 
pressures. 
18 M 42 0.99_ trichloroethylene during 
normocapnia on c.s.f. pressure. 
21 F 34 0.% trichloroethylene during 
normocapnia on c.s.f. pressure. 
22 M 45 0.9% trichloroethylene during 
normocapnia on c.s.f. pressure. 
24 M 29 0.9% trichloroethylene during 
normocapnia on c.s.f. pressure. 
20 F 43 0.9% trichloroethylene during normo- 
capnia on central venous pressure. 
35 M 32 0.9% trichloroethylene during normo- 
capnia on central venous pressure. 
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THE EFFECTS OF CLINICAL CONCENTRATIONS OF HALOTHANE ON 
THE BLOOD FLOW AND OXYGEN UPTAKE OF THE CEREBRAL CORTEX 
BY 
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SUMMARY 
Clinical concentrations of halothane vaporized in nitrous oxide- oxygen caused vaso- 
dilatation in the cerebral cortex of anaesthetized dogs at constant arterial carbon 
dioxide tension. The vasodilatory action on the cerebral circulation was greater the 
higher the concentration of halothane. Consequently 2 per cent halothane increased 
blood flow through the cerebral cortex more than did 0.5 per cent halothane. However, 
the administration of 4 per cent halothane reduced mean blood pressure so markedly that 
blood flow was not elevated above the control value. The oxygen uptake of the cerebral 
cortex was depressed by halothane and this depression was greater with 2 per cent 
halothane than with 0.5 per cent. These results are discussed with reference to the 
effects of halothane on intracranial pressure and on the oxygenation of the brain. 
Over the past three years, evidence has accumula- 
ted which indicates that halothane is a cerebral 
vasodilator. However, there is no knowledge of 
the relationship between cerebral blood flow and 
concentration of halothane administered nor is 
there agreement on the effect of the drug on the 
oxygen uptake of the brain. The following studies 
were undertaken to elucidate the effects of a 
range of concentrations of halothane on the blood 
flow and oxygen uptake of the cerebral cortex. 
METHODS 
Unselected mongrel dogs were anaesthetized with 
a dose of thiopentone just sufficient to produce 
sleep. Following endotracheal intubation, the 
animals were ventilated by intermittent positive 
pressure using a non - return circuit and anaes- 
thesia was maintained with 70 per cent nitrous 
oxide and 30 per cent oxygen. Muscular relaxation 
was obtained with intermittent doses of a dilute 
solution of suxamethonium in order to allow 
control of ventilation and so of arterial carbon 
dioxide tension. One or occasionally two supple- 
mental doses of thiopentone were administered 
during the early stages of the surgical preparation. 
The femoral artery and vein on one side were 
exposed and cannulated; the arterial cannula 
allowed measurement of mean arterial blood pres- 
sure and sampling of arterial blood. The venous 
cannula was for the injection of suxamethonium 
The common carotid artery on one side was ex- 
posed and its superior thyroid branch cannulated. 
After exposing the skull by reflection of skin 
and temporalis muscle, a trephine was made over 
the parietal cortex. The dura was opened, care- 
fully avoiding trauma to the cortical surface. The 
exposed brain was immediately covered with a 
plastic membrane 61). in thickness ( "Melinex "; 
ICI - polyethylene teraphthalate) to prevent dry- 
ing and heat loss. A second trephine was made 
in the midline of the skull to expose the superior 
sagittal sinus and into this a cannula was inserted 
for the sampling of cerebral venous blood. 
Anterior to this trephine the bone overlying the 
sinus was removed in order to sever diploic con- 
nections. 
Blood flow in the cerebral cortex was measured 
by the radioactive inert gas clearance technique 
of Lassen and Ingvar (1961). The radioactive gas 
employed was krypton 85, the beta emissions of 
which were counted by a Geiger Muller tube 
mounted above the exposed cerebral cortex. The 
krypton, dissolved in saline, was injected into the 
cerebral circulation via the cannula in the common 
carotid artery. The speed of its injection was 
controlled to give a relatively constant counting 
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rate from the cortex over a period of 2 -3 minutes. 
During this time, equilibration between the con- 
centration of krypton in the arterial blood and 
the concentration in the cerebral cortex was 
achieved (Harper, 1966a). The injection was then 
suddenly stopped and the rate of clearance of 
krypton from the brain tissue was measured. 
After transposition to semilogarithmic paper, the 
slope of the initial part of this clearance curve 
was measured. The time to half- clearance so 
obtained was inserted into the following equation 
to yield cortical flow (Ingvar and Lassen, 1962). 
Flow (ml /g /min) - ). loge2 X 60 
TZ 
where ), = brain -blood partition coefficient for 
krypton. 
Mean arterial blood pressure was monitored 
with a damped mercury manometer. Pharyngeal 
temperature was measured by a mercury -in -glass 
thermometer. Heating was applied as necessary 
to maintain the pharyngeal temperature close to 
38 °C. Arterial and venous blood samples were 
withdrawn from the femoral artery and sagittal 
sinus following each determination of blood flow 
and were analyzed for oxygen saturation, pH 
and Peo,. 
The oxygen saturation measurements were 
carried out on a Kipp haemoreflector which was 
calibrated for each experiment with the animal's 
own blood. Arterial and venous pH were measured 
with a capillary glass electrode (Radiometer); 
arterial and venous Pco, were measured with a 
carbon dioxide electrode of the type described by 
Severinghaus and Bradley (1958) (Electronic 
Instruments Ltd.). Calibration of the pH electrode 
was with two known phosphate buffers and of 
the Peo, electrode with humidified gases of three 
known carbon dioxide concentrations. 
Haemoglobin concentration of arterial blood 
was measured by the cyanmethaemoglobin method 
with spectrophotometric analysis at 540 mil, 
wavelength. 
Experimental procedure. 
Measurements of blood flow were started when 
a time interval of at least 1 hour had elapsed 
since opening the dura or of at least 2 hours after 
administering the last dose of thiopentone, which- 
ever was the longer. It was known, from prelimin- 
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ary studies, that within these time limits blood 
flow through the cerebral cortex reached a value 
which thereafter remained constant for many 
hours if the experimental conditions were not 
altered. Cerebral cortical blood flow was measured 
during nitrous oxide -oxygen anaesthesia and 
during anaesthesia with 0.5 per cent halothane, 
2 per cent halothane or 4 per cent halothane. The 
halothane was vaporized in nitrous oxide -oxygen 
from a Fluotec II vaporizer, the output of which 
was checked by refractometry; the actual con- 
centrations delivered by the particular Fluotec 
used at each setting of the control dial are given 
in table I. 
TABLE I 
The halothane output of the Fluotec used. 
Indicated dial 
reading ( %) 
Actual halothane 




In most animals only one halothane concen- 
tration was studied but in some experiments 
measurements were made during the administra- 
tion of two different concentrations of halothane. 
All comparisons were made with the values for 
blood flow obtained during unsupplemented 
nitrous oxide -oxygen anaesthesia in the same 
animals. In all, there were 88 measurements of 
flow during 0.5 per cent halothane in 24 dogs 
(with 84 control measurements), 26 measurements 
of flow during 2 per cent halothane in 9 dogs 
(with 34 control measurements) and 10 measure- 
ments during 4 per cent halothane in 5 dogs 
(with 19 control measurements). 
RESULTS 
Blood flow through the cerebral cortex. 
The blood flow through the cerebral cortex 
during administration of 0.5 per cent halothane 
(table II and fig. 1) was not significantly different 
from that under unsupplemented nitrous oxide 
anaesthesia while mean blood pressure was re- 
duced by 11 per cent. However, analysis of the 
flow data, with reference to duration of halothane 
administration, shows that there was a 16 per cent 
increase in flow during the first 20 minutes of 
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TABLE II 















over 60 min 
Blood flow Mean 0.88 0.94 0.88 1.02t 0.96 0.84 
(ml /g/min) SD 0.19 0.27 0.19 0.25 0.18 0.27 
Blood pressure Mean 141 126$ 142 132t 143 1231 

















* P<0.05; t P<0.01; $ P<0.001 
TABLE III 







2% halothane with 
blood pressure greater 
than 90 mm Hg 
Blood flow Mean 0.79 0.98* 0.79 1.07t 
(ml/g/min) SD 0.19 0.36 0.20 0.36 
Blood pressure Mean 138 97$ 139 110$ 













* P<0.05; t P<0.01; $ P<0.001 
0.5 per cent halothane despite a 7 per cent fall in 
mean blood pressure. 
Two per cent halothane (table III and fig. 1) 
produced a 24 per cent increase in flow through 
the cerebral cortex but lowered mean blood pres- 
sure by 30 per cent. When the animals which were 
rendered very hypotensive by this concentration 
of halothane (i.e. with mean blood pressures of 
90 mm Hg and below) were excluded, the increase 
in blood flow with 2 per cent halothane was 36 
per cent. 
During the administration of 4 per cent halo - 
thane (table IV) flow was not significantly different 
from the value during unsupplemented nitrous 
oxide anaesthesia. However, 4 per cent halothane 
reduced the mean blood pressure by 57 per cent 
(to 62 ± 20 mm Hg). 
OXYGEN 
UPTAKF 
OS%HALOTHANE 2 :aHALOTHANE 
FIG. 1 
The effect of 0.5 per cent halothane and of 2 per cent 
halothane on the blood flow and oxygen uptake of the 
cerebral cortex. 
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TABLE IV 
The effect of 4% halothane on blood flow through the cerebral cortex. 
Nitrous oxide 
+ oxygen 4% halothane 
Blood flow Mean 0.95 0.82 
(ml /g /min) SD 0.16 0.22 
Blood pressure Mean 143 621 
(mm Hg) SD 19 20 
Pac02 Mean 39.3 39.1 
(mm Hg) SD 2.5 3.8 
* P <0.05; t P<0.01; 1 P<0.001 
TABLE V 









1st 20 minutes 
Cerebrovascular Mean 1.67 1.45$ 1.68 1.361 
resistance SD 0.37 0.47 0.37 0.36 
Blood pressure Mean 141 1261 142 132f 
(mm Hg) SD 14 17 14 17 
* P<0.05; ± P<0.01; 1 P<0.001 
It will be seen in tables II and III that the 
mean values for flow, blood pressure and Paco. 
during nitrous oxide anaesthesia are slightly 
different between different subgroups. The reason 
for this is that not all animals were represented 
in each group, e.g. in table II not all animals were 
studied during more than 60 minutes of halothane 
anaesthesia, and therefore the nitrous oxide 
measurements from such animals were excluded in 
calculating the mean nitrous oxide values for this 
subgroup. This step was, of course, necessary to 
ensure that in each subgroup comparisons between 
nitrous oxide results and halothane results were 
made in the same animals. 
Cerebrovascular resistance. 
Cerebrovascular resistance was calculated accor- 
ding to the following equation : 
mean arterial blood pressure c.v.r. - 
blood flow through cerebral cortex 
Since cerebrovascular resistance relates flow to 
perfusion pressure, the cerebral venous pressure 
should theoretically be subtracted from the 
arterial pressure. However, the error introduced 
into the calculated c.v.r. by ignoring cerebral 
venous pressure is less than 5 per cent because the 
venous pressure in the superior sagittal sinus of 
the supine dog is only 5 -10 cm H_O (McDowall, 
Harper and Jacobson, 1964). 
With 0.5 per cent halothane, cerebrovascular 
resistance fell by 19 per cent during the first 20 
minutes of administration and by 13 per cent 
overall, both changes being highly significant (see 
table V and fig. 2); 2 per cent halothane caused 
a fall of 43 per cent, and 4 per cent halothane a 
fall of 49 per cent in c.v.r. (see table VI and fig. 2). 
As discussed below, the varying degrees of hypo- 
tension which occurred with halothane administra- 
tion complicate the interpretation of these changes 
(see table VII). 
Oxygen uptake of the cerebral cortex. 
The mean results for the oxygen uptake of 
the cerebral cortex are shown in table VIII and 
figure 1; 0.5 per cent halothane reduced the 
oxygen uptake of the cortex by 14 per cent of the 
value existing during unsupplemented nitrous 
oxide anaesthesia; 2 per cent halothane caused a 
greater (- 33 per cent) reduction in oxygen up- 
take. All these results were obtained at the same 
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FIG. 2 
Changes in cerebrovascular resistance compared with changes in mean blood pressure produced 
by 0.5-4 per cent halothane 
TABLE VI 
The effect of 2% and 4% halothane on cerebrovascular resistance and mean blood pressure. 
Nitrous oxide 
+ oxygen 2% halothane 
Nitrous oxide 
+ oxygen 4% halothane 
Cerebrovascular Mean 1.84 1.05$ 1.56 0.80$ 
resistance SD 0.52 0.32 0.37 0.34 
Blood pressure Mean 138 97$ 143 62$ 
(mm Hg) SD 19 21 19 20 
* P<0.05; t P<0.01; $ P<0.001 
TABLE VII 
Comparison ofchanges in cerebrovascular resistance with changes in mean blood pressure. 
Concentration of 





% c.v.r. change 
% b.p. change 
0.5 -13 -11 1.18 
0.5 -19 -7 2.71 
1st 20 minutes 
2 -43 -30 1.43 
4 -49 -57 0.86 
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In order to analyze statistically the significance 
of the apparently greater reduction in oxygen 
uptake with 2 per cent halothane as compared 
with 0.5 per cent it was necessary to reduce the 
influence of variations in the control values for 
oxygen uptake since the comparisons were made 
in two separate groups of animals. To do this the 
mean value for oxygen uptake during nitrous 
oxide anaesthesia in each individual animal was 
designated 100 per cent and all determinations 
calculated as percentages of this. Calculated in 
this way 0.5 per cent halothane was associated with 
a cortical oxygen uptake of 87.8 ± 16.0 per cent 
of the nitrous oxide value; while 2 per cent halo - 
thane gave a value of 69.8 ± 11.8 per cent of the 
nitrous oxide value. The depression of oxygen 
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uptake produced by 2 per cent halothane was 
significantly greater than that produced by 0.5 
per cent halothane (0.001>P). 
Arteriovenous differences across the cerebral 
cortex. 
The arteriovenous differences for oxygen 
saturation, carbon doxide tension and pH across 
the cerebral cortex during nitrous oxide anaes- 
thesia and during halothane anaesthesia are shown 
in table IX. All these arteriovenous differences 
narrowed when 0.5 per cent halothane was ad- 
ministered. Two per cent halothane caused the 
A -V differences for oxygen and for carbon dioxide 
to narrow even further but the change in A -V pH 
difference did not reach statistical significance. 
TABLE VIII 
The effect of 0.5% and 2% halothane on the oxygen uptake of the cerebral cortex. 
Nitrous oxide 
+ oxygen 0.5% halothane 
Nitrous oxide 
+ oxygen 2% halothane 
Oxygen uptake Mean 0.066 0.057f 0.060 0.0401 
(ml/g/ ) SD 0.014 0.016 0.015 0.011 
Pharyngeal Mean 38.4 38.2 38.4 38.3 
temperature ( °C) SD 0.6 0.9 0.6 0.5 
* P<0.05; t P<0.01; $ P<0.001 
TABLE IX 
The effect of 0.5% and 2% halothane on the arteriovenous differences across the cerebral cortex for oxygen, Pco2, and pH. 
Nitrous oxide 
+ oxygen 0.5% halothane 
Nitrous oxide 
+ oxygen 2% halothane 
Arteriovenous oxygen Mean 39.0 34.01 40.7 23.21 
saturation difference ( %) SD 9.1 8.7 7.6 3.9 
Arteriovenous Mean 13.2 10.8* 13.6 8.9f 
Pco2 difference (mm Hg) SD 3.8 4.3 4.3 4.1 
Arteriovenous Mean 0.062 0.045f 0.063 0.045 
pH difference SD 0.023 0.027 0.035 0.029 
* P<0.05; f P<0.01; P<0.001 
TABLE X 
The effect of 0.5% and 2% halothane on the oxygen saturation of cerebral venous blood sampled from the superior sagittal sinus. 
Nitrous oxide 
0.5% halothane + oxygen 2% halothane 
Nitrous oxide 
+ oxygen 
Cerebral venous Mean 
oxygen saturation SD 
58.3 62.2* 58.1 
9.1 9.1 7.4 
75.0$ 
3.0 
* P<0.05; t P<0.01; $ P<0.001 
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Table X shows the effect of halothane on the 
oxygen saturation of cerebral venous blood, 
sampled from the superior sagittal sinus; 0.5 
per cent halothane raised the venous oxygen 
saturation by 3.9 per cent while 2 per cent halo- 
thane caused a rise of 16.9 per cent. 
DISCUSSION 
Methodology. 
The method of flow measurement used in this 
study indicates the tissue perfusion of the area 
of cerebral cortex lying below the Geiger Muller 
tube. The diameter of this area was 1 -2 cm. 
Furthermore, since the beta radiation of krypton 
has a limited range in tissue, only flow occurring 
within the superficial 1 -1 5 mm of cerebral cortex 
is measured, with negligible contribution from 
the underlying white matter. The measurements 
reported then refer only to the grey matter of 
localized areas of parietal cortex. Harper, Glass 
and Glover (1961), however, have shown that 
flow throughout the superolateral surfaces of the 
cerebral hemispheres is 
dog during nitrous oxide anaesthesia and the 
present author (unpublished observations) has 
established that a similar flow relationship exists 
between different areas of the cortex during 
administration of 0.5 per cent halothane. There 
is, therefore, evidence for accepting that measure- 
ments of flow in the parietal cortex are applicable 
to the entire cerebral cortex under the conditions 
of this study. Since flow through grey matter is 
about 5 times that through white (Landau et al., 
1955) and since the cortical surface accounts for 
a considerable proportion of the total brain 
volume, the observations made are indicative of 
changes occurring in a sizeable component of total 
cerebral blood flow. 
The calculation of the oxygen uptake of the 
cerebral cortex from the flow measurements and 
the arteriovenous oxygen content differences re- 
quires that flow over the entire drainage area of 
the superior sagittal sinus be the same as that 
measured in the localized area studied. The 
venous blood in the superior sagittal sinus has 
drained almost entirely from the cerebral cortex 
(after destruction of the diploic connections) 
(Gleichmann et al., 1962). The validity of the 
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oxygen uptake calculations is, therefore, also 
established by the above evidence that flow over 
the cortical surface is uniform under the condi- 
tions of these experiments. 
The influence of halothane on flow and cerebro- 
vascular resistance. 
These studies have demonstrated that the 
volatile anaesthetic drug, halothane, acts as a 
dilator of the cerebral cortical circulation. This 
vasodilatation results in increases in cerebral 
cortical blood flow despite falls in mean arterial 
blood pressure with 0.5 and 2 per cent halothane. 
Four per cent halothane reduces cerebral perfusion 
pressure so greatly that flow is not increased; 
also in the case of 2 per cent halothane, the flow 
increase is greater when measurements made at 
blood pressures above 90 mm Hg only are con- 
sidered. 
It is well known that cerebral blood flow 
autoregulates to compensate for changes in per- 
fusion pressure (reviewed by Lassen, 1959, and 
Harper, 1966b). In a study by Harper in the 
dog (1965) no change in the cerebral cortical flow 
occurred as the mean arterial pressure was reduced 
(by controlled bleeding) from 150 to 90 mm Hg; 
greater reductions in arterial pressure led to 
proportionate reductions in blood flow. Very 
similar results were obtained by Häggendal (1965) 
also in the dog. In the experiments described in 
this paper, 4 per cent halothane reduced the mean 
blood pressure to 62 mm Hg and flow was close to 
control values. At such levels of hypotension, 
therefore, it is not possible to demonstrate halo- 
thane vasodilatation because the hypotension itself 
produces maximal cerebral vasodilatation. This is 
understandable when one recalls that at this level 
of perfusion pressure even hypercapnia is ineffec- 
tive in raising cerebral flow (Harper and Glass, 
1965). It is for the same reason that the flow in- 
crease with 2 per cent halothane was greater when 
measurements made at blood pressures above 
90 mm Hg only were considered. 
Cerebrovascular resistance fell whenever halo - 
thane was administered. However, the autoregula- 
tion of cerebral blood flow, which has been 
repeatedly demonstrated to occur in the face 
of moderate hypotension, implies that cerebro- 
vascular resistance must fall proportionately with 
blood pressure during hypotension, however 
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produced. The problem is, therefore, to determine 
whether the observed changes in cerebrovascular 
resistance during halothane administration could 
or could not be entirely ascribed to the associated 
falls in mean blood pressure. The results have 
been analyzed from this point of view in table 
VII and figure 2, from which it will be seen that 
c.v.r. fell more than did blood pressure during 
the first 20 minutes of 0.5 per cent halothane and 
during 2 per cent halothane administration. The 
drug was, therefore, under these circumstances 
producing relaxation of the cerebral arterioles in 
excess of that due to the concomitant blood pres- 
sure changes. With 4 per cent halothane the fall 
in c.v.r. was less than the fall in blood pressure 
and this must mean that the point of maximum 
vasodilatation due to hypotension had been 
passed; since the blood pressure was reduced to 
62 mm Hg such a conclusion is in accord with 
the pressure -flow curve of Harper (1965). 
Galindo and Baldwin (1963) reported that halo - 
thane administered in unspecified concentrations, 
did not alter internal carotid artery flow in dogs 
though the blood pressure was reduced by 40.7 
per cent. Since the mean blood pressure during 
halothane administration in their study was 80 
mm Hg, maximum vasodilatation due to hypo- 
tension was probably present and, therefore, 
changes in cerebrovascular resistance due to halo - 
thane would have been difficult to demonstrate. 
However, these authors observed an increase in 
internal carotid flow early in the administration 
of halothane before the blood pressure had fallen 
greatly. Flow in the internal carotid artery of the 
dog is so uncertain a measure of cerebral blood 
flow, however, that it is not possible to draw 
firm conclusions with regard to the cerebral cir- 
culation from such observations (De La Torre, 
Netsky and Meschan, 1959). 
Wollman and associates (1964) reported that 
1.2 per cent halothane increased the total cerebral 
blood flow of man by 15 per cent, a result which 
agrees quantitatively with the findings of the pres- 
ent study. However, the 55 per cent increase in 
total cerebral blood flow reported by McHenry 
and others (1965) with 1 per cent halothane ad- 
ministration is much greater than the increase 
reported here, or the increase found by Wollman 
and associates (1964). McHenry and co- workers 
explain the greater change with halothane, as corn- 
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pared with that of Wollman's group, as being due 
to higher mean blood pressure and to different 
methods of calculating flow. The former point 
may explain part of the discrepancy but their 
method of flow calculation would introduce an 
error in the direction of underestimating the halo - 
thane effect. A more likely cause of the difference 
is that the mean arterial carbon dioxide tension 
was 47 mm Hg during the halothane measure- 
ments, whereas the "control" measurements, made 
on conscious subjects, were presumably at arterial 
tensions of carbon dioxide within the normal 
range. 
Lassen (personal communication) has recently 
studied halothane anaesthesia in man using a 
radioactive clearance technique with external 
counting. He found that 1 per cent halothane 
caused an elevation of 27 per cent in regional 
cerebral blood flow. 
In an earlier study from this laboratory (Mc- 
Dowall, Harper and Jacobson, 1963) a decrease 
in cerebral cortical flow with halothane in dogs 
was reported. This result was due to the use of 
very low concentrations of halothane (less than 
0.5 per cent) vaporized in air (McDowall and 
Harper, 1965). It seems that at such low concen- 
trations regional differences in cerebral cortical 
flow may occur. 
In summary, all workers are agreed that 
halothane in clinical concentrations is a cerebral 
vasodilator. The present study has, however, 
demonstrated that this is true only under certain 
conditions. At low levels of perfusion pressure, 
halothane is without effect on cerebrovascular 
resistance; the same is probably also the case when 
maximum vasodilatation by hypercapnia precedes 
halothane administration. The cerebral vasodila- 
tation produced by halothane increases with in- 
creasing concentration but 4 per cent halothane 
has less effect than 2 per cent because of con- 
comitant hypotension. The effect of 0.5 per cent 
halothane is relatively weak and is not well 
sustained so that after more than 20 minutes of 
administration flow returns to close to control 
values. 
The influence of halothane on oxygen uptake. 
0.5 per cent halothane reduces the oxygen up- 
take of the cortex by 14 per cent and 2 per cent 
halothane produces a reduction of 33 per cent. 
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These measurements were made at constant 
pharyngeal temperature. It must be emphasized 
that these reductions occurred in animals already 
anaesthetized with nitrous oxide after thiopentone 
induction of anaesthesia. This technique of general 
anaesthesia in man has been shown to reduce the 
oxygen uptake of the brain (Wollman et al., 1965) 
and consequently the "control" value for oxygen 
uptake in these experiments may certainly have 
been below the value in conscious dogs. If the 
comparison could have been made with con- 
scious values, then the percentage depression of 
oxygen uptake with halothane would probably 
have been greater. 
Cohen and co- workers (1964) also found that 
cerebral oxygen uptake was reduced by halo - 
thane; they noted a 15 per cent fall with 1.2 per 
cent halothane but ascribed most of this reduction 
to a drop in oesophageal temperature in their 
anaesthetized subjects. The results of McHenry 
and co- workers (1965) and of Lassen (personal 
communication) agree with the present study 
in demonstrating a depression of cerebral oxygen 
uptake with halothane at constant body tempera- 
ture (in both quoted studies the fall was 26 per 
cent with 1 per cent halothane). The relationship 
between oxygen uptake and administered concen- 
tration of halothane revealed in the present study 
has not been previously ascribed. 
The relationship between blood flow and oxygen 
uptake during halothane anaesthesia. 
It is paradoxical that halothane increases cere- 
bral blood flow while reducing cerebral metabolic 
oxygen requirements, the discrepancy becoming 
wider with higher concentrations of halothane 
(until hypotension intervenes). The paradox is 
all the greater because the brain is often stated 
to be an organ in which flow is regulated to 
metabolic demand. This metabolic regulation of 
flow is conceived as being exercised by means of 
local tissue levels of carbon dioxide, oxygen and 
pH. 
From tables IX and X it can be seen that as a 
result of these changes in flow and oxygen uptake, 
halothane narrows the arteriovenous differences 
for oxygen and for carbon dioxide by elevating 
venous oxygen saturation and reducing venous 
Pco,. It is well known that tissue oxygen tension 
is related inter alia to arterial and venous oxygen 
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tensions (Thews, 1963). Ponten and Siesjö (1966) 
have similarly demonstrated a relationship between 
arterial and venous Pco, and the level of tissue 
Pco,. It follows, therefore, that one may consider 
the data in table IX to indicate that halothane 
raises tissue Po, and lowers tissue Pco, in the 
brain. 
Arterial and venous pH were also measured 
but, unlike the situation with oxygen and carbon 
dioxide, it is not justifiable to calculate changes 
in tissue pH from measured values of blood pH 
(because of the blood brain barrier). 
The above experiments do not provide any 
evidence to indicate the mechanism by which 
halothane produces these changes. It is probably 
reasonable to accept provisionally that halothane 
exerts a direct relaxing effect on the smooth 
muscle of the cerebral arterioles and that this 
action resets the "resting tone" of these vessels 
without impairing their responsiveness to changes 
in blood carbon dioxide tension (Alexander et al., 
1964; McHenry et al., 1965; McDowall, 1966). 
This direct action apparently more than counter- 
acts the normal constrictive effect of the observed 
reductions in cerebral metabolic rate both with 
0.5 per cent and with 2 per cent halothane. Smith 
and Vane (1966) have reported that high tensions 
of oxygen in media perfusing isolated vascular 
smooth muscle cause increases in the tone of such 
smooth muscle. They have suggested that one 
possible explanation of this response might be 
that vascular tone is dependent upon an enzyme - 
controlled process and that the rate of this 
enzymatic reaction is limited by the amount of 
oxygen in the surrounding medium. If halothane 
inhibited this enzymatic reaction then vascular 
relaxation such as that observed in the present 
study would occur. 
Clinical implications. 
As halothane increases cerebral blood flow while 
reducing cerebral metabolic demand, the oxygena- 
tion of the brain rises. Furthermore, because these 
effects are related to the concentration of halothane 
administered, deep halothane anaesthesia, especi- 
ally if combined with infusion of vasopressors, 
will produce high tissue oxygen tensions in the 
brain. Such an approach has been utilized during 
operations involving carotid artery occlusion by 
Wells, Keats and Cooley (1963) and by Lyons 
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and others (1964), though, as pointed out by 
Spencer (1964), there was at the time of these 
reports no evidence for the belief that the meta- 
bolic rate of the brain was reduced by general 
anaesthesia other than barbiturate anaesthesia. 
As a result of the cerebral vasodilatation, the 
cerebrospinal fluid pressure rises during halothane 
administration even when the arterial carbon 
dioxide tension is held constant (Marx, Andrews 
and Orkin, 1962; Hunter, 1964; Jennett and 
McDowall, 1964). The increasing dilatation with 
increasing halothane concentration demonstrated 
in this paper is mirrored in the observed relation- 
ship between magnitude of c.s.f. pressure rise and 
inspired halothane concentration (Marx et al., 
1962; McDowall, Barker and Jennett, 1966). The 
changes in c.s.f. pressure produced by halothane 
are quantitatively small and probably clinically 
insignificant in patients with normal c.s.f. path- 
ways. However, this is not the case in certain 
patients with intracranial tumours in whom halo- 
thane administration may elevate the intracranial 
pressure by several hundred millimetres of water 
(Jennett, McDowall and Barker, 1967). 
The effects of halothane on the cerebral circula- 
tion and metabolism can, therefore, in different 
situations be clinically advantageous or disadvan- 
tageous; a detailed knowledge of the actions of 
this commonly used drug should thus be of 
clinical value. 
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EFFETS DE L'HALOTHANE A DES CONCEN- 
TRATIONS CLINIQUES SUR LE DEBIT 
SANGUIN ET LA CONSOMMATION EN 
OXYGENE DU CORTEX CEREBRAL 
SOMMAIRE 
Vaporisé à des concentrations cliniques dans un 
mélange de protoxyde d'azote et d'oxygène, l'halothane 
provoque chez le chien anesthésié une vasodilatation 
dans le cortex cérébral avec des pressions partielles de 
CO2 artériel constantes. Cette action vasodilatatrice est 
d'autant plus marquée que les concentrations en 
halothane sont plus élevées. En conséquence, une con- 
centration en halothane de 2% augmente plus le débit 
sanguin dans le cortex cérébral qu'une concentration de 
0,5%. Cependant, avec une concentration en halothane 
de 4 %, la diminution de la pression sanguine moyenne 
est si prononcée que le débit sanguin n'est pas plus 
grand que chez les animaux témoins. L'halothane 
diminue la consommation d'oxygène du cortex cérébral; 
cette diminution est plus marquée pour une concen- 
tration en halothane de 2% que pour une concentration 
de 0,5 %. On discute ces résultats en tenant compte des 
effets de l'halothane sur la pression intracrânienne et 
sur l'oxygénation du cerveau. 
WIRKUNG KLINISCHER HALOTHAN- 
KONZENTRATIONEN AUF DURCHBLUTUNG 
UND SAUERSTOFFAUFNAHME DER 
GROSSHIRNRINDE 
ZUSAMMENFASSUNG 
Klinische Konzentrationen Halothan in Lachgas - 
Sauerstoffgemisch führten bei Hunden zur Vasodilata- 
tion der Grosshirnrindengefässe. Die arterielle CO; 
Spannung war konstant. Die cerebrale Vasodilatation 
stieg mit der Halothan- Konzentration an, d.h. das 
cerebrale Durchflussvolumen war unter 2 prozent 
Halothan grösser als unter 0,5 prozent. Bei Anwendung 
von 4 prozent Halothan sank der mittlere Blutdruck 
jedoch so stark ab, dass die Durchblutungsgrösse den 
Kontrollwert nicht überschritt. Die Sauerstoffaufnahme 
der Grosshirnrinde verschlechterte sich unter Halo - 
than. Sie war bei 2 prozent Halothan geringer als bei 
0,5 prozent. Die Ergebnisse werden in Hinsicht auf 
intrakraniellen Blutdruck und cerebrale Sauerstoff- 
versorgung diskutiert. 
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The Effect of Halothane on Intracranial Pressure in 
Cerebral Tumors* 
Report of Two Cases 
W. BRYAN JENNETT, M.D., F.R.C.S., D. GORDON MCDOWALL, M.B., Cn.B., F.F.A.R.C.S., 
AND J. BARKER, M.B., CH.B., F.F.A.R.C.S. 
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Halothane in anesthetic concentrations 
causes a marked increase in cerebrospinal 
fluid (C.S.F.) pressure as reported by Son - 
dergard,10 Marx,' Hunter,' and McDowall, 
et al.5 The observations in our own study 
were made on patients with normal C.S.F. 
pathways who were anesthetized with ni- 
trous oxide- oxygen during controlled ventila- 
tion to produce normocapnia. The addition 
of 0.5% Halothane to the anesthetic gases 
increased lumbar C.S.F. pressure in every 
case (Fig. 1), the mean increase being 68.2 
mm H2O (S.D. +31.2 mm H2O; statistical 
significance P <0.001). It was suggested that 
this rise in C.S.F. pressure might prove 
dangerous to patients in whom the pressure 
was already high due to an intracranial 
space- occupying lesion. Our report concerns 
the effect of Halothane on the intracranial 
pressure in two such patients. 
Case Reports 
Case 1. A 48- year -old man with headache 
of 2 months' duration was admitted to the 
hospital after noticing visual hallucinations 
on the left side for 3 weeks. On examination 
he had left homonymous hemianopia, mild 
left hemiparesis, and early papilledema; 
there was nystagmus and left -sided cere- 
bellar ataxia. Carotid angiography suggested 
hydrocephalus, and air ventriculography 
showed a cerebellar tumor. At operation on 
the same day as the ventriculogram, a meta- 
static tumor was removed from the cere- 
bellum; it was thought likely that there was 
at least one other metastasis in the right 
cerebral hemisphere to account for his visual 
signs. 
Case 2. A 36- year -old woman was ad- 
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PATIENT No 2 3 6 14 16 17 32 38 40 
FIG. 1. Effect of I- Ialothane on cerebrospinal fluid 
pressure in patients with normal C.S.F. pathways. (Re- 
produced from Anaesthesia by courtesy of the editor.) 
mitted to the hospital after 5 weeks of head- 
ache and vomiting. She had had a major 
epileptic fit during the puerperium 4 years 
earlier, and for 2 years had been slowing 
down mentally. She had marked papi11- 
edema; the only neurological sign was facial 
weakness. Angiography revealed a large 
frontal tumor. At operation this proved to be 
an extensive infiltrating glioma, reported 
histologically to be an anaplastic astrocy- 
toma. 
Method 
Each case was premeditated with 0.6 mg 
atropine. Anesthesia was induced with a 
sleep dose of thiopentone and, after the 
intravenous injection of suxamethonium 
chloride, a cuffed endotracheal tube was 
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passed. Controlled ventilation with nitrous 
oxide -oxygen was instituted, and tubocurare 
was administered at the earliest indication of 
returning muscle tone. A period of about 30 
minutes was then allowed for stabilization 
during which the head was draped for craniot- 
omy and a frontal burr hole was made. A 
metal brain cannula was inserted into the 
lateral ventricle through a burr hole and 
connected to a Statham pressure transducer, 
amplifier, and ultraviolet recorder. Stability 
of the intracranial pressure was assessed for 
10 minutes, and Halothane (0.5% in Case 1 
and 1.0% in Case 2) was then introduced. No 
further surgery was undertaken until all 
measurements of intracranial pressure were 
completed. Blood pressure was measured 
intermittently by upper arm sphygmo- 
manometry, the systolic pressure being de- 
termined by palpation. The minute volume 
was measured with a Dräger Volumeter on 
the expiratory limb of the non -return anes- 
thetic circuit. Arterial pH and Pco2 were 
measured on capillary blood before, during, 
and after the Halothane administration by 
the micro -Astrup technique (Andersen, et 
al.'). Esophageal temperature was monitored 
to allow correction of the arterial Pco2 
(PaCo2) for temperature, using Rosenthal's 
factor. 
Results 
Case 1. The intracranial pressure rose from 
180/160 mms H2O to 500 /440 mms H2O 
after 13 minutes of administration, at which 
time the Halothane was discontinued. In the 
following minute the intracranial pressure 
rose further to 520/460 mms 1120, but there- 
after fell rapidly towards the control value 
(Fig. 2) . 
Throughout the period of measurement 
the PaCo2 was 38 mm Hg, and the mean 
esophageal temperature was 36.3 °C. 
Case 2. After 7 minutes of 1% Halothane, 
intracranial pressure rose from 155/130 mm 
H2O to 590/470 mm II20 and the Halothane 
was then discontinued. During the next 
minute the intracranial pressure continued to 
rise precipitously, reaching a peak value of 
800 /620 mm 1120, after which it returned 
rapidly to the control value (Fig. 3). During 
these measurements, PaCo2 was 34 mm Hg; 
the mean esophageal temperature was 
85.8 °C; and the systolic blood pressure was 
750 
700 
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FiG. 3. Effect of Halothane on cerebrospinal 
fluid pressure in Case 2. 
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INCREASE IN 
C.S.F. PRESSURE 







FIG. 4. Comparison of the "Halothane rise" in C.S.F. 
pressure in patients whose C.S.F. pathways were normal 
(clear blocks) with that in two patients who had cere- 
bral tumors (lined blocks). The three cases on the right 
had 1% Halothane, the rest, 0.5%. 
130 mm Hg, falling to 100 mm Hg during 
Halothane administration. 
After these measurements were completed 
the ventilation was increased from 6.0 liters/ 
min to 9.0 liters /min, which resulted in a fall 
in PaCo2 to 19 mm Hg. When Halothane was 
reintroduced at this low PaCo2, the C.S.F. 
pressure rise was much less marked and 
stabilized at 350/300 mm H2O. 
Discussion 
Initial C.S.F. Pressure. Although each of 
these two patients had definite preoperative 
evidence of intracranial hypertension, the 
pressures measured during anesthesia, but 
immediately before Halothane administra- 
tion, were not very high. The mean C.S.F. 
pressure (diastolic plus one -third pulse 
pressure) in Case 1 was 167 mm H2O and in 
Case 2 was 138 mm H2O. Under identical 
anesthetic conditions, the control values for 
mean (lumbar) C.S.F. pressure in two groups 
of patients with normal C.S.F. pathways 
previously studied were 118 and 109 mm 
H2O. The fact that the intracranial pressure 
in our two patients was not more markedly 
raised may be ascribed to two factors: the 
PaCo2 was rather low (38 mm Hg and 34 mm 
Hg), and the esophageal temperature was 
only 36.3 °C and 35.8 °C. The length of the 
clinical histories suggests that a considerable 
degree of compensation had already taken 
place. 
Response to Halothane. In spite of the 
initial C.S.F. pressures being only modestly 
increased, the administration of Halothane 
produced dramatic and alarming increases, 
which necessitated discontinuing the Halo - 
thane administration after 13 and 7 minutes 
respectively (Fig. 4). We of course do not 
know to what level the intracranial pressure 
might finally have risen had Halothane ad- 
ministration been continued. It should be 
noted that the routine clinical monitoring of 
blood pressure and pulse rate gave no indi- 
cation that these large increases in intra- 
cranial pressure had occurred. It is likely, 
therefore, that in many clinical situations, 
Halothane administration would not be 
terminated so early. 
Mechanism of Raised Intracranial Pres- 
sure. We have previously presented evidences 
supporting the hypothesis that the increase 
in C.S.F. pressure during Halothane ad- 
ministration is the result of the increase in 
total cerebral blood flow. Other workers have 
demonstrated this increase with this drug.6,I2 
In our two patients, we postulated that the 
increased cerebral blood flow induced by 
Halothane produced a very much greater 
elevation in C.S.F. pressure than in normal 
subjects because of the presence of an intra- 
cranial space- occupying lesion. We have so 
far failed to reproduce this pattern of intra- 
cranial pressure response to Halothane in 
animals with experimental space- occupying 
lesions. This is probably because the experi- 
mental animal has only a few hours to com- 
pensate for the space- occupying lesion 
(saline -filled extradural balloon) while pa- 
tients have had weeks or months in which to 
do so. Compensation, which must involve a 
readjustment to the volumes contributed by 
blood, brain, tumor, and C.S.F., must have 
been exhausted in the human cases, since 
clinical signs of intracranial hypertension 
had already appeared. A further increase in 
the volume of any one component, in this 
case of intracranial blood volume with Halo - 
thane administration, then resulted in large 
and progressive increases in pressure because 
no further compensation was possible. 
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One patient (Case 1) had been investi- 
gated by air ventriculography 2 hours before 
this study was undertaken. Saidman and 
Eger' have shown that the administration of 
nitrous oxide under these circumstances leads 
to a rise in C.S.F. pressure, since the nitrous 
oxide enters the intracranial air bubbles from 
the blood more rapidly than the nitrogen can 
leave. This effect is related to the widely 
different solubilities of the two gases in 
blood. However, in our investigation, the 
C.S.F. pressure had had time, during the 
preceding 30 minutes of nitrous oxide anes- 
thesia, to restabilize before the effect of 
Halothane on the intracranial pressure was 
studied. The influence of transfer of Halo- 
thane into the intracranial air collection 
would be very small because of the low 
partial tension of Halothane in the arterial 
blood. It is more likely that the presence of 
intracranial air damped the extent of the 
Halothane- induced pressure rise. It can in- 
deed be seen, by comparing Figs. 2 and 3, 
that the intracranial pressure rise was slower 
and less marked in the patient who had had 
an air ventriculogram. 
Influence of Hyperventilation. Hyperven- 
tilation has been shown to reduce the amount 
of the increase in C.S.F. pressure with Halo- 
thane administration.' The results in our 
Case 2 confirm that this is also true in pa- 
tients with intracranial space -occupying 
lesions. It would therefore seem wise to use 
hyperventilation before Halothane is used in 
patients with clinical signs of raised intra- 
cranial pressure. 
Clinical Significance. In recent years there 
has been a tendency to dismiss as unimpor- 
tant the changes produced in intracranial 
pressure by general anesthetic drugs (Step- 
hen, et al.," Small, et al.,9 Bozza, et al.2). This 
view may have arisen because of the failure 
to detect consistent changes with these 
agents or because the changes found were so 
small as to be insignificant in patients with 
normal C.S.F. pathways. Hunter,' however, 
has cautioned that even a slight increase 
produced by an anesthetic drug might pro- 
duce a dangerous level of intracranial pres- 
sure in patients with pre- existing intracranial 
hypertension. The situation revealed by our 
present study is even more serious, for Halo- 
thane, which in normal patients produces 
only small changes in C.S.F. pressure, has 
been shown to produce much more marked 
elevations of pressure in patients with space - 
occupying lesions. 
This study does not indicate how often 
Halothane administration produces a clini- 
cally important effect on intracranial pres- 
sure. Sudden deterioration of patients with 
raised intracranial pressure undoubtedly 
does occur on occasion during general anes- 
thesia, but is often ascribed to faulty anes- 
thetic technique. The measurements made 
on these two patients indicate that very 
large rises in intracranial pressure can some- 
times be produced in this group of patients 
by Halothane despite adequate ventilation 
and oxygenation. That difficulties do not 
more commonly arise may be due to the cur- 
rent anesthetic practice of hyperventilating 
many neurosurgical patients prior to Halo- 
thane administration. However, spontaneous 
ventilation with Halothane is often used for 
radiological investigations in patients with 
space- occupying lesions, and we believe this 
to be potentially hazardous. 
A similar situation can arise when anes- 
thesia has to be administered to a patient 
with a head injury who requires surgical 
treatment for associated injuries. Under 
these circumstances, there is no surgical 
demand for controlled respiration, let alone 
for hyperventilation, yet increased intra- 
cranial pressure is commonly present, either 
due to multiple cerebral contusions and 
swelling, or to a hematoma. The dangers of 
anesthesia in the early stages after head in- 
jury are well recognized by neurosurgeons,4 
although they too have usually been ascribed 
to anesthetic difficulties rather than to the 
influence of particular anesthetic drugs. 
Summary 
1. An acute rise in intracranial pressure 
was observed on administering Halothane to 
two patients with intracranial space- occupy- 
ing lesions. 
2. This rise in C.S.F. was much greater 
than that previously reported in patients 
with normal C.S.F. pathways. 
3. Prior hyperventilation, to produce 
hypocapnia, greatly diminished this response 
to Halothane. 
4. The possible dangers of Halothane an- 
esthesia in patients with intracranial space - 
occupying lesions have been discussed. 
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Cerebro- spinal fluid pressure measurements 
during anæsthesia* 
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In recent years the potent influences of hypercapnia, hypoxia and 
respiratory obstruction on the intracranial pressure during anesthesia 
have rightly been stressed. This emphasis on factors related to good 
anesthetic technique has led to the belief that, provided respiratory 
depression is avoided, general anesthetic drugs have negligible effects 
on intracranial pressure I,2,3 The present study was undertaken to 
determine quantitatively the effects of halothane and trichlorethylene 
on the cerebrospinal fluid (csF) pressure in the absence of changes 
in arterial carbon dioxide tension and to correlate any changes found 
with alterations in central and cerebral venous pressures. 
METHOD 
Patient Study 
This study was carried out on 24 patients whose prior consent had 
been obtained. Ages ranged from 22 -64 years; 16 were male and 8 
female. Most were about to undergo surgery for prolapsed lumbar 
disc lesions and all were presumed to have normal csF pathways and 
pressure. 
Premedication was with pethidine 100mg and atropine 0.6mg. 
Anesthesia was induced with a sleep dose of thiopentone and main- 
tained with nitrous oxide and oxygen. D- tubocurarine was adminis- 
tered and intubation performed with a flexometallic cuffed endo- 
tracheal tube after laryngeal spraying with 4 % lignocaine. Ventilation 
was controlled with a Barnet ventilator set at a minute volume pre- 
dicted to produce norm ocapnia. An oesophageal thermoelectric 
probe was inserted and oesophageal temperature recorded inter- 
mittently. 
*Based on a paper read at the 1965 Annual Meeting of the Association of 
Anesthetists of Great Britain and Ireland at Edinburgh 
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The patients were placed in the lateral position and a needle inserted 
into the lumbar subarachnoid space and connected to a pressure 
transducer ; care was taken that only minimal quantities of CSF 
escaped. In some patients a catheter was inserted into an ante - 
cubital vein and advanced until its tip was judged by measurement to 
lie within the subclavian vein. 
In patients numbers 1 -12, pressures were measured with a fine bore 
saline manometer. In patients numbers 14-20, the measurements were 
made with Elema -Schonander low- pressure transducers, amplifiers 
and ink jet recorder. In the remaining patients the recording system 
consisted of Statham transducers, connected via suitable amplifiers to 
an ultra - violet recorder. 
Control pressure measurements were made during ventilation with 
nitrous oxide and oxygen only. 0.5 % or 1 % halothane was added to 
the nitrous oxide -oxygen mixture using a Fluotec II vaporiser and the 
changes in csF and central venous pressures were followed, usually 
for ten minutes. The halothane was then discontinued and the 
pressures observed for a further five to ten minutes. 
In 3 patients after making the control measurements the minute 
volume was increased to produce hyperventilation. Halothane was 
added only after the arterial carbon dioxide tension had been lowered. 
A similar procedure without hyperventilation was followed in 6 
patients to whom trichlorethylene was administered in a concentration 
of 0.9 % (the trichlorethylene was also vaporised from a Fluotec II 
vaporiser for which Cyprane Ltd supplied conversion factors). 
Capillary (finger tip) blood was withdrawn at the beginning and at 
the end of the period of observation. It was analysed for pH and for 
Pco2 by the Astrup interpolation technique 4. The pH electrode was 
maintained at 38 °C and corrections for differences between the 
patients' oesophageal temperature and the electrode temperature were 
made by applying Rosenthal's factor. The mean oesophageal tem- 
perature during the period of measurement was 35.7 °C (range 34.2- 
37.3 °C). 
Animal Experiments 
Unselected, unpremedicated mongrel dogs were anwsthetised with a 
sleep dose of thiopentone, intubated and ventilated by a Starling 
ventilator with 70 % nitrous oxide and 30 % oxygen. Muscular 
paralysis was obtained by intermittent administration of a dilute 
solution of suxamethonium chloride (0.5mg /ml). The pharyngeal tem- 
perature was measured and maintained at 38 °C. 
CSF pressure was measured via a plastic cannula inserted into the 
cisterna magna. Cerebral venous pressure was measured via a needle 
inserted through a midline trephine into the superior sagittal sinus. A 
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venous cannula placed in the right atrium via an external jugular vein 
indicated the central venous pressure. All measurements were made 
with pressure transducers and an ultra -violet recorder. 
RESULTS 
Patients 
The influence of 0.5 % halothane was studied in 9 patients in whom the 
arterial Pco 2 was in the range 37- 45mm /Hg (mean 40.2 + 2.6mm/ 
Hg). The control value for CSF pressure in this group was 117.1 ± 
62.6mm /H 20. On the administration of 0.5 % halothane the CSF pres- 
sure increased in every case; the mean increase was 68.2 ± 31.2mm/ 











0.5% Halothane 0.9 % Trichlor- 
ethylene 
PATIENT No 2 3 6 14 16 17 32 38 40 18 21 22 24 25 
FIGURE 1 Absolute increases in CSF pressure with halothane and with trichlor- 
ethylene in patients (The numbers are not consecutive because the present study 
was carried out on certain patients only in a series of 40) 
TABLE I 
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MEANS 117.7 +62.6 185.9 +60.8 - 115 ±71.8 68.2 ±31.2 40.2 ±2.6 
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results are illustrated in detail in table 1 and figure 1. In 7 of these 9 
patients, the changes in CSF pressure were also measured after with- 
drawing the halothane; there was in each case a return almost to the 
initial level (table 1 and figure 2). 
The magnitude of the fluctuations of the CSF pressure induced by 
the arterial pulse pressure was difficult to determine with the saline 
manometer because of the slow response time and heavy damping. In 
4 of the 5 patients receiving halothane whose pressures were measured 
electronically the size of the arterial CSF pulsations increased with 












ON HALOTHANE 0.5 % OFF PATIENT 
17 
Pco, =46 
o 5 10 15 
minutes 
FIGURE 2 The effect of halothane on CSF pressure in one patient 
TABLE 2 
Amplitude of the arterial pulsations of the CSF 





mm /H ,O mm /H ,O mm /H,0 
14 4 16 6 
17 38 77 37 
32 53 74 
38 90 90 80 
40 25 42 25 
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The increases in CSF pressure occurred very quickly after intro- 
ducing halothane - within one minute in 5 cases and within 2 minutes 
in the other 3. The time to reach peak pressure was very variable (from 
3 to 16 minutes) while the return to the baseline occurred within 3- 
10 minutes of discontinuing the halothane. 
In 2 patients the halothane concentration was increased after 
observing the effect of 0.5 % halothane. In one (no. 32), the CSF 
pressure rose from 129 to 204mm/H20 with 0.5 % halothane and in- 
creased further to 252mm /H 20 with 2% halothane. In the other (no. 
38) 0.5 % led to a rise from 190 to 270mm/H20, while 1% produced a 
CSF pressure of 307mm /H 20. 
Central venous pressure (as defined in methodology section) was 
measured in 10 patients receiving halothane and a mean rise of 
6mm /H 20 was noted (range 0 to +30mm /H 20) (see table 3). 
TABLE 3 
Comparison of changes in CSF and central venous pressures in patients with halothane administration 
CSF CHANGE CENTRAI. VENOUS CSF CHANGE 
CENTRAL VENOUS 
PRESSURE CHANGE 
PATIENT WITH 0.5% CHANGE WITH PATIENT WI H 0.5% WITH 0.5 
NO HALOTHANE 0.5 % HALOTHANE NO HALOTHANE HALOTHANE 
mm /H,0 mm /H,0 mm /H ,0 mm /H ,0 
3 +107 + 30 36 NOT DONE NO CHANGE 
6 + 43 NO CHANGE 37 NOT DONE NO CHANGE 
31 + 84 + 4 38 + 80 + 8 
33 + 4 + 13 39 + 25 NO CHANGE 
34 + 9 NO CHANGE 40 -4- 39 NO CHANGE 
Trichlorethylene. 5 patients received trichlorethylene in a concen- 
tration of 0.9 %. In all these patients CSF pressure rose sharply on the 
introduction of trichlorethylene into the anesthetic mixture. The 
mean control value was 109.4 ± 31.5mm /H 20 and the mean average 
increase with trichlorethylene was 105.2mm /H20 ±46.2 (range 
+59 to +176mm /H20). The mean arterial Pco2 at the time of 
these measurements was 38.6mm /Hg ± 2.1 (see table 4 and figures 1 
and 3). Measurements of central venous pressure showed no change 
in 2 patients during trichlorethylene administration and in a third a 
rise of 30mm /H 20. 
TABLE 4 















































MEANS 109A +31.5 214 .6 +775 119.2 +44.5 105.2 ±46.2 38.6 ±2.1 
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Hyperventilation with halothane. 3 of the patients who received 
0.5% halothane were inadvertently hyperventilated to an arterial 
Pco2 of less than 35mm /Hg and a further 3 patients were deliberately 
hyperventilated before the administration of halothane. All of these 
patients had low levels of CSF pressure during hyperventilation with 
nitrous oxide -oxygen; under these circumstances the administration 
of 0.5 % halothane produced only very small rises in CSF pressure. 
The mean increase was 17.7mm /H 20 (range +4 to +40mm /H 20) at 
a mean arterial Pco2 of 28.2mm /Hg (table 5). 
Animals 
In 4 dogs the administration of 0.5 % halothane during controlled 
ventilation with nitrous oxide -oxygen resulted in increases in CSF 
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FIGURE 3 The effect of trichlorethylene on CSF pressure in one patient 
TABLE 5 
Influence of halothane in patients during hypocapnia 
CSF PRESSURE 
PATIENT 0.5 APTERHALOTHANE INCREASE WITH 
NO CONTROL HALOTHANE DISCONTINUED HALOTHANE ART. PCO, 
mm/H,0 mm/H,0 mm/H2O mm/H,0 mm/Hg 
12 20 30 32 10 29 
31 44 84 50 40 31 
39 -4 21 -24 25 33 
8 21 39 18 27 
33 9 13 4 21 
34 16 25 9 - 
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arterial Pco2 of 44mm /Hg. The administration of 2% halothane in- 
creased the CSF pressure further in the two dogs in which this was 
studied (table 6). 
In 2 of these animals (nos. 8 and 9) cerebral venous pressure was 
also measured. At all times the cerebral venous pressure was slightly 
less than the CSF pressure. With the administration of halothane, 
cerebral venous pressure increased in parallel with the CSF pressure 
and on the withdrawal of halothane both pressures fell together (see 
figure 4). In the other 2 animals (nos. 2 and 5) central venous pressure 
was measured and no significant change occurred in this parameter 
with halothane. 
In every instance the increases in CSF pressure with halothane 
occurred within one minute of starting the administration and the 
peak of CSF pressure was reached in from 3 -13 minutes. With con- 
TABLE 6 













HALOTHANE ART Pco, 
mm/H,0 mm/H.0 mm/H,0 mm/H,0 mm/H,0 mm/Hg 
2 139 212 141 73 37 
5 183 264 71 81 43 
8 170 210 240 160 40 43 
9 146 251 276 118 105 38 
DOG NO 8 
20 
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FIGURE 4 The effect of various concentrations of halothane on CSF and cerebral 
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Dog No. 5 
FIGURE 5 The effect of prolonged halothane administration on CSF pressure 
in one dog 
tinued administration this peak, the began to 
decline again in 6 out of 7 occasions. In one animal, in which 0.5% 
halothane was administered for one hour and 40 minutes (see figure 
5), the CSF pressure had fallen again to the initial level after 52 min- 
utes. On withdrawal of halothane in this animal, the CSF pressure fell 
further, to a level that was 100mm /H 20 below the control value. In 
animal 8, 0.5 % halothane produced a peak at 5 minutes followed by 
a decline almost to baseline in 12 minutes; increasing the halothane 
concentration to 2 % then produced a further rise in CSF pressure. 
Failure to maintain the CSF pressure rise with either 0.5 % or 2% 
halothane was also seen in dog 9. 
DISCUSSION 
These results demonstrate that both 0.5 % halothane and 0.9 
trichlorethylene, vaporised with nitrous oxide and oxygen, produce 
large increases in CSF pressure in man and dog. The degree of the in- 
crease varies greatly from one subject to another and is not consis- 
tently related to the initial CSF pressure, when this is normal, nor to 
the arterial Pco2 in the range 37 to 45mm /Hg. As always happens 
when the mean CSF pressure is elevated for any reason 5, 6, the arterial 
pulsations of the CSF increase in amplitude during halothane and 
trichlorethylene administration. 
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Stephen and his colleagues 3 concluded that anmsthetic drugs do 
not alter CSF pressure. They measured CSF pressure during induction 
of anmsthesia with various drugs including trichlorethylene, but 
halothane was not yet available. These workers may have failed to 
detect trichlorethylene -induced pressure changes against the back- 
ground of the large pressure alterations which normally accompany 
induction of anmsthesia. Some of the results of Sondergaard7 are 
similarly obscured by the events of induction including hypercapnia 
during respiratory depression; although end -tidal Pco 2 was measured 
there was no method of attributing the proportion of the rise in CST 
pressure due to the rise in arterial Pco2 and that due to the drug itself. 
Nonetheless Sondergaard7 concluded that part of the increase in csF 
pressure during halothane administration was due to the drug directly. 
With trichlorethylene he found that csF pressure and end -tidal Pco2 
rose during induction but that the establishment of a clear airway 
caused a fall in both parameters; he therefore concluded that trich- 
lorethylene of itself had no effect on CSF pressure. 
CSF pressure and central venous pressure 
Marx et al. 8 observed that halothane anmsthesia increased the CSF pres- 
sure above the resting level (i.e. before induction of anmsthesia). The 
mean csF pressure before anmsthesia found by these workers was abnor- 
mally high (244 ± 32mm /H 20) and the increases with halothane were 
much smaller than those obtained in the present study; they recorded 
a mean rise in CSF pressure with 0.5 % halothane of only 17mm /H2O 
at Pco2 values `within the normal range'. The `venous pressure' rose 
with halothane by percentage increases which closely resembled the 
percentage increases in CSF pressure. They therefore concluded that 
increases in csF pressure due to halothane per se are related solely to 
increases in systemic venous pressure. However, their mean value for 
venous pressure of 126 ± 6mm /H 20 in spontaneously breathing 
unanmsthetised patients suggests either a misleadingly low zero 
reference point or that the venous pressure measured was greatly in 
excess of central venous pressure and therefore had little relevance to 
CSF pressure. In fact the site of measurement is not specified beyond 
the information that a catheter was introduced via an antecubital 
vein. From the absolute control values quoted it would seem likely that 
peripheral venous pressure of the arm was monitored. Changes in 
this pressure may of course be due to changes in central venous 
pressure but they can equally well result from halothane- induced 
vasodilatation of skin ',vessels producing increased limb blood flow. 
Furthermore the expression of changes in pressure as percentages by 
these authors artificially magnifies any actual increase in venous 
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pressure when compared with CSF pressure since the absolute level of 
the former is so much less than that of the latter. For these reasons 
the demonstration by Marx et al. 8 that equal percentage increases in 
CSF and venous pressures occur with halothane need not imply that 
the rise in CSF pressure is secondary to a primary rise in venous 
pressure. In the present study the administration of 0.5 % halothane 
or of 0.9 % trichlorethylene produced either no change in central 
venous pressure or only a very small increase. 
Marx et al. 8 demonstrated that the elevation in CSF pressure with 
halothane varied with the concentration of the drug administered. In 
the present study both patients (32 and 38) and both dogs (8 and 9) 
receiving more than 0.5 % halothane showed further increases in CSF 
pressure when the concentration of halothane exceeded 0.5 %. 
Hunter9 has published a record of the changes in intracranial 
pressure in a patient produced by the intermittent administration of 
1 % halothane during controlled ventilation. The changes shown 
closely resemble the pattern observed in the present study. 
Causes of pressure changes 
The possible causes of increased CSF pressure are : 
1 Increased volume of brain parenchyma or of CSF 
2 Increased volume of intracranial blood secondary to an in- 
crease in cerebral blood flow (cBF) or in central venous 
pressure (both of which increase cerebral venous pressure). 
Only intracranial blood volume can alter rapidly and changes in 
this are therefore likely to account for the transient alterations in CSF 
pressure during anæsthesia. However, an experiment was performed 
in two dogs to explore the relationship between cerebral venous 
pressure and CSF pressure, because it has been asserted that increases 
in CSF volume cause increases only in CSF pressure and not in cerebral 
venous pressure 10, 11 In these two dogs the increase in CSF pressure 
with halothane was associated with a parallel change in cerebral 
venous pressure, which is strong evidence against the hypothesis that 
the CSF pressure rise caused by halothane is secondary to increased 
CSF volume. Of the two factors affecting intracranial blood volume, 
central venous pressure was shown in this study to change very little 
during the administration of 0.5 % halothane or 0.9 % trichlorethy- 
lene; it seems that increase in CBF is the most likely explanation for 
the CSF pressure changes induced by these two agents. 
Total CBF has been directly measured in a group of anæsthetised 
volunteers; during administration of 1.2 % halothane CBF was 14% 
greater than in a group of conscious subjects 12. This would correlate 
well with the rise in CSF pressure in the present study, but Christensen 
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et al. 1 3 reported that 1 % halothane did not appear to act as a cerebral 
vasodilator in man. 
Measuring blood flow through a localised area of cortex in dogs, 
McDowall et al. 14 reported a 46 % fall in CBF during the adminis- 
tration of 0.5 % halothane or less in air. Subsequently McDowall and 
Harper 15 reported that the administration of 0.5 % halothane in 
nitrous oxide and oxygen caused a progressive fall in CBF after an 
apparent early increase; flow fell in the second half hour of adminis- 
tration by 16 % and in the second hour by 23 %. These workers 16 
have since found that after ten minutes of 0.5 % halothane CBF is 9 
higher than the control value; this difference, however, failed to reach 
statistical significance. With 2 % halothane flow was increased by 
36 %, a statistically significant increase. It would seem that altera- 
tions in both CBF and in CSF pressure are related to halothane con- 
centration. 
Time relations of pressure changes 
Another interesting correlation between changes in CBF and in CSF 
pressure under halothane anesthesia is that both show a return 
towards the resting level after an initial increase. On 6 out of 7 occa- 
sions in dogs CSF pressure rose to a peak in 3 to 13 minutes and then 
fell towards the control level despite continuing halothane adminis- 
tration. In dog 5, in which the changes were followed for the 
longest period of time, the CSF pressure returned to the baseline 
after 52 minutes of administration and then dropped below it. 
On withdrawal of halothane in this dog there was a further sharp 
reduction in CSF pressure. 
There are two possible interpretations of this sequence of events. 
The first is that compensation for increased CBF occurs during halo- 
thane administration by means of a compensatory reduction in CSF 
volume. The effect of such a fall in CSF volume would be to restore 
the CSF pressure to its initial value despite the augmented CBF. The 
other possibility is that, as described by McDowall and Harper 15 
CBF falls during the administration of 0.5 % halothane after an initial 
vasodilatation. In favour of this hypothesis is our observation that 
cerebral venous pressure falls as the CSF pressure declines during 
continuing halothane administration; such a fall in cerebral venous 
pressure would occur from a reduction in CBF but would not, 
according to Becht 1 o and Weed and Flexner 11, occur with a re- 
duction in CSF volume. Compensatory CSF changes have been demon- 
strated during the increase in CBF produced by CO2 inhalation 17, 
during the increase in cerebral venous pressure produced by jugular 
ligation 18 and, in the opposite direction, during the reduction in CBF 
associated with hyperventilation 19. 
200 ANÆSTHESIA Vol 21 
It was not possible, because of the obvious limitations on time, 
to follow these relatively slow adjustments of CSF pressure in man. 
However, it is interesting that in three of the patients in this study 
the CSF pressure had already started to fall from its peak level 
during the period of observation. Such a secondary fall in pressure 
could account for the results of Bozza et al.1 who found no change 
in durai tension at craniotomy under halothane anesthesia; by the 
time the surgeon had exposed the dura (from the appearance of which 
these workers assessed intracranial pressure the,) pressure would 
already have fallen from its peak level. The CSF pressure increases 
during the administration of trichlorethylene may also be the result 
of increases in cerebral blood flow. Such increases in CBF with 
trichlorethylene have been briefly described by Nowill et a/.20 
The report by McDowall et aí.21 that no change in cortical blood 
flow occurs during trichlorethylene administration to dogs requires 
further investigation; it may be that the duration of administration 
is critical here as with halothane. 
When patients in this study were deliberately hyperventilated, CSF 
pressure fell although the initial level was normal. When 0.5% 
halothane was administered during hypocapnia only insignificant 
increases in CSF pressure occurred. Ryder et al.6 have shown that 
any increase in CBF has less influence on CSF pressure when that 
pressure is initially low and this is the likely explanation for the 
failure of halothane to induce a rise in CSF pressure in hypocapnia. 
It seems clear that appreciable increases in intracranial pressure 
occur with the introduction of 0.5 % halothane or 0.9 % trichlorethyl- 
ene when the arterial Pco 2 is above 35mm /Hg. The CSF pressure may 
decline after the initial rise despite continuing administration of the 
volatile agent so that by the time the dura is exposed no obvious 
increase in dural tension is noticeable. Such gradual compensation 
could prove too slow for the patient whose intracranial pressure is 
already high, and there could be a risk of precipitating a critical rise 
of intracranial pressure during the early stages of anesthesia with 
halothane. This could be averted, as suggested by Marx et al. 8, if the 
patient were previously hyperventilated. 
SUMMARY 
CSF pressure was measured during anesthesia in patients via lumbar 
puncture and in dogs via cisternal puncture. 
Introduction of 0.5% halothane or 0.9 % trichlorethylene in 
normocapnic subjects caused an appreciable rise in CSF pressure, asso- 
ciated with little or no rise in central venous pressure. With hypo - 
capnia the rise in CSF pressure was much less pronounced. 
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With continued administration of these agents the CSF pressure is 
gradually restored to normal. 
Increased cerebral blood flow is proposed as the most likely ex- 
planation for the rise in CSF pressure. 
To avoid precipitating a crisis in patients with raised intracranial 
pressure it is recommended that a period of hyperventilation should 
precede the introduction of halothane or trichlorethylene. 
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CEREBRAL BLOOD FLOW DURING TRICHLOROETHYLENE 
ANAESTHESIA: A COMPARISON WITH HALOTHANE 
BY 
D. G. MCDOWALL, A. M. HARPER AND 1. JACOBSON 
The University Department of Anaesthetics, Royal Infirmary, Glasgow, and The 
University Departments of Surgery, Royal Infirmary and Western Infirmary, 
Glasgow, Scotland 
SUMMARY 
Cerebral blood flow has been measured in dogs using the method of Ingvar and Lassen 
(1962) in which flow is calculated from the rate of clearance from the exposed cerebral 
cortex of krypton 85 after its injection into the carotid artery. It was found that the 
addition of trichloroethylene in concentrations of 0.4 -0.9 per cent to a nitrous oxide - 
oxygen anaesthetic mixture did not alter the cerebral blood flow significantly. Trichloro- 
ethylene did, however, reduce the oxygen consumption of the cerebral cortex by 20 
per cent. These findings are compared with the previously reported effects of halothane. 
The striking differences in the response of the cerebral blood vessels to the two agents 
is discussed. 
Trichloroethylene and halothane are the inhala- 
tional agents most generally recommended for 
neurosurgical anaesthesia (Lee, 1959; Wylie and 
Churchill- Davidson, 1959). In attempting to pro- 
duce optimal conditions for neurosurgery, a know- 
ledge of the effects of anaesthetic drugs on cere- 
bral haemodynamics is obviously important. Halo - 
thane has been studied recently (Galindo and 
Baldwin, 1963; McDowall, Harper and Jacobson, 
1963), but little is known about the effects of 
trichloroethylene on cerebral blood flow and cere- 
bral oxygen uptake. 
METHOD 
Blood flow through the cerebral cortex was 
measured by the method of Lassen and Ingvar 
(1961), and Ingvar and Lassen (1962). This in- 
volves the measurement of the rate of clearance 
of krypton 85 from an area of exposed cerebral 
cortex. We have previously given a detailed 
account of our experimental technique in using this 
method for the assessment of the effects of halo - 
thane on cerebral haemodynamics (McDowall, 
Harper and Jacobson, 1963). The same procedure 
was followed in the present series of experiments, 
except for the following points. 
Forty -nine measurements of blood flow through 
connected to a saline manometer for the measure- 
ment of cerebral venous pressure and for the col- 
lection of samples of cerebral venous blood. The 
right atrial pressure was monitored in one dog 
through a cannula passed via the external jugular 
vein and connected to a saline manometer. 
In four of the experiments the level of anaes- 
thesia was monitored by an Offner electroence- 
phalograph, using stainless steel electrodes. Bi- 
polar, bifrontal and right frontal -occipital record- 
ings were taken during each blood flow measure- 
ment. 
Trichloroethylene was administered from a 
Fluotec. Mark II vaporizer, the drug being vapor- 
ized by the same mixture of nitrous oxide and 
oxygen as was used for the control flow measure- 
ments. The setting on the vaporizer dial was 1.5 
per cent in two experiments and 3 per cent in four. 
(These settings represent 0.43 and 0.87 per cent 
trichloroethylene respectively. *) 
In each experiment three measurements of cere- 
bral blood flow were made during ventilation with 
nitrous oxide and oxygen alone. Blood flow was 
then measured during the administration of tri- 
chloroethylene. In four experiments the effects of 
carbon dioxide and hyperventilation during tri- 
chloroethylene anaesthesia were observed. 
the cerebral cortex were made itu six unelected *Correction factor kindly supplied by Messrs. Cyprane 
mongrel dogs. A cannula in the sagittal sinus was Ltd. 
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TABLE I 
Details of results obtained for cerebral blood flow,)cerebral oxygen uptake and cerebrovascular resistance (c.v.r.) with nitrous oxide and oxygen and with trichloroethylene, nitrous oxide and oxygen. 
Dog 
No. 
Nitrous oxide and oxygen only Trichloroethylene, nitrous oxide and oxygen 
Blood flow 
(ml /g /min) 
c.v.r. Oxygen uptake 
(ml /g /min) 
Blood flow 
(ml /g /min) 
c.v.r. Oxygen uptake 
(ml /g /min) 
1 0.74 1.89 ' 0.051 1.11 1.13 0.044 
0.79 1.48 0.055 0.87 1.53 0.036 
0.67 1.74 ,- 0.047 0.71 1.94 0.052 
0.61 2.31 0.041 
0.80 1.83 0.042 
0.79 1.91 0.049 
0.76 1.99 0.052 
2 0.73 1.59 0.096 0.96 1.20 0.088 
0.80 1.46 . 0.098 0.90 1.17 0.079 
0.79 1.48 0.093 0.81 1.30 0.074 
0.76 1.45 0.086 
3 0.71 1.94 - 0.77 1.80 - 
0.82 1.69 - - 0.79 1.7.1 - 
0.80 1.86 - 0.70 2.07 - 
0.80 1.74 - 
' 0.76 1.85 - 
4 0.84 1.69 0.066 0.58 2.36 0.060 _ 
0.76 1.88 0.089 0.54 2.55 0.055 
0.72 1.98 0.079 . 0.61 2.16 0.063 
0-58 2.26 0.057 
0.60 2.18 0.060 
0.61 - 2.15 0.062 
0.60 2.18 0.057 
0.62 2.03 0.051 
5 0.53 3.70 0.056 0.59 2.99 0.057 
0.57 3.36 0.055 0.54 - 3.35 0.062 
0.58 3.21 0.060 0.58 3.12 0.040 
0.61 3.06 - 0.034 
0.53 3.32 0.042 
6 0.88 182 - 0.90 1.89 - 
0.90 1.78 - 0.93 1.83 - 
0.97 1.96 - 
TABLE II 
Means of value for cerebral blood flow, cerebrovascular resistance (c.v.r) and cerebral oxygen uptake. 
Means Blood flow c.v.r. Oxygen uptake 
Nitrous oxide -(-oxygen (All dogs) 0.7610.11 2.0310.67 0.07010.019 
Trichloroethylene +nitrous oxide+ oxygen (All dogs) 0.7210.15 2.0810.60 0.05610.015* 
Trichloroethylene +nitrous oxide +oxygen (excluding 
Dog 4) 
0.76 
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Cerebral blood flow during trichloroethylene anaesthesia expressed as percentage increase ( +) 
or decrease ( -) of the control value in the same animal. The time scale indicates the duration 
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The results of measurements of cerebral blood flow, 
cerebrovascular resistance and cerebral oxygen up- 
take are shown in table I, and the mean values for 
these parameters are presented in table II. On the 
average, trichloroethylene did not cause any change 
in cerebral blood flow from the control levels except 
in experiment 4, in which a reduction of 25 per 
cent occurred. 
Figure In shows each cerebral blood flow 
measurement during trichloroethylene administra- 
tion as a percentage change of the average control 
value obtained in the same animal. It will be seen 
that the great majority of the results lie very close 
to the control level, but that in two animals there 
was a transient increase in flow in the first 15 min- 
utes of the administration. The results reported 
previously for halothane are shown in figure 1B 
for comparison (McDowall, Harper and Jacobson, 
1963). 
The cerebrovascular resistance was similar in 
the control and trichloroethylene groups. Trichlo- 
roethylene administration reduced the oxygen up- 
take of the cerebral cortex by an average of 20 per 
cent. 
There was no significant alteration in blood pres- 
sure, arterial oxygen saturation, pH or Pco, (table 
III). Cerebral venous pressure was slightly, but not 
significantly (0.05<P<0.1) higher during trichlo- 
roethylene administration. The right atrial pressure 
was recorded in one dog and rose from -1 to +2 
cm H_O during trichloroethylene anaesthesia. 
When carbon dioxide was administered during 
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trichloroethylene anaesthesia the flow increased by 
116 per cent at a average Pco, of 74 mm Hg, 
while hyperventilation to a Pco, of 21 mm Hg 
reduced flow by 28 per cent (table IV). In the 
electroencephalograph there was a progressive 
decrease in amplitude and increase in slow activity 
during trichloroethylene anaesthesia as illustrated 
in figure 2. In Dog 1, however, high amplitude 
slow activity was evident early in the administra- 
tion, and this was followed by a progressive 
decrease in amplitude with time. 
DISCUSSION 
Using this technique for measuring cerebral blood 
flow, one measures only flow occurring in the su- 
perficial layers of a limited area of parietal cortex. 
These measurements of flow are applicable, how- 
ever, to the entire cortex, since it has been shown 
that cortical blood flow is fairly uniform during 
anaesthesia (Landau et al., 1955; Harper, Glass 
and Glover, 1961), but they cannot be considered 
as necessarily indicating changes in total cerebral 
blood flow. Nevertheless, as blood flow through 
grey matter has been shown to be three to five 
times that through white (Landau et al., 1955; 
Kety, 1963), cortical flow must account for a con- 
siderable proportion of total cerebral flow. 
In assessing the effect of an anaesthetic agent on 
cortical blood flow it is important to maintain con- 
stant the other determinants of flow. These other 
factors are the perfusion pressure and the arterial 
tensions of carbon dioxide and oxygen. In this 
study, the mean aortic blood pressure was not 
Nitrous Oxide Early Trichloroethylene Late Trichloroethylene 
46011106,0,04tfikAr ,-0404NAN0*11., 
-001?.'0-41l,ip4-1 e*4^).0.40.014140104.641, AA\f\r--- 
FIG. 2 
The effect of trichloroethylene on the e.e.g. after 45 minutes and after 2 hours of 
administration. 
TABLE III Values for mean blood pressure, cerebral venous pressure, central venous pressure, arterial pH, arterial Pco2, arterial and venous oxygen saturations during each measurement of cerebral blood flow. 














































1 145 .7 - 7.31 35.5 97 56 135 12 - 7.32 41.5 100 76.5 120 4 - 7.35 37.0 100 58 140 10 - 7.37 31.0 99.5 74.5 120 4 - 7.35 34.0 99 57 145 7 - 7.37 36.0 100 56 
145 5 - 7.36 34.0 99.5 59 
150 4 - 7.37 35.0 99 67.5 
155 6 - 7.36 34.0 99 62 
155 5.5 - 7.35 35.5 99 58 
2 120 5.5 - 7-26 35.0 100 51 120 7 - 7.23 38.0 100 67 120 4 - 7.26 36.0 99 53 110 8 - 7.24 40.0 99 66 120 5 - 7.26 37.5 100 56 110 7 - 7.25 34.0 99 65 
115 8 - 7.23 37.0 98.5 56 
3 145 10 - 7.33 35.0 100 - 145 8 - 7.33 32.0 100 - 
145 10 - 7.32 36.5 98 - 140 7 - -7.31 35.5 100 - 
155 8 - 7.33 31.0 100 - 150 7 - 7.34 34.0 92 - 
145 8 - 7.35 30-0 100 - 
145 7 - 7.34 34.0 100 - 
4 145 4 0 7.31 39.5 97 62 140 4 -1 7.31 38.0 -98 52 
145 3 0 7.31 36.5 100 48 140 3 -1 7.31 36.0 98 53 
145 3 0 7.29 37.5 97 48 135 4 +1 7.31 36.0 98 52 
135 5 +1 7.30 37.0 98 54 
135 6 +2 7.30 38.0 98-5 54 
135 5 +2 7.30 35.5 98 52.5 
135 5 +2 7-28 34.0 98 56 
130 6 +2 7-29 36.0 97.5 61 
5 200 4 - 7.36 33.5 93 52 180 5 - 7.35 35.5 97 59 
195 5 - 7.33 39.5 93 55 185 6 - 7.35 33.5 98 53 
190 5 - 7.34 37.5 98 58 185 6 - 7.33 35.0 98 71 
190 6 - 7-30 35.5 95 73 
180 6 - 7.31 35.0 98 67 
6 160 - - 7.29 37.5 97 - 170 - - 7-29 36.0 98 - 
160 - - 7.29 37.5 96 - 170 - - 7.31 32.0 98 - 
190 - - 7.34 29.5 95 - 
151.1 5.4 35.9 97.7 54.5 146.8 6.3 35.3 98.4 61.0 
±27.1 ±2.3 ±2.6 ±2.3 ±4.2 ±21.6 ±3.1 _I.2.5 71.6 ±7.7 
TABLE IV 




Passive hyperventilation Addition of carbon dioxide 
Pco, 
Blood flow 
(ml /g /min) 
Cerebral venous 
pressure 
(cm H20) Pco, 
Blood flow 











60.0 1.80 14 
4 20.5 - 0.51 6 79.0 1.09 11 
5 23.0 0.41 5.5 84.0 1.80 13 
Mean 21.5 0.52 0 6.7 74.0 1-56 12-7 
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altered significantly by the administration of tri- 
chloroethylene. Since ventilation was controlled 
throughout each experiment, it was possible to 
maintain the arterial carbon dioxide tension with- 
in narrow limits, while the oxygen content of the 
inspired gases was adjusted to maintain a steady 
level of arterial oxygen saturation. 
The effect of trichloroethylene on cerebral blood 
flow. 
Under these controlled conditions, the addition 
of trichloroethylene (in concentrations of 0.4 -0.9 
per cent) to the nitrous oxide- oxygen anaesthetic 
mixture did not alter the average cortical blood 
flow. In two of the six animals there was a tran- 
sient 30 per cent increase in flow which settled 
during the first half -hour of administration, and 
in one dog the flow was reduced by approximately 
25 per cent throughout. 
Nowill, Stephen and Searles (1953) used the 
thermoelectric technique of Gibbs (1933) to 
measure cerebral blood flow during trichloroethy- 
lene anaesthesia in rabbits and one monkey. They 
found that trichloroethylene, vaporized in oxygen, 
produced an increase in flow which was less than 
that which resulted from the administration of 5 
per cent carbon dioxide. The authors do not state 
what anaesthetic, if any, was used in obtaining 
their control levels. Bozza, Maspes and Rossanda 
(1961) estimated intracranial tension by the look 
and feel of the dura at operation and found that 
"general anaesthesia" (which included the use of 
trichloroethylene in an unspecified number of 
patients) "did not appreciably modify the condi- 
tions of the operating field ". However, as their 
technique did not detect a significant difference in 
the operating conditions between hypoventilation 
and normal ventilation, quite large changes due to 
trichloroethylene could have been missed. 
The effect of trichloroethylene compared with 
halothane on cerebral oxygen uptake. 
Oxygen consumption was calculated from the 
cerebral cortical flow and the arteriovenous oxygen 
di fference, the venous sample being obtained from 
the superior sagittal sinus. As the superior sagittal 
sinus in the dog contains mainly cortical venous 
blood (Gleichmann et al., 1962), the oxygen con- 
sumption obtained is that of the grey matter of the 
cerebral cortex. For this reason the values given, 
s 
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here are considerably higher than those obtained 
when cerebral oxygen consumption is calculated 
from total cerebral flow and arterial -internal 
jugular oxygen difference. 
The oxygen uptake of the cerebral cortex was 
20 per cent lower during trichloroethylene admin- 
istration than during unsupplemented nitrous oxide 
anaesthesia. There are no previous measurements 
of the effect of trichloroethylene on cerebral oxygen 
uptake. Halothane in concentrations of 0.5 per cent 
or less has been shown to depress cerebral oxygen 
uptake by about 50 per cent, and, while the exact 
relationship between cerebral oxygen uptake and 
anaesthesia is uncertain (Butler, 1950; Hunter and 
Lowry, 1956), these results fit well with clinical 
experience of the relative potency of the two 
agents. 
Other observations during trichloroethylene 
anaesthesia. 
Although the average cerebral blood flow during 
trichloroethylene administration was no higher 
than the control level, the cerebral venous pressure 
rose slightly. In one dog, central venous pressure 
was recorded and was found to rise by 3 cm H_O 
during 2 hours of trichloroethylene administration, 
perhaps due to direct cardiac depression (Krantz 
et al., 1935). As the cerebral venous pressure rose 
by the same amount at the same time, it is sug- 
gested that the increase in cerebral venous pres- 
sure was due to the change in central venous pres- 
sure. However, this explanation is not supported 
by the work of Dobkin, Harland and Fedoruk 
(1962), who found no change in inferior vena caval 
pressure in dogs anaesthetized with trichloroethy- 
lene. 
Nowill, Stephen and Searles (1953) described 
the changes which occurred in the electroence- 
phalogram of rabbits and one monkey during their 
study of trichloroethylene as consisting only of 
slight slowing and a small decrease in amplitude. 
In the experiments reported here, the electrocor- 
ticogram showed similar small changes in the first 
hour, but with more prolonged administration the 
changes became quite marked. 
As has been previously reported (Nowill, 
Stephen and Searles, 1953; Ostlere, 1953; Dobkin, 
Harland . and Fedoruk, 1962), even prolonged 
administration of trichloroethylene caused no fall 
in arterial pH or in mean blood pressure. 
BLOOD FLOW DURING TRICHLOROETHYLENE ANAESTHESIA 
The mode of action of trichloroethylene and 
halothane on cerebral blood flow. 
In an earlier study, using the same technique, 
halothane was shown to decrease cerebral cortical 
flow by 46 per cent (McDowall, Harper and Jacob- 
son, 1963). As the cerebral cortical oxygen uptake 
was reduced by 49 per cent, it was considered that 
the flow reduction was due to this decrease in 
oxygen consumption, mediated by an autoregula- 
tory mechanism functioning to maintain a constant 
cortical tissue Pco2. As Sokoloff (1959) has said, 
"Any influence they [the general anaesthetics] may 
have is possibly chiefly secondary to their effects 
on blood pressure, cerebral metabolic rate and the 
respiratory gas tensions in the blood." 
These results with trichloroethylene do not sup- 
port this statement, since flow remained unaltered 
despite a 20 per cent reduction in cerebral meta- 
bolic rate (without any change of blood pressure 
or respiratory gas tensions). This finding could be 
explained by either of the following hypotheses : 
(1) Anaesthesia interferes with the local con- 
trol of the cerebral vessels so that they are 
unable to respond to the usual regulatory 
mechanisms. 
(2) The unchanged flow with trichloroethylene 
is due to a balancing of a vasoconstrictive 
stimulus due to lowered oxygen consump- 
tion against a direct vasodilatory action of 
the drug on the vessel wall. 
Hypothesis (1) receives some support from the 
work of Schieve and Wilson (1953), for they re- 
ported that the response of the cerebral vessels to 
added carbon dioxide was depressed by barbiturate 
anaesthesia. However, the results in table IV show 
that trichloroethylene does not impair the flow res- 
ponse to either increases or decreases in arterial 
Pco2. In addition, Jacobson, Harper and McDowall 
(1963) have shown that during trichloroethylene 
anaesthesia, inhalation of 100 per cent oxygen pro- 
duces a reduction in flow of 12 per cent; this is 
very close to the 13 per cent reduction found in 
conscious volunteers by Kety and Schmidt (1948). 
As, therefore, the cerebrovascular response to 
changes in arterial gas tensions is not impaired 
by trichloroethylene it is likely that the response 
to local changes in Po, and Pco2 is also normal. 
Some support for hypothesis (2) comes for the 
observation in two animals of an initial increase in 
flow in the early minutes of administration. This 
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could be due to a direct vasodilator action of tri- 
chloroethylene increasing flow before the drug had 
produced depression of cerebral oxygen uptake. 
This was, however, not a consistent response and, 
even in the two dogs in which it was noted, a 
closer scrutiny of the results shows that depres- 
sion of oxygen uptake had already occurred. 
It would, therefore, appear that the effects of 
anaesthetic agents on cerebral blood flow cannot 
be related solely to the depression of cerebral oxy- 
gen uptake that they produce. Either their effects 
are due entirely to individual direct action on the 
vessel walls -in which case halothane is a potent 
local constrictor and trichloroethylene has no effect 
-or they are due to a combination of direct action 
and response to local metabolic requirements, 
when halothane would be without direct action and 
trichloroethylene would cause direct dilatation of a 
degree equal to the constrictive stimulus of a 20 
per cent reduction in the oxygen requirements. It 
is proposed to investigate further the relationship 
between cerebral blood flow and depression of oxy- 
gen uptake and the connection, if any, between 
vasomotor effects and particular chemical struc- 
tures, by studying a range of volatile anaesthetic 
agents. 
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CIRCULATION SANGUINE CÉRÉBRALE 
PENDANT L'ANESTHÉSIE AU TRICHLORO- 
ÉTHYLÈNE- COMPARAISON DES EFFETS 
AVEC CEUX DE L'HALOTHANE 
SOMMAIRE 
L'irrigation sanguine du cerveau fut mesurée chez le r 
chien par la méthode d'Ingvar et Lassen (1962), et 
l'emploi du calcul à partir du taux de clearance de 
85 krypton dans le cortex cérébral, le krypton ayant 
été injecté au préalable dans la carotide. Les auteurs 
constatèrent que l'administration de 0.4 à 0.9% de 
trichloréthylène mélangé à l'habituelle préparation de 
protoxyde d'azote et d'oxygène ne provoqua aucune 
altération significative de la circulation sanguine du ì. 
cerveau. Par contre le trichloréthylène reduisit la 
consommation d'oxygène du cortex cérébral de 20%. 
Après comparaison de ces constatations avec celle des 
effets de l'halothane -dont les auteurs ont parlé aupar- 
avant - ils discutent les différences surprenantes du 
mode de réaction des vaisseaux cérébraux sanguins 
aux deux substances. 
CEREBRALE DURCHBLUTUNG WÄHREND 
DER TRICHLORÄTHYLEN -ANÄSTHESIE: 
EIN VERGLEICH MIT HALOTHANE 
ZUSAMMENFASSUNG 
Nach der Methode von Ingvar und Lassen (1962), bei 
der der Durchfluß aus der Clearance -Rate von Kryp- 
ton 85 an der freigelegten Gehirnrinde nach einer In- 
jektion in die Carotisarterie errechnet wird, wurde die 
Durchblutung des Gehirnes an Hunden gemessen. Es 
wurde festgestellt, daß der Zusatz von Trichloräthylen 
in Konzentrationen von 0.4 -0.9 % zu einem An- 
ästhesiegemisch von Lachgas und Sauerstoff die 
cerebrale Durchblutung nicht wesentlich veränderte. 
Trichloräthylen reduzierte jedoch den Sauerstoffver- 
brauch der Gehirnrinde um 20 %. Diese Befunde 
werden mit den kürzlich berichteten Wirkungen des 
Halothane verglichen. Die augenfälligen Unterschiede 
in bezug auf die Reaktion. der cerebralen Blutgefäße 
auf die zwei Substanzen werden besprochen. 
ï 
Reprinted from the 
British 
Journal of Anaesthesia 
Vol. XXXV, No. 7, July 1963 
CEREBRAL BLOOD FLOW DURING HALOTHANE ANAESTHESIA 
BY 
D. G. MCDOWALL, A. M. HARPER AND I. JACOBSON 
ALTRINCRAM 
JOHN SHERRATT & SON 
Brit. 7. Anaesth. (1963), 35, 394 
CEREBRAL BLOOD FLOW DURING HALOTHANE ANAESTHESIA 
BY 
D. G. MCDOWALL, A. M. HARPER AND I. JACOBSON 
The University Departments of Surgery, Western Infirmary and Royal 
Infirmary, Glasgow, Scotland 
SUMMARY 
Cerebral blood flow has been measured in dogs using the method of Lassen and Ingvar 
(1961), and Ingvar and Lassen (1962), which involves measurement of the rate of clear- 
ance of krypton 85 from an area of exposed cerebral cortex after injection into the internal 
carotid artery. In every measurement during halothane anaesthesia there was a consider- 
able reduction in cerebral blood flow compared with the flows obtained with nitrous 
oxide and oxygen. The average reduction in flow was 46 per cent and this was accom- 
panied by an average increase in cerebrovascular resistance of 50 per cent. Measurements 
were also made of the cerebral oxygen uptake (CMRO_) and halothane produced an 
average decrease in uptake of 49 per cent. Possible mechanisms for the observed results 
are discussed. 
Despite the very widespread use of halothane in 
anaesthesia today, there seems to be little know- 
ledge of its action on cerebral blood flow 
(Graham, 1959). It seemed to us that the evalua- 
tion of the effects of this drug on cerebral haemo- 
dynamics and oxygen consumption would be of 
interest. 
METHOD 
The blood flow through the brain cortex was 
measured by the method of Lassen and Ingvar 
(1961), and Ingvar and Lassen (1962). This is an 
inert gas clearance method with the following 
rationale: krypton 85 (an inert, beta -emitting 
radioactive gas) is dissolved in dextran and in- 
jected over several minutes into the carotid artery. 
The gas diffuses almost equally into the blood and 
the brain tissue. On cessation of the injection the 
krypton diffuses back into the blood and the rate 
at which it is cleared from the brain tissue will 
depend on the quantity of blood perfusing the 
brain. There is no significant arterial recirculation 
of the gas as it is almost completely excreted in 
the lungs. The rate of clearance from the brain is 
measured by a Geiger counter mounted over the 
exposed brain cortex. As krypton 85 emits mainly 
beta particles, measurements of blood flow will be 
from the cerebral cortex alone. 
Forty -six measurements of blood flow through 
the cerebral cortex were made on five unselected 
mongrel dogs. Anaesthesia was induced with thio- 
pentone. A cuffed endotracheal tube was inserted 
and a 4:1 mixture of nitrous oxide and oxygen 
administered by a Starling respiratory pump, the 
stroke volume of the pump being adjusted to give 
an arterial carbon dioxide tension of 30 to 40 mm 
Hg. Suxamethonium chloride was given by inter- 
mittent injection to facilitate controlled ventilation. 
The Starling pump provided a non -rebreathing cir- 
cuit which was essential to prevent recirculation 
of the krypton 85. Cannulae were inserted into a 
femoral vein and into the aorta via a femoral artery, 
the latter being connected to a thrcc -way tap for 
the withdrawal of arterial blood samples and to a 
mercury manometer for the measurement of mean 
arterial blood pressure. The thyroid branch of the 
carotid artery was cannulated centripetally, the tip 
of the cannula lying in the carotid artery. The 
sagittal sinus was cannulated in its posterior third. 
The brain was exposed through a trephine hole 
made in the parietal bone and a segment of dura 
1 cm in diameter excised. A thin polyethylene 
membrane was placed over the exposed brain cor- 
tex. Measurements of blood flow were made by 
injecting over 2 to 3 minutes about 0.5 me of 
krypton 85 dissolved in dextran into the carotid 
artery. The clearance of krypton 85 was measured 
by a Geiger counter mounted 1 mm above the 
brain cortex and connected to a ratemeter and 
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direct writing recorder. Blood flow was calculated 
from the formula : 
Flow in ml /gm /mm- loge2x60 
T 
where A.= blood : brain cortex partition coefficient 
for krypton 85 
and T = the duration in seconds for the decrease 
to one -half the initial value of a straight 
line fitted to a semilogarithmic plot of 
the initial part of the clearance curve 
(Ingvar and Lassen, 1962). 
One minute after each measurement of blood 
flow through the cerebral cortex simultaneous 
blood samples were taken from the aorta and the 
sagittal sinus. The arterial blood samples were 
analyzed for pH and Pco_ on the Micro -Astrup 
apparatus (Andersen et al., 1960) and both arter- 
ial and venous blood samples for oxygen saturation 
on a Kipp haemoreflector. 
Throughout each experiment the level of anaes- 
thesia was monitored by an Offner electroence- 
phalograph, using stainless steel electrodes. Bipo- 
lar, bifrontal and right fronto- occipital recordings 
were taken during each blood -flow measurement. 
For the flow measurements under halothane 
anaesthesia, halothane was administered from a 
Fluotec Mark II vaporizer, the drug being vapor- 
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ized either in air or oxygen. The setting of the 
vaporizer was varied to maintain a constant level 
of anaesthesia by reference to the blood pressure 
and the electrocardiographic tracing, in any one 
dog and a reasonably constant level between 
dogs. The concentration used was that at which 
th°rz was a reduction in mean blood pressure of 
about 20 per cent and at which the e.e.g. showed 
low voltage fast activity superimposed on slow 
waves of moderate voltage, i.e. pattern 2 of the 
classification described by Gain and Paletz (1957). 
The vaporizer settings used to obtain these condi- 
tions were either 0.5 per cent or slightly lower 
concentrations obtained by setting the control to 
positions between `off" and 0.5 per cent. 
The first four experiments were divided into 
four parts: the animal was anaesthetized with 
(1) 80 per cent nitrous oxide and 20 per cent 
oxygen. 
(2) 0.5 per cent or less than 0.5 per cent 
halothane in air. 
(3) 0.5 per cent or less than 0.5 per cent 
halothane in oxygen. 
(4) 80 per cent nitrous oxide and 20 per cent 
oxygen. 
In one experiment only, anaesthesia was pro- 
gressively deepened by administering halothane in 
TABLE I 
Details of results obtained for cerebral blood flow, cerebral oxygen uptake and cerebrovascular resistance (c.v.r.) in 
anaesthesia with nitrous oxide and oxygen, and halothane in air or oxygen. 
Nitrous oxide and oxygen Halothane and air Halothane Nitrous oxide and oxygen 












uptake No. (ml /g/ (ml /g/ c.v.r. (ml /g/ (ml /g/ c.v.r. (ml /g/ c.v.r. (ml /g/ (ml /g/ c.v.r. 
mm) min) min) min) min) min) min) 
1 0.63 0.054 2.38 0.51 0.035 2.23 0.46 2.93 0.65 0.036 2.43 
0.80 0.062 1.94 0.48 0.039 2.92 0.52 2.60 0.70 0.053 2.21 
0.74 0.052 2.10 - - - - - - - - 
2 0.94 - 1.68 - - - 0.42 2.62 0.60 - 2.50 
0.88 - 1.84 - - - 0.44 2.50 0.63 - 2.38 
0.81 - 1.98 - - - 0.39 2.95 - - - 
3 0.53 0.034 3.40 0.38 0.019 4.08 0.36 4.30 0.48 0.034 3.75 
0.54 0.031 3.33 0.41 0.023 3.78 0.36 4.17 - - - 
0.56 0.029 3.21 0.34 0.020 4.56 - - - - - 
4 0.77 0.067 2.60 0.26 0.023 5.96 0.26 5.19 0.61 0.065 2.79 
0.79 0.059 2.53 0.25 0.024 5.54 0.25 5.80 0.59 0.057 3.05 
0.73 0.048 2.67 0.25 0.020 4.14 0.25 5.60 0.57 0.065 3.25 
Mean 0.73 0.048 2.47 0.36 0.025 4.15 0.37 3.87 0.60 0.052 2.80 
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concentrations varying from less than 0.5 per cent 
to 3 per cent and measurements of cerebral flow 
were made at each increase in gas concentration. 
RESULTS 
The results of the first four experiments are shown 
in table I. The mean values for blood flow, oxygen 
uptake and cerebrovascular resistance (c.v.r.) are 
given in table II. In each experiment halothane 
caused a fall in blood flow from 32 to 60 per cent 
of the flow during nitrous oxide anaesthesia. The 
cerebrovascular resistance rose on an average by 
50 per cent and the cerebral oxygen uptake fell 
by 49 per cent. There was no significant difference 
in the results obtained under halothane and air 
compared with halothane and 100 per cent oxygen. 
TABLE II 
Means of the results obtained for cerebral blood flow, 
cerebral oxygen uptake and cerebrovascular resistance in 
experiments one to four. 
Grand means Nitrous oxide Halothane 
Blood flow ml /g /min 0.68 0.37 
Oxygen uptake ml /g /min 0.050 0.025 
Cerebrovascular resistance 2.60 3.99 
*Statistically significant difference (P < 0.01) 








T5 =43 secs. 
2 Flow= 0488mligmimin. 











T% = 91 secs. 
Flow= 0.42 ml. /gm. /min. 
Pco2 r 39 mmHg. 
IT t t 
0---120 150 200 250 300 
Time-seconds. 
FIG. 1 
Semilogarithmic plots of two clearance curves obtained 
from experiment 2. 
TABLE III 
Values for blood pressure, arterial pH, Pco2 and oxygen saturation and cerebral venous oxygen saturation during each 
measurement of cerebral blood flow. 
Exp. 
No. 










































1 150 7.38 33 95 52 140 7.36 36 89 54 135 7.35 36 100 58 160 7.32 41 87 59 
155 7.35 36 94 55 140 7.35 36 93 51 135 7.35 33 100 61 155 7.34 35 92 53 
155 7.34 36 89 53 
2 158 7.29 39 100 85 110 7.27 39 - - 150 7.37 40 99 51 
162 7.28 41 100 85 110 7.31 34 - - 150 7.46 27 98 49 
160 7.28 38 98 76 
3 180 7.31 40 99 69 155 - - 96 71 155 7.32 39 100 79 180 7.33 33 93 63 
180 7.29 40 97 69 155 7.28 46 94 67 150 7.29 37 100 81 
180 7.28 41 97 71 155 7.28 46 96 67 
4 200 7.38 36 99 55 155 7.43 32 98 54 135 7.39 37 100 70 170 7.34 44 99 45 
200 7.38 36 99 61 155 7.39 38 96 52 145 7.39 36 100 61 180 7.36 43 91 42 
195 7.40 28 99 65 145 7.34 45 96 71 140 7.37 43 100 65 185 7.36 45 98 40 
Mean 173 7.33 37 97 66 150 7.35 40 95 61 135 7.34 37 100 68 166 7.36 39 95 50 
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Semilogarithmic plots of two clearance curves 
obtained from experiment 2 are shown in figure 1. 
The other parameters measured are shown in 
tables III and IV. Figure 2 is a histogram to show 
the effects of halothane on flow, oxygen uptake 
and cerebrovascular resistance, expressed as per- 
centage increases or decreases of the values 
obtained during preceding nitrous oxide anaes- 
thesia. 
Halothane anaesthesia caused an average fall of 
18 per cent in mean arterial blood pressure from 
the values obtained under nitrous oxide (range 10 
to 32.5 per cent). The lowest mean blood pressure 
during any flow measurement was 110 mm Hg. 
There was no significant difference in the arterial 
carbon dioxide tensions, the arterial oxygen satura- 
tions or the cerebral venous oxygen saturations be- 
tween nitrous oxide and halothane. 
TABLE IV 
Means of values of blood pressure, arterial pH, Pco,, 
oxygen saturation and cerebral venous oxygen saturation 
in experiments 1 to 4. 
Grand means Nitrous oxide Halothane 
Blood pressure (mm Hg) 170 142* 
Arterial pH 7.34 7.34 
Arterial Pco, (mm Hg) 37.6 38.3 
Arterial oxygen 
saturation (% sat.) 96.4 97.2 
Venous oxygen 
saturation (% sat.)t 59.9 641 
0.2 >P >0.1 
















The columns represent the changes in the mean values 
for cerebral blood flow, cerebral oxygen uptake and 
cerebrovascular resistance during halothane -air, halo - 
thane- oxygen and nitrous oxide after halothane anaes- 
thesia expressed as percentage increases or decreases 
of the values obtained during preceding nitrous 
oxide anaesthesia. It will be seen that the large changes 
found during halothane administration returned 
almost completely to their pre -existing levels after 
withdrawal of halothane. 
Table V shows the effect of different levels of 
halothane anaesthesia on the blood flow and cere- 
brovascular resistance. There is no significant 
alteration in blood flow at inspired concentrations 
of halothane ranging from less than 0.5 per cent 
to 3 per cent. With 3 per cent halothane there is, 
TABLE V 














Less than 130 7.35 46 0.46 2.82 
0.5 130 7.35 46 0.38 3.42 
0.5 120 7.34 48 0.41 2.93 
120 7.38 42 0.41 2.93 
1.0 110 7.39 40 0.35 3.14 
1.5 100 7.38 42 0.42 2.32 
2.0 100 7.40 38 0.34 2.94 
3.0 75 7.38 34 0.38 1.98 
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TABLE VI 
The results for cerebral blood flow obtained when the arterial Pco2 was raised and lowered under halothane anaesthesia. 
Exp. 
No. 
Nitrous oxide Halothane oHalothane + 4% carbon dioxide 
oHalothane -I- 
6% carbon dioxide 
Halothane + 

































1 0.70 36 0.47 35 0.80 58 - - 0.92 102 - 
2 0.76 37 0.42 37 0.65 61 - - - - - - 
3 0.68 39 0.28 39 0.48 54 0.65 81 - - 0.27 I 22 
however, a fall in cerebrovascular resistance due to 
compensatory vasodilatation associated with a fall 
in mean arterial blood pressure. 
Table VI shows the effect of the inhalation of 
varying concentrations of carbon dioxide and of 
hyperventilation on the cerebral blood flow under 
halothane anaesthesia. Inspired concentrations of 
carbon dioxide of 4 to 6 per cent were found to 
restore the cerebral blood flow to control levels. 
Hyperventilation did not produce any significant 
further decrease in blood flow. 
DISCUSSION 
Background. 
Among the general anaesthetic drugs, only thio- 
pentone (Pierce et al., 1962) and ether (Schmidt 
and Hendrix, 1937) have been carefully investi- 
gated with regard to their effects on cerebral 
haemodynamics. Thiopentone has been shown to 
be associated with cerebral vasoconstriction while 
vasodilatation occurs with ether. There seem to 
have been no measurements made of the cerebral 
vascular effects of halothane. In the absence of 
direct measurements there has been a tendency to 
assume that halothane is a cerebral vasodilator 
(Wylie and Churchill- Davidson, 1960). Clinically, 
however, anaesthetists and surgeons have noted the 
good operating conditions produced by halothane 
in neurosurgery and have ascribed these to reduced 
brain size and lower brain tension. 
In this study we have found a reduction in the 
cerebral blood flow of approximately 46 per cent, 
an increase in cerebrovascular resistance of 50 per 
cent and a decrease in cerebral oxygen uptake 
(CMRO,) of 49 per cent, all these results being 
statistically significant. 
Technique. 
It has been demonstrated that the krypton 85 
clearance method reflects faithfully the marked 
changes which occur in arterial blood flow with 
alterations in arterial carbon dioxide tension 
(Ingvar and Lassen, 1962; Harper, Glass and 
Glover, 1961). In our experiments the fall in blood 
flow under halothane anaesthesia was of the same 
order as that which accompanies prolonged hyper- 
ventilation. However, halothane anaesthesia causes 
reduction in two other variables which might in- 
fluence the cerebral blood flow, namely blood pres- 
sure and cardiac output. In discussing the possible 
influence of these variables on our results, constant 
reference will be made to the importance we attach 
to the demonstration of the raised cerebrovascular 
resistance under halothane anaesthesia. The ce e- 
brovascular resistance is defined as the ratio of the 
cerebral blood pressure gradient (arterial minus 
venous blood pressure) to the blood flow. In these 
experiments we have ignored the venous pressure 
as its value, compared with the arterial pressure, 
is extremely low. With a constant arterial blocd 
pressure and an increase in cerebral blood flow, 
the cerebrovascular resistance will fall, indicating 
vasodilatation of the cerebral blood vessels. Simi- 
larly with a constant blood pressure, but a decrease 
in blood flow, the cerebrovascular resistance will 
rise, indicating vasoconstriction. Again if both 
blood pressure and blood flow decrease, but the 
latter proportionately more than the former, the 
cerebrovascular resistance will again rise indicating 
vasoconstriction. The cerebrovascular resistance 
can only be expressed quantitatively in mm Hg if 
the pressure in the artery immediately proximal to 
the organ or tissue where flow is being measured 
is known. Our blood pressure measurements were 
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made in the aorta but we have shown that this pres- 
sure is identical with that in the carotid artery and 
are sure that it bears a constant relationship to that 
in the artery supplying the area of cortex under 
view. 
Hypotension. 
Halothane causes a fall in arterial pressure and 
the dog seems to be at least as sensitive to this 
action of the drug as man. The average mean 
blood pressure in these dogs dropped from 173 to 
141 mm Hg on changing from nitrous oxide to 
halothane, an average drop of about 18 per cent. 
Could this degree of blood pressure reduction 
account for any part of the lowered flow demon- 
strated? 
Stone, MacKrell and Wechsler (1955) showed 
that during controlled hypotension with hexame- 
thonium bromide producing an average reduction 
of 44 per cent in mean arterial pressure (i.e. more 
than twice the average reduction in blood pressure 
on these dogs), the cerebral blood flow remained 
at prehypotensive levels, due to compensatory 
cerebral vasodilatation. Similarly, Crumpton and 
Murphy (1952) found no decrease in cerebral flow 
with hypotension, which they ascribed to a com- 
pensatory reduction in cerebrovascular resistance. 
In dogs, using the technique described in this 
paper, Harper and Bell (1963) found that the mean 
arterial blood pressure could be lowered from 150 
to 90 mm Hg without causing any reduction in 
cortical blood flow. The lowest mean pressure 
during any flow measurement in this series was 
110 mm Hg. The results of Morris et al. (1953) 
are at variance with the above, for they found a 
decrease in cerebral blood flow of 30 per cent fol- 
lowing a reduction in mean arterial pressure of 39 
per cent. What all these authors do agree on, how- 
ever, is that there is a decrease in cerebrovascular 
resistance with hypotension, which either com- 
pletely or partially maintains normal cerebral blood 
flow. Indeed Lassen (1959) states: "Within a wide 
pressure range, the cerebral blood flow is inde- 
pendent of changes of the arterial blood pressure ". 
In the results presented here, halothane caused a 
much smaller blood -pressure drop, i.e. 18 per cent, 
a much greater drop in cerebral blood flow (46 
per cent) and a large rise in cerebrovascular resis- 
tance (50 per cent). We can, therefore, assume 
that this degree of hypotension contributed little, 
if anything, to the reduced cerebral flow found. 
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It is interesting that in the dog subjected to deep 
halothane anaesthesia there was, at an inspired 
concentration of 3 per cent, a reduction in cere- 
brovascular resistance of approximately 30 per cent 
compared with the level at 2 per cent and this was 
associated with a marked drop in blood pressure. 
This suggests that although cerebral blood flow is 
lowered by halothane, the ability to maintain this 
reduced flow in the face of serious hypotension is 
preserved. 
Cardiac output. 
The reduction in cardiac output, which may 
occur during halothane anaesthesia (McGregor et 
al., 1958; Severinghaus and Cullen, 1958; Wyant 
et al., 1958), must be considered in evaluating 
these results. Stirling et al. (1960) have shown 
that all concentrations of halothane impair right 
ventricular function but that the impairment is not 
severe below an inspired concentration of 1.5 per 
cent. McGregor et al. (1958) found a reduction in 
cardiac output of 16.4 per cent at an inspired con- 
centration of 1 per cent, while Severinghaus and 
Cullen (1958) found a reduction of 31 per cent 
using positive pressure ventilation but with an in- 
spired concentration of 1.5 per cent. It therefore 
seems improbable that the reduction in cardiac 
output produced by the concentration of halothane 
used (0.5 per cent or less) could account for the 
observed reduction in cerebral flow. 
Possible Mechanisms of the Cerebral 
Vasoconstrictive Effect of Halothane 
Anaesthesia 
The effects of carbon dioxide. 
A lowering of the arterial carbon dioxide tension 
is well known to produce vasoconstriction of the 
cerebral blood vessels (Kety and Schmidt, 1946); 
indeed hypocapnia is usually considered to be the 
most potent constrictor of the cerebral vascular 
tree known and yet a similar degree of constric- 
tion was repeatedly produced in these dogs by 
light halothane anaesthesia, in the presence of a 
carefully controlled normal Pco,. When hyper- 
ventilation was added to the halothane anaesthesia, 
a lowering of the arterial Pco, to a level of 22 mm 
Hg did not produce further constriction. We were 
able to show that in order to reverse the vasocon- 
strictive action of halothane it was necessary to 
raise the Pco, to a level between 50 and 80 mm Hg. 
The effects of oxygen. 
A high arterial Po_ causes cerebral vasoconstric- 
tion leading to a reduction in cerebral blood flow 
of about 12 -15 per cent (Sokoloff, 1959). In our 
results there was no difference between the flow 
during halothane- oxygen as compared with halo- 
thane -air anaesthesia, possibly because halothane 
has produced near maximal constriction. 
It might be suggested that our flow comparisons 
with nitrous oxide anaesthesia were fallacious be- 
cause of hypoxic cerebral vasodilatation during 
anaesthesia with this agent. However, measure- 
ments of arterial saturation during each flow 
measurement ruled out this possibility. 
Direct action on the vessel wall. 
Halothane might produce constriction of cere- 
bral arteries and arterioles by a direct action on 
the vessel wall. Burn and Epstein (1959), demon- 
strated by cross -perfusion experiments that the 
direct action of halothane on the arteries of the 
dog's hind limb is vasodilatation. However, it is 
probably a mistake to extend observations made on 
other parts of the vascular tree to the cerebral cir- 
culation, which is unique in many of its physiolo- 
gical and pharmacological responses (Sokoloff, 
1959). Wyant and colleagues (1958) showed an 
increase in pulmonary vascular resistance during 
halothane anaesthesia, a part of which was 
ascribed to active pulmonary vasoconstriction, so 
that the cerebral circulation would not be quite 
unique if it responded in this way. 
Autonomic vascular control. 
Halothane might produce vasoconstriction by 
sympathetic stimulation, by sensitization of the 
vessel walls to tonic sympathetic impulses, by in- 
creasing the level of circulating catechol amines or 
increasing the vessel sensitivity to these amines or 
by inhibition of parasympathetic vasodilatory 
impulses. 
Sympathetic stimulation could not account for 
the large decrease in cerebral blood flow found, 
for it is widely agreed that sympathetic vasocon- 
striction of cerebral vessels is weak (Sokoloff, 
1959). Blockade of the stellate ganglia in man 
produces no increase in cerebral flow (Harmel et 
al., 1949), so that potentiaticn of tonic sympathetic 
impulses by halothane is improbable. 
Measurements of catechol amines during halo- 
thane anaesthesia indicate no increase in their 
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concentrations in the blood (Price et al., 1959; 
Hamelberg et al., 1960; Black and McArdle, 
1962). 
Vasodilator fibres supplying the cerebral vascul- 
ature have been demonstrated to travel in the facial 
nerve and then in the greater superficial petrosal 
nerve to reach the internal carotid plexus (Chorob- 
ski and Penfield, 1932). The effects of halothane on 
the parasympathetic ganglia are in dispute; on one 
hand it is argued that the observed bradycardia 
signifies lack of block (Stephen et al., 1958), while 
on the other, the depression of salivation is con- 
sidered as evidence of such blockade. In any case, 
Sokoloff feels that there is no convincing evidence 
of significant resting vasodilatory tone, so that 
halothane blockade, if it occurred, would have little 
effect. 
Lowered tissue Pco,. 
In face of these unlikely alternative explana- 
tions, we consider that the decrease in cerebral 
blood flow is due to the reduction in the cerebral 
metabolic consumption of oxygen which Pierce et 
al. (1962) found with thiopentone, and we have 
found with halothane. This leads to a decrease in 
carbon dioxide production by the cells so tending 
to lower the cerebral intracellular Pco_, and this 
causes vasoconstriction of the vessels supplying 
these cells, either by a local axon reflex or by a 
direct action of the lowered Pco, on the vessel 
walls. 
Far from disproving this hypothesis, the demon- 
stration by Pierce and his colleagues of an un- 
changed jugular venous Pco, surely argues strongly 
for the efficiency of this homeostatic mechanism. 
The adjustment of flow to metabolic demand in 
this way is, of course, merely an extension of the 
method of local control of cerebral blood flow 
which operates under normal physiological condi- 
tions. 
The observations, admittedly only in one dog, 
that the reduction in blood flow and oxygen con- 
sumption did not increase with deepening anaes- 
thesia are intriguing. Firstly, this lends further 
support to the suggestion that the cerebral flow 
reduction observed in light halothane anaesthesia 
is not dependent on hypotension or lowered cardiac 
output, for, if it were, the flow reduction would 
have been progressive with deepening anaesthesia. 
Secondly, the compensatory responses to serious 
hypotension are not blocked by halothane. 
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Cerebral oxygen uptake. 
The evaluation of the effects of halothane on 
cerebral metabolic requirements for oxygen is, of 
course, of great significance in the presence of the 
46 per cent reduction in blood supply. We have 
found that oxygen requirements are reduced pari 
passu with the reduction in blood flow. The 
decrease in cerebral oxygen uptake is of the same 
order as that observed under thiopentone anaes- 
thesia (Pierce et al., 1962). In no case was signi- 
ficant venous desaturation observed, so that tissue 
Po_ was presumably within normal limits. These 
results, i.e. 46 per cent reduction in flow and a 
49 per cent reduction in oxygen uptake, give added 
support to the mechanism suggested for the vaso- 
constriction found. 
CONCLUDING REMARKS 
In view of this evidence and that quoted for thio- 
pentone, and remembering the normal mechanism 
for cerebral blood flow control we feel that it is 
possible that all potent general anaesthetic agents, 
intravenous and inhalational, will prove to be con- 
strictors of the cerebral vasculature and that this 
action will be shown to be secondary to the reduc- 
tion in cerebral oxygen consumption which these 
agents probably produce. The only possible excep- 
tions to this hypothesis will, we think, be agents 
like ether with a pronounced local dilatating effect. 
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CIRCULATION SANGUINE CÉRÉBRALE 
PENDANT L'ANESTHÉSIE AU HALOTHANE 
SOMMAIRE 
La circulation sanguine cérébrale a été mesurée par 
les auteurs sur le chien selon la méthode de Lassen 
et Ingvar (1961) et d'Ingvar et Lassen (1962) utilisant 
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la mesure de la rapidité d'élimination de 85 krypton 
d'une région du cortex cérébral dégagée après injec- 
tion du Kr dans l'artère carotide interne. Chaque 
mesure prise pendant l'anesthésie à l'halothane montra 
une réduction considérable de la circulation sanguine 
du cerveau comparativement à celle maintenue par 
l'oxyde nitreux et par l'oxygène: La réduction 
moyenne était de 46 %, s'accompagnant d'une augmen- 
tation de 50% de la résistance cérébro- vasculaire. Les 
auteurs ont mesuré également l'absorption de l'oxygène 
(CMRO,) et ils ont alors constaté que l'halothane 
diminua ce dernier également de 49 %. Ils discutent le 
mécanisme possible des résultats observés. 
DIE ZEREBRALE BLUTZIRKULATION 
WÄHREND DER HALOTHAN- NARKOSE 
ZUSAMMENFASSUNG 
Die zerebrale Blutzirkulation wurde bei Hunden nach 
der Methode von Lassen und Ingvar (1961), Ingvar und 
Lassen (1962). wobei die Clearance -Rate von Krypton 
85 von einem freigelegten Bezirk der Gehirnrinde nach 
Injektion in die Arteria carotis interna bestimmt wird. 
gemessen. Bei jeder Messung während einer Halothan- 
Narkose fand sich eine beträchtliche Abnahme der 
Blutzirkulation im Gehirn im Vergleich mit den 
Werten bei Lachgas und Sauerstoff. Die durchschnitt- 
liche Abnahme der Zirkulation betrug 46 %, und diese 
wurde von einer durchschnittlichen Steigerung im 
zerebro -vaskulären Widerstand um 50% begleitet. Es 
wurden ebenfalls Messungen der Sauerstoffaufnahme 
des Gehirns (CMRO,) vorgenommen, Halothan rief 
eine durchschittliche Abnahme der Sauerstoffaufnahme 
um 49% hervor. Die möglichen Mechanismen für die 
beobachteten Untersuchungsergebnisse werden be- 
sprochen. 
